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ABSTRACT 
Duy Pham 
 
TWIST1 AND ETV5 ARE PART OF A TRANSCRIPTION FACTOR NETWORK 
DEFINING T HELPER CELL IDENTITY 
 
CD4 T helper cells control immunity to pathogens and the development of 
inflammatory disease by acquiring the ability to secrete effector cytokines. 
Cytokine responsiveness is a critical component of the ability of cells to respond 
to the extracellular milieu by activating Signal Transducer and Activator of 
Transcription factors that induce the expression of other transcription factors 
important for cytokine production. STAT4 is a critical regulator of Th1 
differentiation and inflammatory disease that attenuates the gene-repressing 
activity of Dnmt3a. In the absence of STAT4, genetic loss of Dnmt3a results in 
de-repression of a subset of Th1 genes, and a partial increase in expression that 
is sufficient to observe a modest recovery of STAT4-dependent inflammatory 
disease. STAT4 also induces expression of the transcription factors Twist1 and 
Etv5. We demonstrate that Twist1 negatively regulates Th1 cell differentiation 
through several mechanisms including physical interaction with Runx3 and 
impairing STAT4 activation. Following induction by STAT3-activating cytokines 
including IL-6, Twist1 represses Th17 and Tfh differentiation by directly binding 
to, and suppressing expression of, the Il6ra locus, subsequently reducing STAT3 
activation. In contrast, Etv5 contributes only modestly to Th1 development but 
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promotes Th differentiation by directly activating cytokine production in Th9 and 
Th17 cells, and Bcl6 expression in Tfh cells. Thus, the transcription factors 
Twist1 and Etv5 provide unique regulation of T helper cell identity, ultimately 
impacting the development of cell-mediated and humoral immunity.  
 
 
 
Mark H. Kaplan, Ph.D.-Chair 
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INTRODUCTION 
Innate and adaptive immunity  
Immune responses that include innate and adaptive immunity are vital biological 
functions protecting the host from pathogens and toxic substances. Innate 
immunity including macrophages, neutrophils, dendritic cells, natural killer cells, 
mast cells, eosinophils, and basophils, acts as the first line of defense against 
microorganisms and infections. Adaptive immunity, requiring lymphocytes 
provides a more versatile and long-term protection. Both innate and adaptive 
immunity works in concert to provide effective and sufficient protective 
mechanisms against harmful agents in the environment.  
 
The host body is constantly exposed to microorganisms present in the 
environment. The common routes of entry are through mucosal surfaces (airway, 
gastrointestinal tract, and reproductive tract) and external epithelia (skin, wound, 
and abrasions). The host body utilizes different methods to protect against the 
pathogens. Epithelial surfaces act as the first line of defense providing 
mechanical (structure), chemical (pH and enzymes), or microbiological (normal 
flora) barriers against infection. When pathogens cross epithelial barriers, they 
are recognized and ingested by dendritic cells or ingested and killed by other 
innate cells such as macrophages and neutrophils. Dendritic cells and 
macrophages reside in the submucosal tissues. They are helped in pathogen 
clearance by the recruitment of neutrophils to the site of infection. These cells 
express receptors that recognize repeating patterns on the surface of the 
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pathogens, thus being able to pathogen-specific molecular patterns. These 
receptors, known as pattern-recognition receptors, include mannose-binding 
lectin (MBL), macrophage mannose receptor, and scavenger receptors that 
trigger phagocytosis, and Toll-like receptors (TLRs) that activate innate immune 
function and cytokine production. Upon ingestion of the pathogens, macrophages 
and neutrophils utilize several mechanisms for killing such as vesicular 
containing acidification, toxic oxygen-derived products, toxic nitrogen oxides, 
antimicrobial peptides, and enzymes. In addition, recognition of the pathogens by 
macrophages results in the initiation of an inflammatory response that helps the 
clearance of microorganisms, prevents the spread of the infection in the 
bloodstream, and promotes tissue repair. TLR activation in macrophages and 
other innate cells results in the production of pro-inflammatory cytokines (IL-1, IL-
6, IL-12, and TNFα), chemokines (CXCL8), and co-stimulatory molecules (CD80 
and CD86) that amplify innate and adaptive immune responses. Another 
component of the innate immune response is the complement system that is 
made up of many distinct plasma proteins. The complement system works by a 
series of proteolytic reactions mediated by proteases that result in recruitment of 
inflammatory cells, opsonization of pathogens, and killing of pathogens.  
 
Other innate immune cells such as natural killer (NK) cells, NKT cells, γδ T cells, 
B-1 cells, mast cells, basophils, and eosinophils are also important in innate 
immune responses. NK cells are activated by interferons (IFNs) and 
macrophage-derived cytokines to protect against intracellular infections. NK cell 
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activation results in the release of cytotoxic granules that induce apoptosis of 
target cell. NK cells express receptors for self antigens that prevent their 
activation by uninfected cells. Natural killer T (NKT) cells, γδ T cells, and B-1 cells 
belong to the group of innate-like lymphocytes. NKT cells are characterized by 
the expression of invariant T-cell receptor α chain that recognizes glycolipid 
antigens presented by CD1 molecules. NKT cells exist in the thymus and in 
peripheral lymphoid organs that secrete IL-4, IL-10, and IFNγ and have 
regulatory function. γδ T cells are a subset of the T cells with antigen receptors 
composed of γ and δ chains. γδ T cells are found in the lymphoid and epithelial 
tissues, respond to antigens through mechanism that are still not entirely defined. 
B-1 cells are subset of B cells that express CD5 receptor. B-1 cells produce 
antibodies in response to carbohydrate antigens in a T-cell independent 
mechanism. Mast cells, basophils, and eosinophils arise from myeloid 
progenitors and have various distinct roles in innate immune responses. While 
mast cells and basophils defend against pathogens and wound healing by 
releasing granules containing histamine and active agents, eosinophils release 
toxic proteins, and free radicals to kill antibody-coated parasites. In addition, 
these cell types play important roles in mediating allergic reactions.  
 
Although innate immunity is often sufficient to protect against foreign pathogens, 
it fails to provide a specific and long-term protection against recurrent invaders. 
Thus, adaptive immunity, requiring T and B lymphocytes primed by antigen 
presenting cells (B cells, dendritic cells, and macrophages) play a crucial role in 
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eliminating pathogens when the innate immune system is insufficient to limit 
infection. The main functions of the adaptive immunity are to discriminate 
between self- and non-self- antigens, to regulate inflammatory responses and 
eliminate specific pathogens, and to develop immunological memory. T and B 
cells express T- and B-cell receptors (TCR and BCR, respectively) to recognize 
antigen. B-cell receptors are composed of membrane-bound and secreted 
immunoglobulin (Ig). While membrane-bound immunoglobulin acts as receptor 
for antigen, the secreted Ig binds antigens and elicits humoral effector functions. 
One unique function of TCR and immunoglobulins is their ability to recognize 
variable molecules with high specificity and affinity through the variable (V) 
region that binds to antigens. However, TCR (composed of TCRα and TCRβ 
chains) on T cells differs from BCR on B cells in that it recognizes peptide 
fragments of foreign proteins bound to the major histocompatibility complex 
(MHC) molecules class I and class II. The two classes of MHC molecule are 
expressed differentially on cells that present antigens to CD4 (MHC class II) and 
CD8 (MHC class I) T cells. CD8 T cell function is to eliminate intracellular 
pathogens such as viruses through T cell-mediated cytotoxicity of infected cells. 
CD8 T cells induce infected cells to undergo programmed cell death, secrete 
proteins (perforin, granzymes, and granulysin) to trigger apoptosis, and express 
Fas ligand to activate apoptosis. In contrast, CD4 T cells provide helps to other 
cells to carry out effector functions, and are known as T helper (Th) cells (Figure 
1). For example, Th1 cells activate macrophages to become more efficiently in 
clearing intracellular microorganisms. Th2 cells play a role in controlling defense 
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against extracellular parasites. Th9 cell function is to provide protection against 
helminth infection, although IL-9 can be involved in autoimmune diseases and 
allergic inflammation. Th17 cells produce IL-17 cytokine that plays important role 
in inflammation and anti-microbial immunity. Regulatory T (Treg) cells are 
important in maintaining tolerance to self-antigens and play a crucial role in 
autoimmune diseases. A recently described subset of T helper cells, known as T 
follicular helper (Tfh) cells, specializes in helping B cells to differentiate into 
plasma cells that secrete high affinity and specificity antibodies to mediate 
humoral immune responses against extracellular pathogens. The role of other T 
helper cell subsets will be discussed in the subsequent sections.  
 
Altogether, the innate and the adaptive immune responses create an effective 
barrier to pathogens and environmental toxins.  
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Figure 1. Model of T helper cells 
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JAK-STAT pathway  
Responsiveness to the extracellular milieu is a core component of the 
adaptability of the immune system. Cytokines mediate intracellular 
communication and can promote the differentiation and proliferation of 
responsive cells. One of the signaling pathways activated by cytokines is the 
Janus kinase (JAK)/signal transducer and activator of transcription (STAT) 
pathway that was discovered during studies of gene induction by interferons 
(IFNs) (Darnell et al., 1994). There are four members of the JAK family including 
JAK1, JAK2, JAK3, and tyrosine kinase 2 (TYK2) with conserved kinase domain 
(Stark et al., 1998). There are seven members of the STAT family including 
STAT1, STAT2, STAT3, STAT4, STAT5A, STAT5B, and STAT6 (Darnell, 1997). 
The role of STAT proteins in T helper cell development will be discussed in the 
subsequent sections.  
 
The structure of STAT proteins includes a DNA-binding domain, a transactivation 
domain, and a SRC homology 2 (SH2) domain. In the JAK/STAT signaling 
pathway, receptor dimerization and subsequent activation of JAK tyrosine 
kinases occurs upon the binding of a cytokine to the cell surface receptor. 
Activated JAKs phosphorylate specific residues on the receptor to create a 
docking site for STAT binding. STATs are phosphorylated by JAKs, then 
dimerize, leave the receptor, translocate to the nucleus, and activate gene 
transcription (Figure 2) (Shuai and Liu, 2003). Because of the important role of 
the JAK/STAT pathway in controlling immune responses, it is tightly regulated at 
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several levels. JAKs are regulated at the post-translational level by suppressor of 
cytokine signaling (SOCS) proteins, protein tyrosine phosphotases (PTP), and by 
ubiquitylation and ISGylation (Shuai and Liu, 2003). SOCS regulates JAK by 
inhibiting JAK kinase activity or by binding directly to the activated receptor 
(Croker et al., 2008). PTPs dephosphorylate JAKs thus inhibiting signaling (Xu 
and Qu, 2008). Ubiquitylation of JAKs results in degradation (Ungureanu et al., 
2002), but it is not known how JAKs are regulated by ISGylation. STATs are 
regulated at the post-translational level by modifications including 
phosphorylation, methylation, acetylation, ubiquitylation, ISGylation, and 
sumoylation that each alter STAT function in dimerization, nuclear translocation, 
DNA binding, and transactivation (Shuai and Liu, 2003). In addition, STATs are 
regulated by the Protein Inhibitor of Activated STAT (PIAS) family that has been 
shown to inhibit STAT-mediated gene activation (Chung et al., 1997; Liu et al., 
1998). 
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Figure 2. Activation of the JAK-STAT pathway following cytokine 
stimulation 
 
Dysregulation of JAK/STAT signaling pathway results in defects in immune 
responses. For example, STAT1 mutations have been documented in patients 
with susceptibility to viral and mycobacterial infections (O'Shea et al., 2011). 
Patients with hypermorphic mutations in STAT1 are susceptible to autoimmunity, 
cerebral aneurysms, and squamous-cell carcinoma (O'Shea et al., 2013). 
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T cells is correlated with Crohn’s disease (Lovato et al., 2003). Stat4-deficient 
mice have been linked with increased nephritis and mortality in a model of lupus 
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Mycobacterium tuberculosis, Babesia, Leishmania major, L. mexicana, T. gondii, 
and Trypanosoma cruzi (Watford et al., 2004). STAT4 mutation with a defect in 
nuclear translocation is associated with recurrent M. avium infection in patients 
(Toyoda et al., 2004). In addition, polymorphisms of STAT4 have been described 
in multiple studies and are associated with diseases such as systemic lupus 
erythematosus (SLE), rheumatoid arthritis, Sjogren’s syndrome, and Crohn’s 
disease (O'Shea et al., 2011). Given that STAT5B plays important roles in 
regulating IL-2 and growth-hormone signaling and Treg cell differentiation, 
dysregulation of STAT5B has been linked with immunodeficiency and 
autoimmune diseases (Cohen et al., 2006; Imada et al., 1998; Udy et al., 1997; 
Yao et al., 2007). Patients that lack STAT5B have severe opportunistic infections 
and elevated levels immunoglobulins (O'Shea et al., 2013). STAT6 is required for 
the development of allergic inflammation and immunity to helminth parasites. As 
the result, Stat6-mutant mice have decreased pulmonary inflammation and 
increased inflammatory immunity. In addition, polymorphisms of STAT6 are 
associated with allergic disease (Goenka and Kaplan, 2011). 
  
In summary, JAK/STAT pathway plays a crucial role in controlling the immune 
responses and is highly regulated to prevent immune disorders.   
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Transcriptional regulation of Th1 cells 
Th1 cells are critical regulators of inflammation and play obligate roles in 
immunity to intracellular pathogens and in the development of autoimmune 
inflammation (Kaplan, 2005; Watford et al., 2004). Th1 development initiates 
when a T cell, activated by antigen in the context of MHC class II molecules, is 
stimulated by IL-12 and IFNγ (Afkarian et al., 2002; Hsieh et al., 1993; Wenner et 
al., 1996). IL-12 and IFNγ stimulation result in the phosphorylation of STAT4 and 
STAT1 respectively, both transcription factors that are required for optimal Th1 
differentiation (Afkarian et al., 2002; Kaplan et al., 1996a; Thierfelder et al., 
1996). The Tbx21 gene, encoding the T-box transcription factor T-bet, is a critical 
target for both factors, with STAT1 binding early in differentiation, and STAT4 
binding later (Lighvani et al., 2001; Schulz et al., 2009; Yang et al., 2007). STAT4 
and T-bet are required for the expression of many genes expressed in Th1 cells, 
although both factors activate the expression of a subset of Th1 genes in the 
absence of the other factor (Thieu et al., 2008). IFNγ production is the hallmark of 
Th1 cells, and both STAT4 and T-bet, in cooperation with other transcription 
factors including Hlx1 and Runx3, activate expression from the Ifng locus (Figure 
3) (Djuretic et al., 2007; Mullen et al., 2002). 
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Figure 3. The transcriptional network in Th1 cells 
 
STAT4 binds a multitude of DNA sequences throughout the genome, and 
genome-wide studies have begun to define targets in Th1 cells. Using a 
chromatin immunoprecipitation (ChIP)-on-chip approach, STAT4 was found to 
bind at least 1500 sites in the 10 kb span around murine promoters in response 
to acute IL-12 stimulation in differentiating T cells (Good et al., 2009). Using a 
ChIP-seq approach in differentiated Th1 cells, STAT4 bound almost 4500 sites, 
with slightly over one-third located in the promoter regions, providing a good 
concordance of the two studies (Good et al., 2009; Wei et al., 2010). Both studies 
found the STAT consensus sequence TTCN3GAA in the majority of bound sites. 
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Despite this, numerous genes that bound STAT4 were not induced by IL-12 
stimulation, and for genes that were induced, there was no correlation between 
the peak intensity of STAT4 binding to a site and the fold induction of the 
associated gene (Good et al., 2009; Wei et al., 2010). Thus, although we now 
have a detailed appreciation for STAT4 target genes in Th1 cells, it is still not 
clear how STAT4 activates long-lasting changes in Th1 gene expression. 
 
Epigenetic events that include DNA methylation and histone modification play a 
key role in T cell differentiation. DNA methyltransferase (DNMT) enzymes 
catalyze DNA methylation at CpG dinucleotides, resulting in gene repression in T 
helper cells (Allis et al., 2007; Kouzarides, 2007b; Pekowska et al., 2011; Yu et 
al., 2007; Yu et al., 2012). Histone modifications that occur at the tails of the core 
histones include methylation, acetylation, phosphorylation, sumoylation, and 
ubiquitination. The addition and removal of histone marks alter chromatin into 
either an active or repressed state correlating with the amount of transcription at 
the locus. Tri-methylation of histone H3 lysine 4 (H3K4) correlates with active 
gene transcription (Kouzarides, 2007a). Acetylation of histones at specific lysine 
residues (H3K9, K18, K27 and K36) result in decreased association with DNA 
and greater access for trans-acting factors (Kouzarides, 2007a; Shahbazian and 
Grunstein, 2007). In contrast, tri-methylation of histone H3 lysine 27 (H3K27) is 
associated with gene repression (Kouzarides, 2007a; Shahbazian and Grunstein, 
2007). Histone modifying enzymes are recruited to DNA by transcription factors 
and are able to recognize histone marks thus allowing the extension of histone 
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modification across adjacent regions of the target locus (Kouzarides, 2007a). For 
example, Jumonji C domain protein (Jmjd3) is a histone demethylase that 
specifically removes the methyl group of H3K27 methylation. The result is gene 
activation involving in developmental processes and the inflammatory responses 
(Swigut and Wysocka, 2007).  
 
Once STAT4 is bound to a locus, it can recruit other transcription factors and 
chromatin modifying enzymes. At the Il2ra locus, STAT4 is responsible for the 
recruitment of c-Jun-containing complexes and the histone acetyltransferase 
CBP (O'Sullivan et al., 2004). In the absence of STAT4, IL-12 does not induce 
histone acetylation at the Il2ra locus (O'Sullivan et al., 2004). At the Il18r1 locus, 
STAT4 is required for global histone acetylation, H3K9 acetylation, H3K4 di- and 
tri-methylation, and for limiting H3K27 tri-methylation (Yu et al., 2008; Yu et al., 
2007). Genome wide analysis of STAT4 binding sites also found a requirement 
for STAT4 in H3K4me3 (Wei et al., 2010). At the Ifng and IL12Rβ2 loci, STAT4 
recruits BAF-containing SWI/SNF complexes that are required for nucleosome 
remodeling (Letimier et al., 2007; Zhang and Boothby, 2006). The Ifng locus 
contains multiple regulatory elements and conserved non-coding sequence 
(CNS) within 60-70 kb upstream and downstream of its promoter. STAT4 and 
other STATs (including STAT1 and STAT5) have been shown to facilitate histone 
acetylation and to recruit chromatin-remodeling complexes to the Ifng locus 
resulting to the induction of permissive epigenetic modification and the activation 
of Ifng gene expression (Wilson et al., 2009a).  
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STAT4 also limits DNA methylation of the Il18r1 locus by reducing the 
association of Dnmt3a, one of the two de novo DNA methyltransferases, with the 
Il18r1 promoter, and the promoters of several additional Th1 genes (Yu et al., 
2007). T cells deficient in Dnmt3a, but not Dnmt3b, the other de novo DNA 
methyltransferase, have increased IFNγ production and increased flexibility in 
their ability to switch from Th2, Th17 or Treg cultures to an IFNγ-secreting 
phenotype. Dnmt3a also represses alternative lineage gene expression in Th1 
cells. The Il13 locus is particularly sensitive to Dnmt3a-deficiency, and GATA3 
can more effectively induce Il13 expression in Dnmt3a-deficient Th1 cells than in 
wild type Th1 cells (Yu et al., 2012). Thus, Dnmt3a is required for appropriate 
gene repression in T helper subsets. Collectively, epigenetic modification 
mediated by multiple factors is essential for Th1 cell differentiation (Figure 4).  
 
Figure 4. Schematic diagram of the Ifng gene 
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Transcriptional regulation of Th2 cells 
T helper type 2 (Th2) cells are important for host immunity to extracellular 
parasites. Th2 cells mediate function through the production of IL-4, IL-5, IL-13, 
and IL-25. Defects in Th2 cell development result in asthma and other allergic 
inflammatory diseases. Th2 cell differentiation occurs under the presence of IL-4 
and anti-IFNγ. IL-4 activates STAT6 that directly binds to gene encoding 
transcription factors including GATA3, Gfi-1, BATF, and Runx1. While GATA3 is 
a Th2 master transcription factor and Gfi-1 and BATF are required for its optimal 
cell expansion, Runx1 represses GATA3 expression thus inhibiting Th2 cell 
differentiation (O'Shea et al., 2011; Zhu et al., 2002). Other signaling pathways 
such as β-catenin and T cell factor 1 (TCF1) have been reported to contribute to 
Th2 cell differentiation through the induction of GATA3 expression in an IL-4-
independent manner (Paul and Zhu, 2010). Other STAT proteins also promote 
the differentiation of Th2 cells. IL-2-STAT5 signaling pathway has been shown to 
be important in regulating Th2 cell differentiation, and that both GATA3 and 
STAT5 bind to regulatory elements in the Th2 cytokine loci (Zhu et al., 2003). In 
addition, STAT3 activation has been detected in Th2 cell development, and that 
STAT3 is required for STAT6 bound to target genes in Th2 cells (Stritesky et al., 
2011). Mice with Stat3-deficient T cells display reduced inflammation in a mouse 
model of allergic airway inflammation (Stritesky et al., 2011). Thus, the 
integration of multiple STAT proteins and transcription factors is required for 
optimal Th2 cell development (Figure 5).  
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Figure 5. The transcriptional network in Th2 cells 
 
Originally, IL-4 was viewed as a central cytokine that acts on STAT6 in Th2 cell 
differentiation. However, other cytokines such as thymic stromal lymphopoietin 
(TSLP), IL-25, and IL-33 have been demonstrated to be important for Th2 cell 
development. TSLP produced from epithelial cells, mast cells, and basophils 
signals through TSLPR expressed on CD4+ T cells and activates STAT5 (Al-
Shami et al., 2005; Yao et al., 2013). In contrast, IL-25 is produced by Th2 cells, 
and it is suggested to be required for the balance between Th1 and Th2 cells 
during T.muris infection model (Owyang et al., 2006). IL-33 together with TSLP 
could induce the production of IL-13 without TCR signaling (Guo et al., 2009) 
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Epigenetic modifications also play an important part in regulating Th2 cell 
differentiation. The Il4, Il5, and Il13 loci contain DNase I hypersensitive sites 
located in CNS regions that are accessible by regulatory transcription factors. For 
example, STAT6 and GATA3 have been shown to bind to hypersensitive site V 
(HSV) of the Il4 and ll13 loci (Wilson et al., 2009a). GATA3 not only induces Th2 
gene transcription but also recruits histone acetyltransferases (HATs) and 
histone H3K4 methyltransferases, displacing MBD2 and associated HDCA-
containing complexes, diminishing DNMT1 association and inhibiting DNA 
methylation, and recruiting chromatin-remodeling complexes to the Th2 cytokine 
loci (Wilson et al., 2009a). Similarly, STAT3 and STAT6 are required for some 
histone modifications, accessibility of chromatin (STAT3), and recruiting HATs 
and other chromatin modifying enzymes to Th2 gene loci (Stritesky et al., 2011; 
Wilson et al., 2009a). The regulation of Th2 cytokine gene expression is 
represented below (Figure 6).  
 
Figure 6. Schematic diagram of the Th2 genes 
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Transcriptional regulation of Th9 cells 
T helper type 9 (Th9) cells have emerged as a new T helper cells in recent years. 
IL-9 is the hallmark cytokine of Th9 cells that is required for allergic inflammation 
and immunity to intestinal parasites. IL-9 has effects on various cell types such 
as smooth muscle cells, stem cells, lymphocytes, mast cells, and epithelial cells 
that are important for the development of immunity and inflammation (Goswami 
and Kaplan, 2011).  
 
Th9 cell differentiation requires both IL-4 and TGF-β signaling (Dardalhon et al., 
2008; Veldhoen et al., 2008b). IL-4 activates STAT6 that induces the expression 
of transcription factors that are important for Th9 differentiation such as GATA3, 
IRF4, and BATF (Goswami et al., 2012; Jabeen and Kaplan, 2012). STAT6 can 
promote Il9 expression, though it binds the Il9 gene poorly compared to other 
genes (Jabeen and Kaplan, 2012). In addition, STAT6 represses T-bet 
expression that together with Runx3 negatively regulates IL-9 production in Th1 
cells (Goswami et al., 2012). While IRF4 promotes Il9 expression by directly 
binding to its locus (Staudt et al., 2010), one potential GATA3 function in Th9 
cells is to repress the expression Foxp3 (Mantel et al., 2007). Th9 cell 
differentiation also requires TGF-β signaling pathway that induces PU.1 
expression (Goswami et al., 2012). PU.1 has been shown to repress Th2 cell 
development and promotes Il9 expression by directly binding to its locus 
suggesting that PU.1 is the master transcription factor that drives Th9 cell 
differentiation (Chang et al., 2010). Other cytokines and STAT protein have been 
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shown to regulate Th9 cells. TSLP activates STAT5 that directly binds and 
promotes Il9 gene expression in Th9 cells (Yao et al., 2013). Infants with atopic 
dermatitis have increased IL-9 and TLSP in the serum compared to non-atopic 
infants (Yao et al., 2013). IL-2, IL-25, and IL-1 cytokines can enhance IL-9 
production from CD4+ T cells by activating transcription factors including NF-κB 
that bind to the Il9 promoter (Jabeen and Kaplan, 2012). A transcription factor 
network of Th9 cells is summarized in Figure 7.  
 
 
Figure 7. The transcriptional network in Th9 cells 
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Epigenetic programming also plays an important role in regulating IL-9 
production in CD4+ T cells. The Il9 gene contains at least three CNS 6 kb 
upstream and downstream of the Il9 promoter that contains binding sites for 
PU.1, IRF4, GATA3, NFAT, and STAT4 proteins (Perumal and Kaplan, 2011) 
suggesting a complex regulation of Il9 that requires multiple cis-regulatory 
elements and specific trans-activating factors. In addition, PU.1 recruits and 
forms a complex with Gcn5 (a histone acetyltransferase (HAT)) resulting in an 
increased histone acetylation at the Il9 locus (Goswami and Kaplan, 2012). 
There are decreased association of p300/CBP associated factor (PCAF) and 
increased association of histone deacetylases at the Il9 locus in Th9 cells 
suggesting histone modification plays an important role in the regulation of Il9 in 
Th9 cells (Figure 8) (Goswami and Kaplan, 2012). 
 
Figure 8. Schematic diagram of the Il9 gene 
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Transcriptional regulation of Th17 cells 
T helper type 17 (Th17) cells secrete IL-17A, IL-17F, IL-21, and IL-22, and are 
primary mediators in controlling infection and promoting autoimmune diseases 
(Korn et al., 2009). Naïve CD4+ T cells differentiate into Th17 cells in the 
presence of IL-1β, TGF-β, and IL-6 while IL-23 is required for the maintenance of 
IL-17-producing cells (Harrington et al., 2005; Mangan et al., 2006; Stritesky et 
al., 2008). Cytokine stimulation results in the induction of a network of 
transcription factors including RORγt, BATF, IRF4, and other factors (Figure 
9)(Ciofani et al., 2012; Wu et al., 2013; Yosef et al., 2013). Some of the factors in 
this network are required for the development of additional Th subsets, and 
cooperate with specialized factors to promote acquisition of distinct phenotypes. 
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Figure 9. The transcriptional network in Th17 cells 
 
IL-6 and IL-23 activate STAT3 that directly binds to genes encoding transcription 
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Th17 development (Brustle et al., 2007; Durant et al., 2010; Ivanov et al., 2006; 
Manel et al., 2008; Schraml et al., 2009; Veldhoen et al., 2008a; Xu et al., 2009). 
Bcl-6 is another STAT3 target gene that has been shown to indirectly control 
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2010; Mondal et al., 2010). STAT3 promotes Il23r expression that is required for 
the development of inflammatory Th17 cells (Zhou et al., 2007). Conversely, 
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the cytokine environment. STAT5 inhibits expression of Il6ra and Il6st, limiting 
Th17 differentiation (Liao et al., 2011). STAT3 is also required for multiple T 
helper cell lineages including Th2, Th17, and Tfh (Ma et al., 2012a; Mathur et al., 
2007; Nurieva et al., 2008; Stritesky et al., 2011; Yang et al., 2008b). As part of 
its function STAT3 activates genes that are common among these lineages (Maf, 
Batf, and Irf4) and genes that are lineage-specific, such as Rorc for Th17 and 
Bcl6 for Tfh (Bauquet et al., 2009; Brustle et al., 2007; Durant et al., 2010; Ivanov 
et al., 2006; Schraml et al., 2009; Yu et al., 2009). However, a balance between 
positive and negative regulatory factors controls the differentiation of each of 
these subsets. The IL-2-STAT5 signaling pathway limits IL-17 production, and 
the balance between STAT3 and STAT5 activation determines the ability of cells 
to produce inflammatory cytokines (Durant et al., 2010; Yang et al., 2011).  
 
Il17 gene regulation is controlled by epigenetic events at multiple CNS regions 
(Figure 10). Upon Th17 cell differentiation, eight CNS in the Il17a-Il17f locus 
becomes more accessible because of the increased histone H3 acetylation and 
K4 tri-methylation at the locus (Akimzhanov et al., 2007). CNS2 has been 
reported to interact with both Il17a-Il17f promoters and is required for their 
transcription in Th17 cells (Wang et al., 2012). Moreover, Wang et al. showed 
that CNS2 is required for the recruitment of histone-modifying enzymes p300 and 
Jmjd3 to the Il17a-Il17f locus.  
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Figure 10. Schematic diagram of the Il17 gene 
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Transcriptional regulation of T regulatory cells 
Regulatory T (Treg) cells are unique in the ability to maintain immunological self-
tolerance and homeostasis by suppressing various effector lymphocytes. There 
are two types of Treg cells: natural Treg (nTreg) cells that arise in the thymus 
early in the development and inducible Treg (iTreg) cells that develop in the 
peripheral lymphoid organs upon TCR engagement or antigen presented in an 
inappropriate mileu. Treg cells are characterized by the expression of Ctla4, Il2ra 
and transcription factor Foxp3, a master regulator of its functions (Hori et al., 
2003; Ohkura et al., 2013). Mutation or deletion of Foxp3 results in 
immunodysregulation polyendocrinopathy enteropathy X-linked syndrome with 
autoimmune diseases in human and fatal systemic autoimmunity in mice (Ohkura 
et al., 2013).  
 
In addition to Foxp3 that controls Treg cell development, Bcl-6 has been shown 
to indirectly regulate Treg cell function by potently repressing Gata3 
transcriptional transactivation (Sawant et al., 2012). Although the suppression 
function of Bcl6-/- Treg cells are normal compared to wild type cells in the Th1-
type colitogenic T cell responses in vivo, Bcl6-/- Treg cells fail to control Th2 
responses in a model of allergic airway disease resulting in increased lung 
inflammation (Sawant et al., 2012). Runx1 belongs to the Runx family and 
controls IL-2 production in Treg cells through the association with Foxp3 (Ono et 
al., 2007). In addition, Runx1 is required for Foxp3 expression and suppressive 
function of Treg cells (Kitoh et al., 2009; Rudra et al., 2009). Eos is a member of 
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Ikaros family and has been shown to play an important role in iTreg function by 
controlling the repressive activity of Foxp3 (Pan et al., 2009b). Another member 
of Ikaros family, Helios, is important for nTreg cell development, but how Helios 
functions is unknown (Wei et al., 2009). DNA-binding inhibitor Id3 controls Treg 
cell differentiation by diminishing GATA3 binding at the Foxp3 promoter 
(Maruyama et al., 2011).  
 
Furthermore, STAT proteins have an indispensible role in Treg cell 
differentiation. IL-2 activates STAT5 that binds to the Foxp3 promoter and the 
first intron of Foxp3 and initiates gene transcription (O'Shea et al., 2011). In 
addition, STAT5 induces Il2ra expression, which is upregulated during Treg cell 
development (O'Shea et al., 2011). In contrast, STAT4 has been shown to limit 
the development of iTreg by increasing the repressive chromatin modifications at 
the Foxp3 locus thus impairing STAT5 binding to Foxp3 (O'Malley et al., 2009) . 
A transcription factor network of Treg cells and the regulation of the Foxp3 gene 
expression are summarized in Figure 11 and 12.  
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Figure 11. The transcriptional network in Treg cells 
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(Ohkura et al., 2012) . Moreover, Ets-1, a member of the ETS family of 
transcription factors, binds and demethylates Foxp3 CNS2 region resulting to 
enhanced gene expression at the Foxp3 locus (Polansky et al., 2010).    
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Figure 12. Schematic diagram of the Foxp3 gene 
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Transcriptional regulation of T follicular helper cells 
One crucial function of T helper cells is to help B cells. T follicular helper (Tfh) 
cells are specialized to provide help to B cells. These Tfh cells help germinal 
center B cells to differentiate into plasma cells and memory B cells that produce 
high affinity antibodies for long-lasting protection through somatic hypermutation 
and affinity maturation. A unique feature of Tfh cells is their location. Tfh cells 
express high levels of chemokine receptor CXCR5 that facilitates the relocation 
of Tfh cells from the T cell zone of the lymphoid tissue into the B cell follicle 
(Deenick and Ma, 2011; Ma et al., 2012b). The result is a T cell-B cell interaction 
that provides B cell help. In addition to CXCR5 expression, Tfh cells also express 
programmed death-1 (PD-1) and inducible co-stimulator (ICOS) that provide an 
inhibitory signal to the T cells, (Deenick and Ma, 2011). Furthermore, Tfh cells 
coexpress other surface markers such as CD40 ligand, OX40, CXCR5, CD200, 
B and T lymphocyte attenuator (BTLA), members of the SLAM family, and 
SLAM-associated protein (SAP) (Deenick and Ma, 2011). Tfh cells produce IL-4 
and IL-21 that are required for optimal B cell help and plasma cell differentiation, 
respectively (Crotty, 2011).  
 
Tfh cell differentiation is controlled by the master regulator transcriptional 
repressor Bcl-6 (Johnston et al., 2009; Nurieva et al., 2009; Yu et al., 2009). Bcl-
6 controls Tfh cell differentiation by antagonizing transcription factors important 
for Th1 (T-bet), Th2 (GATA3), or Th17 (Rorγt) differentiation (Crotty, 2011). Bcl-6 
also represses Blimp-1 expression, an antagonist of Bcl-6 (Martins and Calame, 
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2008). Bcl-6 negatively regulates miRNA cluster miR-17-92 that inhibits CXCR5 
in Tfh cells (Yu et al., 2009). In addition to Bcl-6, other transcription factors such 
as MAF, BATF, and IRF4 are also involved in Tfh differentiation (Crotty, 2011). 
Transcription factor MAF together with NFAT and JunB control Il4 expression 
(Zhu et al., 2010), and directly binds to the Il21 promoter (Hiramatsu et al., 2010). 
Batf-deficient mice have defect in Tfh cells, B cell CSR, and GC development 
(Betz et al., 2010). In addition, Irf4-mutant mice have defects in Tfh cell 
development (Crotty, 2011). Both BATF and IRF4 control Tfh cell differentiation 
by regulating Bcl6 expression (Bollig et al., 2012; Ise et al., 2011). 
  
STAT proteins have been suggested to be involved in Tfh cell development. IL-6 
and IL-21 activate STAT3 that is required for the development of Tfh cells 
(Nurieva et al., 2008). Stat3-deficient T cells failed to differentiate into Tfh cells 
resulting in a poor B cell responses (Nurieva et al., 2008). However, it has been 
observed the redundancy in the role of IL-6 and IL-21 in Tfh cell development 
(Eto et al., 2011) suggesting a complex role of STAT3 in Tfh cell differentiation. 
STAT4 also plays an important role in the early Tfh cell development. IL-12 
activates STAT4 signaling that promotes both Il21 and Bcl6 gene expression 
(Nakayamada et al., 2011). Since STAT4 induces T-bet expression that 
represses Bcl6 and other markers of Tfh cells, STAT4 is a positive regulator of 
both Th1 and Tfh cells (Nakayamada et al., 2011). In contrast, STAT5 signaling 
has been reported to repress the development of Tfh cells (Johnston et al., 2012; 
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Nurieva et al., 2012). Therefore, multiple STAT proteins and transcription factors 
play an essential role in controlling Tfh cell development (Figure 13). 
 
Figure 13. The transcriptional network in Tfh cells 
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T helper cell plasticity and overall functions 
Naïve CD4+ T cells can differentiate into T helper subsets with distinct effector 
functions that require in specific cytokine signaling, STAT proteins, and 
transcription factors. However, CD4+ T cells also have the ability to redirect their 
functional programs under certain conditions into other types of effectors cells.  
CD4+ T cells co-express transcription factors of different lineages that result in 
multifunctional effector cells. In an LCMV infection model, Th2 cells can acquire a 
Th1 phenotype through antigen-specific TCR stimulation and an inflammatory 
environment by converting into GATA3+T-bet+ cells that coproduce both IL-4 and 
IFNγ (Hegazy et al., 2010). Similarly, the existence of Foxp3+Rorγt+ (Zhou et al., 
2008) and Foxp3+T-bet+ cells (Koch et al., 2009) have been described in specific 
in vivo conditions. CD4+ T cells also acquire the ability to switch to another T 
helper cells through receptor expression. Stimulating Th2 cells with type 1 
interferons that activate both STAT1 and STAT4 induces IL-12Rβ2 expression on 
those cells (Hegazy et al., 2010). As a result, type 1 interferon stimulated Th2 
cells are able to respond to IL-12. Thus, type 1 interferons together with IL-12 
and IFNγ are able to promote IFNγ-producing Th2 cells (Hegazy et al., 2010). 
Th17 cells express receptors for both IL-12 and IL-23 thus could be converted to 
Th1 cells in the presence of IL-12 (Bluestone et al., 2009). Epigenetic 
modification also plays an essential role in T helper cell plasticity. While 
trimethylation of histone H3 lysine 4 (H3K4me3) is associated with active gene 
transcription, trimethylation of histone H3 lysine 27 (H3K4me27) indicates 
inactive gene transcription. For example, H3K4me3 at the Ifng locus and 
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H3K27me3 at the Il4 and Il17 loci are found with Th1 cells. In contrast, H3K4me3 
at the Il4 locus and H3K27me3 at the Ifng and Il17 loci are found in Th2 cells. 
However bivalent epigenetic status at the Tbx21 and Gata3 loci also exist in 
Th17 and Treg cells suggesting a preconditioned to be converted toward Th1 or 
Th2 cell fates (Zhou et al., 2009).  
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Transcriptional repressor Twist1 
Twist1 is a transcriptional repressor and a member of the basic helix-loop-helix 
(bHLH) family of proteins  that plays a positive role in dorso-ventral patterning in 
Drosophila embryos (Barnes and Firulli, 2009). Twist1 functions as either a 
homodimer or heterodimer with other bHLH factors, where the dimerization 
partners dictate the function (Castanon et al., 2001). Altering the balance 
between Twist1 and Hand2 association has a significant impact on limb and 
craniofacial defects in humans with Saethre-Chotzen syndrome (Firulli et al., 
2005). Twist1 has been shown to determine the onset of osteoblast 
differentiation (Bialek et al., 2004), and functionally represses muscle 
development (Hamamori et al., 1997; Hebrok et al., 1994; Spicer et al., 1996). 
Twist1 also plays a role in mediating outflow track cushion formation within the 
developing heart (Vincentz et al., 2008). In addition, Twist1 maintains energy 
homeostasis by altering mitochondria metabolism in the brown fat (Pan et al., 
2009a). Twist1 not only plays a central role in embryonic development, it is an 
essential factor in tumor development and progression. Twist1 has been 
associated with epithelial-mesenchymal transition (EMT) in tumorigenesis 
(Vernon and LaBonne, 2004). Twist1 is an oncogene that plays important role in 
breast cancer, prostate cancer, hepatocellular carcinoma, and other (Kwok et al., 
2005; Matsuo et al., 2009; Vesuna et al., 2012). Although the role of Twist1 in 
developmental and cancer biology has been explored (Yang et al., 2004), the 
function of Twist1 in the immune response is only beginning to be understood. 
Twist1 regulates cytokine production in macrophages through a negative 
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feedback loop by targeting NF-κB activation that results in decreased TNFα and 
IL-1β (Sharif et al., 2006; Sosic et al., 2003). The repressive mechanism may 
involve binding of Twist1 to E-boxes in cytokine promoters to inhibit the 
transcriptional activity of NF-κB (Sharif et al., 2006; Sosic et al., 2003). In Th1 
cells, NF-κB, NFAT, and IL-12-STAT4 signaling can induce Twist1 expression, 
and Twist1 limits inflammation by suppressing IFNγ and TNFα production 
(Niesner et al., 2008). However, a detailed mechanism of how Twist1 regulates 
cytokine production in Th1 cells and other T helper subsets has not been 
described.  
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Transcription factor Etv5 
Etv5 belongs to the PEA3 subfamily of ETS transcription factors that regulates 
gene expression by binding to a conserved motif GGAA/T (Oh et al., 2012). Etv5 
has been shown to play important role in coordinating limb development (Zhang 
et al., 2010b; Zhang et al., 2009), controlling gene expression in the 
spermatogonial stem cell (Wu et al., 2011), and regulating EMT in many type of 
cancers (Oh et al., 2012). Etv5 inhibits sonic hedgehog (Shh) expression in the 
anterior limb bud that is essential for the anterior-posterior (A-P) patterning of the 
vertebrate limb (Zhang et al., 2009). In addition, Etv5 physically interacts with 
Twist1 to inhibit Shh expression in the limb bud (Zhang et al., 2010b). Etv5 
positively regulates microRNA-21 (mir21), Bcl6b, and LIM homeobox 1 (Lhx1) 
that are known to control spermatogonial stem cells (SSC) self-renewal (Niu et 
al., 2011). Chromosomal translocations resulting from the fusion between Etv5 
and transmembrane protease serine 2 (TMPRSS2) correlate with prostate 
cancer (Oh et al., 2012). In endometrial cancer, Etv5 cooperates with lipoma-
preferred partner (LPP) and promotes zinc finger E-box-binding transcription 
factor Zeb1 expression leading to the suppression of E-Cadherin, an important 
factor that is associated with EMT (Colas et al., 2012).  
 
Although the role of Etv5 in developmental and cancer biology has been defined, 
the function of Etv5 in the immune response is still poorly understood. The IL-12-
STAT4 signaling pathway induces Etv5 expression in Th1 cells to augment IFNγ 
production in Th1 cells through an unknown mechanism (Ouyang et al., 1999; 
 38 
 
Thieu et al., 2008). Thus, it remains to elucidate the role of Etv5 in the 
development of Th1 and other T helper cells.  
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Goal of the thesis 
Intensive research has been conducted to describe lineage-specific transcription 
factors regulating the development of different T helper cell subsets. However, 
how different positive and negative factors integrate together to control the 
plasticity of T cell subsets at the transcriptional level is not fully understood. 
Thus, the main goal of this thesis is to define the functional interaction of 
transcription factors that have a positive or negative regulatory role in the 
development of T helper cells. 
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MATERIALS AND METHODS 
Mice 
C57BL/6 mice were purchased from Harlan Sprague Dawley (Indianapolis, IN, 
USA). Stat4-/- and Stat3-mutant mice were previously described (Kaplan et al., 
1996b; Stritesky et al., 2011). Twist1fl/fl (Chen et al., 2007) and Etv5fl/fl mice 
(Zhang et al., 2009) were crossed with CD4-Cre transgene mice to generate 
Twist1fl/fl CD4-Cre+ and Etv5fl/fl CD4-Cre+ mice with Cre-negative littermates as 
WT mice. Twist1fl/fl CD4-Cre mice were backcrossed to C57BL/6 mice for six 
generations with Cre-negative littermates as wild type mice for in vivo 
experiments. Twist1cc/wt mice (Bialek et al., 2004) were crossed with Twist1fl/fl 
CD4-Cre+ mice to generate Twist1fl/cc CD4-Cre+ and Twist1fl/wt CD4-Cre+ as WT 
control. Dnmt3afl/fl CD4-Cre positive C57BL/6 mice (Yu et al., 2012) were mated 
with Stat4-/- to generate Dnmt3afl/flStat4-/- CD4-Cre positive with Cre-negative 
littermates as control mice. The following primers and PCR cycling conditions 
were used for genotyping: for Cre, forward 5’-
GTGAAACAGCATTGCTGTCACTT-3’ and reverse 5’-
GCGGTCTGGCAGTAAAAACTATC-3’, initial denaturation at 94oC for 2 min, 30 
cycles of 94oC for 45 sec, 60oC for 45 sec, and 72oC for 45 sec, and a final 
extension for 10 min at 72oC;  for Twist1, forward 5’-AGATTGGG 
CACCGTAGCAG-3’ and reverse  5’-TGACAGCAGTAGTGGCAA GC-3’, wild type 
allele 320 bp and mutant allele 370 bp ,initial denaturation at 94oC for 3 min, 35 
cycles of 94oC for 30 sec, 60oC for 1 min, and 72oC for 1 min, and a final 
extension for 2 min at 72oC; for Twist1cc, forward 5’-
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ACGAGCTGGACTCCAAGATG-3’ and reverse 5’-GGAGCTCCGCTGCTAGTG-
3’, 40 cycles of 94oC for 30 sec, 59oC for 15 sec, and 72oC for 12 sec, and a final 
extension for 5 min at 72oC, purify the PCR product and send for sequencing; for 
Etv5 forward 5’-CTCGCAGAGGACAAGGTAGTGAC-3’, reverse 1 5’-
GTGTGCACGACATGTTCAAGG-3’ and reverse 2 5’-
CTCTTGCACAGGACCCATGTTAG-3’, wild type allele 270 bp and mutant allele 
368 bp, initial denaturation at 94oC for 3 min, 35 cycles of 94oC for 30 sec, 58oC 
for 45 sec, and 72oC for 1 min, and a final extension for 10 min at 72oC; for 
Dnmt3a, forward 5’-CTGTGGCATCTCAGGGTGATGAGCA-3’ and reverse 5’- 
AAGCCTCAGGCCCTCTAGGCAAGA-3’, wild type allele 100 bp and mutant 
allele 200 bp, initial denaturation at 94oC for 2 min, 35 cycles of 94oC for 45 sec, 
65oC for 45 sec, and 72oC for 45 sec, and a final extension for 7 min at 72oC. 
Mice were maintained under specific pathogen-free conditions. All experiments 
were performed with the approval of the Indiana University Institutional Animal 
Care and Use Committee. 
 
In vitro T cell differentiation  
Naïve CD4+CD62L+ T cells were isolated from spleen and lymph nodes using a 
MACS isolation system (Miltenyi Biotec). CD4+ T cells were activated with plate-
bound anti-CD3 (2 ug/ml 145-2C11 BD Pharmingen) and soluble anti-CD28 
(37.51, 0.5 ug/ml BD Pharmingen for Th0, Th1, Th2, and Th17 or 1 ug/ml for Th9 
and Treg) with additional cytokines (all from PeproTech) and antibodies to 
generate Th1 (5 ng/ml IL-12; and 10 ug/ml anti-IL-4 11B11), Th2 (10 ng/ml IL-4; 
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and 10 ug/ml anti-IFNγ XMG), Th9 (20 ng/ml IL-4; 2 ng/ml TGF-β; and 10 ug/ml 
anti-IFNγ XMG) or Th17 (100 ng/ml IL-6; 10 ng/ml IL-23,; 10 ng/ml IL-1β; 2 ng/ml 
TGFβ;10 ug/ml anti-IL-4, 11B11; and 10 ug/ml anti-IFNγ, XMG) or Treg (2 ng/ml 
TGF-β, and 10 ug/ml anti-IL-4, 11B11) culture conditions. In some culture 
conditions, Th17 cells were generated without TGF-β or with IL-21 (10 ng/ml) 
instead of IL-6. Cells were expanded after 3 days without additional cytokines 
(Th0, Th1 and Th2), with 50 U/ml human-IL-2 (Treg), full concentration (Th9) or 
half concentration of IL-6 (Th17) of the original cytokines in fresh medium. Cells 
were harvested on day 5 for analysis. In some experiments, non-polarized T cells 
and Th1 cells (expanded after 3 days in fresh medium) were harvested on days 3 
and 5 respectively, and restimulated with 5 ng/ml IL-12 for 1, 4, and 6 h for 
further analyses.  
 
Retroviral expression vectors and retroviral transduction 
Bicistronic retrovirus expressing EGFP only (MIEG) and T-bet and EGFP (T-bet) 
were previously described (Chang et al., 2005; Mathur et al., 2006) PBMN-IRES-
GFP-IL-12Rb2c was a kind gift from Dr. Takashi Usui (Kyoto University). Etv5, 
Il12rb2c or Twist1 (Open Biosystems) cDNAs were digested and sub-cloned into 
MIEG3-EGFP, MIEG3-hCD4, or MSCV-YFP, respectively. Flag-tagged Twist1 
(Firulli et al., 2005) and Flag-tagged Twist1cc pCDNA3.1 that was made using 
QuikChange Site-Directed Mutagenesis Kit (Stratagene) with primer pair forward 
5’-TCAGCTACGCCTTCCCCGTCTGGAGGATG-3’ and reverse 5’-
CATCCTCCAGACGGGGAAGGCGTAGCTGA-3’, were digested, and subcloned 
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into MIEG3-EGFP. Runx3 cDNA (Open Biosystems) was amplified 5’-BglII-
forward 5’- AGATCTATGCGTATTCCCGTAGACCC -3’ 3’- SalI and reverse 5’- 
GTCGACTCAGTAGGGCCGCCA-3’), digested and sub-cloned into MSCV-
Thy1.1. HLX1 (Open Biosystems) cDNA was amplified forward Hlx1-EcorI-F5’- 
ATCAGAATTCATGTTCGCAGCCG-3’ and reverse Hlx1-XhoI-R 5’- 
ACTACTCGAGCTATAAGCAGCCAAGCG-3’), sub-cloned into the TOPO vector 
(Invitrogen), digested and sub-cloned into either MIEG-EGFP or MSCV-Thy1.1. 
Twist1-targeting shRNA oligo was designed as described (Niesner et al., 2008) 
and introduced into RNAi-Ready pSIREN-RetroQ-ZsGreen according to the 
manufacture manual (Clonetech). Retroviral stocks were prepared by calcium 
phosphate transfection of 70% confluent Phoenix GP cells using 15 ug of DNA, 3 
ug of env DNA and 10 ug of gag pol DNA per transfection. The medium (DMEM, 
10% FBS, 5% Penicillin/streptomycin) was replaced after 12 h, and viral 
supernatants were collected after 24 h and 48 h later. Purified CD4+ T cells were 
cultured under Th1 cell differentiation condition. On day 2, cells were transduced 
with retrovirus expressing vector control or gene of interest centrifugation at 2000 
rpm at 25oC for 1 h in the presence of 8 ug/ml polybrene. Viral supernatant was 
replaced with the former culture supernatant supplemented with 50 U/ml human 
IL-2. After spin infection, cells were expanded on day 3 and analyzed on day 5. 
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Gene expression analysis (qRT-PCR) 
Total RNA was isolated using Trizol reagent (Invitrogen Life Technologies) and 
reversed transcribed to make cDNA according to the manufacturer’s instructions 
(Invitrogen Life Technologies). Quantitative Real Time (qRT)-PCR reaction was 
set up including cDNA, TaqMan Fast Universal Master Mix, commercially 
available primers, and DEPC H2O to 10 ul. Gene expression was normalized to 
housekeeping gene expression (β2-microglobulin). The relative gene expression 
was calculated by the change-in-threshold (-∆∆CT) method. 
 
Table1-Taqman RT-PCR primers 
Species Gene Product catalog number 
Mouse 
Ahr Mm00478932_m1 
Ahrr Mm00477443_m1 
B2m Mm00437762_m1 
Batf Mm00479410_m1 
Ccr4  Mm00438271_m1 
Ccr8 Mm01351703_m1 
Crem Mm00516347_m1 
Cxcl1 Mm04207460_m1 
Cxcl10 Mm00445235_m1 
Cxcl2 Mm00436450_m1 
Cxcl3 Mm01701838_m1 
Erg Mm01214248_m1 
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Mouse 
Etv5 Mm00465816_m1 
Fasl Mm00438864_m1 
Furin Mm00440646_m1 
Gata3 Mm00484683_m1 
Hlx1 Mm00468656_m1 
Id3 Mm00492575_m1 
Ifng Mm01168134_m1 
Il12rb2 Mm00434200_m1 
Il17a Mm00439618_m1 
Il17rb Mm00444709_m1 
Il18r1 Mm00515178_m1 
Il1rn Mm01337566_m1 
Il4 Mm00445259_m1 
Il6ra Mm00439653_m1 
Il6st Mm00439665_m1 
Il9 Mm00434305_m1 
Irf1 Mm01288580_m1 
Itgae Mm00434443_m1 
Jmjd3 Mm01332680_m1 
Maf Mm01546091_s1 
Ptpn13 Mm00478426_m1 
Rorc Mm01261022_m1 
Runx3 Mm00490666_m1 
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Mouse 
Sfpi1 Mm00488142_m1 
Socs1 Mm00782550_s1 
Socs3 Mm00545913_s1 
Stat3 Mm01219775_m1 
Stat4 Mm00448890_m1 
Tbx21 Mm00450960_m1 
Tcfe2a Mm01175588_m1 
Tnfsf13b Mm00446347_m1 
Twist1 Mm00442036_m1 
Human 
B2M Hs00984230_m1 
BATF Hs00232390_m1 
IFNG Hs00989291_m1 
IL17A Hs00174383_m1 
IL17F Hs00369400_m1 
MAF Hs00193519_m1 
RORC Hs01076122_m1 
TWIST1 Hs00361186_m1 
 
Enzyme-linked immunosorbent assay (ELISA) 
To assess cytokine production, 96-well NUNC MaxiSorp plates were coated with 
capture antibodies in 0.1 M NaHCO3 (pH 9) buffer overnight at 4oC. Plates were 
washed three times with 0.05% Tween20/PBS buffer and blocked with 2% 
BSA/PBS for 2 h at room temperature. Cell-free supernatant collected after 24 h 
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of anti-CD3 (2 ug/ml) stimulation or standards were diluted in 2% BSA/PBS, 
added to plates, incubated overnight at 4oC or 2 h at room temperature. Plates 
were washed three times with 0.05% Tween20/PBS buffer and biotinylated 
antibodies (final concentration at 1 ug/ml) in 2% BSA/PBS, Avidin-alkaline 
phosphatase (1:2000 dilution) in 2% BSA/PBS were added sequentially at room 
temperature for 2 h and 1 h, respectively. Washes were performed between each 
step. For plate development, 5 mg/ml phosphatase substrate (Sigma 104) in 
substrate buffer (10% diethanolamine, 0.05 mM MgCl2, 0.02% NaN3, pH 9.8) was 
added. The absorbance was measured at 405 nm (Bio-Rad microplate reader 
model 680). Similar protocol was used to assess antigen-specific antibodies titer 
except 96-well NUNC MaxiSorp plates were coated with 10 ug/ml Myelin 
Oligodendrocyte Glycoprotein Peptide (MOGp35-55) or Sheep Red Blood Cell 
membrane protein in 0.1 M NaHCO3 (pH 9) buffer overnight at 4oC. Plates were 
washed three times with 0.05% Tween20/PBS buffered blocked with 2% 
BSA/PBS for 2 h at room temperature. Serum was diluted in 2% BSA/PBS, 
added to plates, and incubated overnight at 4oC or 2 h at room temperature. 
 
Table 2-ELISA capture antibodies 
Capture 
antibodies 
Clone Company 
Final 
Concentration 
GM-CSF MP1-22E9 BD Pharmingen 2 ug/ml 
IFNγ R4-6A2 BD Pharmingen 2 ug/ml 
IL-10 JES5-2A5 BD Pharmingen 4 ug/ml 
 48 
 
IL-13 eBio13A eBioscience 2 ug/ml 
IL-17A TC11-18H10 BD Pharmingen 2 ug/ml 
IL-17F Cat#AF2057 R&D 2 ug/ml 
IL-2 JES6-1A12 BD Pharmingen 4 ug/ml 
IL-4 11B11 eBioscience 2 ug/ml 
IL-9 D8402E8 Biolegend 1 ug/ml 
TNFα 1F3F3D4 eBioscience 2 ug/ml 
 
Table 3-ELISA biotinylated antibodies 
Biotinylated 
antibodies 
Clone Company 
Final 
Concentration 
GM-CSF MP1-31G6 BD Pharmingen 1 ug/ml 
IFNγ XMG1.2 BD Pharmingen 1 ug/ml 
IgE R35-72 BD Pharmingen 1 ug/ml 
IgG Poly4053 Biolegend 1 ug/ml 
IgG1 A85-1 BD Pharmingen 1 ug/ml 
IgG2a/c R19-15 BD Pharmingen 1 ug/ml 
IL-10 SXC-1 BD Pharmingen 1 ug/ml 
IL-13 eBio1316H eBioscience 1 ug/ml 
IL-17A TC11-8H4 BD Pharmingen 1 ug/ml 
IL-2 JES6-5H4 BD Pharmingen  1 ug/ml 
IL-4 BVD6-24G2 BD Pharmingen 1 ug/ml 
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IL-9 D9302C12 Biolegend 1 ug/ml 
IL-17F RD BAF2057 R&D 1 ug/ml 
TNFα XT3/XT22 eBioscience 1 ug/ml 
 
Cell sorting and flow cytometry  
Transduced cells were collected on day 5, stained with fluorochrome conjugated 
surface antibodies and sorted for single or doubly positive cells using a 
Reflection cell sorter (iCyt). Sorted cells were rested or re-stimulated with 2 ug/ml 
anti-CD3 for qRT-PCR (6 h) and ELISA (24 h) to assess gene expression and 
cytokine production, respectively. For surface staining, resting T cells were 
stained with with fluorochrome conjugated surface antibodies for 30 min at 4oC, 
washed with 2% BSA/PBS and fixed with 2% paraformaldehyde for 10 min at 
room temperature before analysis. For phosphorylated STAT and transcription 
factor (T-bet and Runx3) analyses, cells were fixed with 1.5% formaldehyde for 
10 min at room temperature, permeabilized using 100% ice cold methanol for 10 
min at 4oC, and stained for fluorochrome conjugated antibodies for 30 min at 
room temperature before analysis. Foxp3/Transcription factor staining kit 
(ebioscience) was used for other transcription factor staining (Foxp3, Twist1, Bcl-
6, and Rorγt). For cytokine staining, cells were stimulated with either 2 ug/ml anti-
CD3 with Golgi Plug inhibitor (1:1000 dilution, BD Pharmingen) or 50 ng/ml PMA 
and 500 ng/ml Ionomycin and 3 uM monensin (Sigma Aldrich) added for the last 
3 h of a 5 h activation, fixed with 2% paraformaldehyde for 10 min at room 
temperature, permeabilized using 0.1% saponin for 10 min at 4oC, and stained 
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for fluorochrome conjugated antibodies for 30 min at 4oC before analysis. For 
viability staining, cells were washed twice with PBS and stained for fixable 
viability dye eFluor 780 (ebioscience) for 30 min at 4oC. For biotinylated 
antibodies intracellular staining, fixed with 2% paraformaldehyde for 10 min at 
room temperature, permeabilized using 0.1% saponin for 10 min at 4oC, and 
stained for biotinylated antibodies for 30 min at 4oC follows by fluorochrome 
conjugated streptavidin for an additional 30 min at 4oC. Cells were washed in 
between steps using 2% BSA/PBS.  
 
Table 4-Flow cytometry antibodies 
Antibody Clone Company 
B220 RA3-6B2 BD Pharmingen 
Bcl-6 K112-91 BD Pharmingen 
CD19 6D5 BD Pharmingen 
CD3 G4.18 BD Pharmingen 
CD4 RPA-T4 BD Pharmingen 
CD8 HIT8a BD Pharmingen 
CD90.1 OX-7 Biolegend 
CXCR5 SPRCL5 eBioscience 
Etv5 C-20 Santa Cruz 
Fas Jo2 BD Pharmingen 
Foxp3 236A/E7 eBioscience 
GATA3 L50-823 BD Pharmingen 
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GL-7 GL7 BD Pharmingen 
hCD4 11830 R&D 
ICOS C398.4A Biolegend 
IFNγ XMG1.2 Biolegend 
IL-12Rβ2 305719 R&D 
IL-17A TC11-18H10 BD Pharmingen 
IL-17F O79-289 BD Pharmingen 
Il-18Rα BG/IL18RA Biolegend 
IL-4 11B11 BD Pharmingen 
IL-9 RM9A4 Biolegend 
Jmjd3 Cat#NBP1-06640B Novus Biologicals 
NK1.1 PK136 BD Pharmingen 
PD-1 29F.1A12 Biolegend 
PNA Cat#B-1075 Vector Laboratories 
pSTAT3 4/P-STAT3 BD Pharmingen 
pSTAT4 38/P-STAT4 BD Pharmingen 
pSTAT5 47 BD Pharmingen 
Rorγt AFKJS-9 eBioscience 
Runx3 527327 R&D 
Streptavidin Cat#12-4317 eBioscience 
T-bet 4B10 Biolegend 
TNFα MP6-XT22 Biolegend 
 52 
 
Twist1 Cat#IC6230A R&D 
 
Immunoblot and Immunoprecipitation  
Sorted cells or differentiated T cells were pelleted by centrifugation at 2000 rpm 
at 4oC for 5 min, incubated in lysis buffer (10% glycerol, 1% IGEPAL, 50 mM 
Tris-HCl (pH 7.4), 150 mM NaCl and 1 mM EDTA (pH 8) for 20 min on ice, and 
supernatant was collected by spinning for 15 min max speed at 4oC. Whole-cell 
protein lysates diluted in 4X loading buffer (250 mM Tris-HCl, 2% SDS, 20% 
βME, 40% glycerol and 0.04 mg/ml bromophenol blue) were boiled at 100oC for 5 
min, spun at max speed at 4oC for 5 min, loaded, run on 4-12% Bis-Tris gel at 
100 V for 2 h, and transferred onto nitrocellulose membrane (Whatman GmbH) at 
40 mA overnight at 4oC. The membrane was blocked using 5% non-fat dry milk in 
0.05%Tween20/PBS for 1 h at room temperature, immunoblotted using primary 
antibodies and secondary antibodies diluted in 0.05% Tween20/PBS overnight at 
4oC and 1 h at room temperature, respectively; and washed three times with 
0.05% Tween20/PBS between steps. The membrane was developed using 
Western Lighting Chemiluminescence reagent (Perkin elmer Life Sciences, 
Wellesley, MA) and classic blue autoradiography film BX (Molecular 
Technologies). The membrane was stripped using stripping buffer (10% SDS, 
62.5 mM Tris-HCl and 0.7% βME) and re-probed with other primary antibodies. 
For immunoprecipitation, whole-cell protein lysates were generated from 
differentiated T cells or 293T cells transfected with constructs expressing genes 
of interest using calcium phosphate. Whole-cell protein lysates were pre-cleared 
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with Protein A agarose (Thermo Scientific) for 1 h at 4oC, before 
immunoprecipitation of equal amounts of protein with primary antibodies 
overnight at 4oC. Immunocomplexes were captured by Protein A agarose for 1 h 
at 4oC and eluted at 100oC for 5 min in Laemmli’s sample buffer. 
Immunoprecipitates were separated by 10% SDS-PAGE and immunoblotted with 
primary antibodies.  
 
DNA affinity precipitation assay  
Differentiated T cells were pelleted by centrifugation at 2000 rpm at 4oC for 5 
min, washed with cold PBS, and the following buffers were added sequentially 
and incubated on ice: lysis buffer (10 mM Tris-HCl (pH 7.4), 10 mM NaCl and 
0.3% MgCl2) for 10 min, 20% NP-40 for 10 min, cells were pelleted, nuclear lysis 
buffer (50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 0.5% NP-40 with proteinase 
inhibitor) for 20 min. Cells were pelleted, and supernatant was stored at -20oC as 
nuclear extract. Oligonucleotides containing a Twist1 binding site were described 
previously (Firulli et al., 2007). Additional oligonucleotides (biotinylated at 5’) 
containing wild type and mutated (bold) Runx3 and T-bet binding sites 
(underline) are: wild type Runx3 and T-bet 5’-
ACCTATGTGGTCTGCCTTTTCTTCTTTCTGGGCACGTTGA-3’, mutant Runx3 
5’-ACCTAAGAGGACTGCCTTTTCTTCTTTCTGGGCACGTTGA-3’, mutant T-
bet 5’-ACCTATGTGGTCTGCCTTTTCTTCTTTCTGGGCTCGTTGA-3’, and 
mutant Runx3-T-bet 5’-
ACCTAAGAGGACTGCCTTTTCTTCTTTCTGGGCTCGTTGA-3’. Biotinylated 
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oligonucleotides were incubated with streptavidin-agarose beads for 30 min at 
4oC. The complex was washed three times with pull-down buffer (25 mM HEPES, 
15 mM NaCl, 0.5 mM DTT, 0.5% NP-40, 0.1 mM EDTA pH 7.5, and 10% 
glycerol). Nuclear extracts were added and incubated at 4oC for 2 h. The 
complex was washed three times with pull-down buffer, eluted at 100oC for 5 min 
in Laemmli’s sample buffer, and separated using 10% SDS-PAGE gel.  
 
Chromatin Immunoprecipitation (ChIP) 
Cultured T cells (5-10 x 106) were cross-linked for 10 min with 1% formaldehyde, 
quenched with 0.125 M Glycine for 5 min and washed with cold PBS. Cell 
pelleted were resuspended in lysis buffer (5 mM Pipes, 85 mM KCl, 0.5% NP-40 
with protease inhibitor) for 10 min on ice, spun down and aspirated the 
supernatant. Nuclei were resuspended in nuclear lysis buffer (50 mM Tris-HCl pH 
8, 10 mM EDTA pH 8, 1% SDS and protease inhibitor) for 10 min on ice. An 
ultrasonic processor (Vibra-cell) was used to shear genomic DNA to a size range 
of 200-300 bps at 30% amplitude for 8 sets of 10 second bursts. Cells were 
pelleted at max speed for 15 min at 4oC, and supernatant was kept at -80oC for 
the subsequent steps. Supernatant was diluted 10-fold in ChIP dilution buffer 
(0.01% SDS, 1% v/v TritonX-100, 1.25 mM EDTA pH 8, 16.7 mM Tris-HCl pH 8, 
166 mM NaCl, 20 ug/ml salmon sperm DNA, 10 ug/ml BSA and protease 
inhibitor) and pre-cleared with Protein A (or G) agarose bead slurry (50%) for 1.5 
h at 4oC. Primary antibodies were added, mixed, and incubated overnight at 4oC. 
The immunocomplexes were precipitated with protein A (or G) agarose beads for 
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2 h at 4oC, washed with low salt/high salt/LiCl salt buffers and two times with TE 
buffer, and eluted with elution buffer (2 mM EDTA, 20 mM Tris-HCl pH 8, and 
20% SDS) after mixing the bead/immunocomplexes for 10 min at room 
temperature following by 10 min at 37oC and cross-links reversed at 65oC 
overnight supplemented with 10 mg/ml protease K. DNA was purified by phenol-
chloroform extraction and ethanol precipitation, resuspended in H2O, and 
analyzed by qPCR with Taqman or SYBR primers. DNA was quantified from the 
standard curve generating from serial dilutions of input DNA. The percentage 
input was calculated by subtracting the amount of immunoprecipitated DNA from 
the IgG control from the amount of immunoprecipated DNA from the specific 
antibody and normalized against the amount of input DNA.  
 
Table 5-Immunoblots and ChIP antibodies 
Antibody Clone Company 
β-Actin C4 Santa Cruz 
Dnmt3a 64B1446 IMGENEX 
E47 G127-32 BD Pharmingen 
Etv5 H-100 Santa Cruz 
Flag M2 Sigma Aldrich 
H3K27ac Cat#07-360 Millipore 
H3K27me3 Cat#07-449 Millipore 
H3K36ac Cat#ab9050 Abcam 
H3K4me3 Cat#ab8580 Abcam 
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H3K9/18ac Cat#07-593 Millipore 
IgG 12-370 Millipore 
Jmjd3 RB10082 Abgent 
PEBP2β FL-182 Santa Cruz 
Runx3 6821C3a Santa Cruz 
STAT3 C-20 Santa Cruz 
STAT4 C-40 Santa Cruz 
T-bet 4B10 Santa Cruz 
Twist1 Twist2C1a Santa Cruz 
 
Chromosome conformation capture assay (3C) 
Chromosome conformation capture assay (3C) was performed as described 
(Hadjur et al., 2009; Hagege et al., 2007; Sekimata et al., 2009) with some 
modifications. 107 cells were cross-linked with 2% formaldehyde for 10 min at 
room temperature and quenched with 0.125 M Glycine for 5 min. Cells were 
lysed with ice-cold lysis buffer (10 mM Tris-HCl pH 8, 10 mM NaCl, 0.2% NP-40, 
Protease inhibitor cocktail) for 30 min. Nuclei were resuspended in 0.5 ml of 
restriction enzyme buffer (NEB3) containing 0.3% SDS and shaken for 1 h at 
37oC. Triton X-100 (final concentration 1.8%) was added and shaken for 1 h at 
37oC to sequester the SDS. Crosslinked DNA was digested overnight with 400-
800 U BglII containing 1 mM ATP that has been shown to enhance digestion 
efficiency (Court et al., 2011). Enzyme was inactivated by addition of SDS (final 
concentration 1.6%) and samples were shaken for 20 min at 65oC. The reaction 
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was diluted with 7 ml of ligation buffer (50 mM Tris-HCl pH 8, 10 mM MgCl2, 10 
mM DTT, 1 mM ATP, 1 mg/ml BSA), and Triton X-100 (final concentration 1%) 
was added and shaken for 1 h at 37oC. DNA fragments were ligated with 4000 U 
T4 ligase (NEB) for 4 h at 16oC followed by 40 min at room temperature. 
Crosslinks were reversed by incubation with 300 ug proteinase K overnight at 
65oC. The samples were further incubated with 300 ug RNase for 30-45 min at 
37oC, and the DNA were purified by phenol-chloroform extraction and ethanol 
precipitation. Ligation products were quantified by qPCR using primers as listed 
below. To generate control templates for the positive controls and to correct for 
differences in ligation and PCR efficiency between different templates, BAC 
clones were used to generate control template containing all possible ligation 
products. Equimolar amounts of three BAC clones spanning the mouse Ifng 
locus (RP23-353P23, RP23-138P22, and RP23-55O21) and BAC spanning the 
mouse Gapdh locus (RP23-410F11) from CHORI were mixed, digested, phenol 
chloroform extracted and ethanol precipitated, and ligated at a DNA 
concentration of 300 ng/ul. This sample was used as the DNA reference 
standard. Relative crosslinking frequencies between the analyzed pairs were 
calculated as described (Hagege et al., 2007) and were normalized to control 
interaction frequencies using primer pairs within the Gapdh locus.  
 
Table 6: SYBR and Taqman primers for ChIP assay  
Assay  Gene Sequence (5’3’) 
SYBR Stat3 Rorc F-AGCTTTGCTGTGGAAGATGTTTC 
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binding R-GAAGGGCTGGTAGGGAAGTCA 
SYBR 
STAT3 
binding 
Il17a 
F-GGATTAAGGGCACACGTGTTG 
R-TTTCCCCACTCTGTCTTTCCA 
Maf 
F-
AACAGTGTTGGCTTTGTCTACTATGG
GAT 
R-
GTAGGCGGTGCTCTGATATATTGCTG
TT 
Batf 
F-
CATTGCTGTGATGATGATGGTGACGA
T 
R-
AAGGCTGGCAAGATGACTCAGAGAAT
A 
Etv5 
proximal 
F-GGTGCTGATTGGTCAATGG 
R-CTGCCCATCACCTCTTGTTT 
Etv5 
distal 
F-CGCTACCCACGTTCTAGTCA 
R-CCTGCCTGTGTCATGATAGG 
Twist1 
proximal 
F-GCCAGGTCGGTTTTGAATGG 
R-CGTGCGGGCGGAAAGTTTGG 
Twist1 
distal 
F-AGCATGCAGGGCTTAATTTG 
R-ACTGTGCTTCCAAAGGTGCT 
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SYBR 
Tbet/Runx3 
binding 
Ifng 
CNS-34 
F-AGCTCCCATTAATGACACACC 
R-CTGAGACTGTGGTTGACACTC 
Ifng 
CNS-22 
F-
AAAGGTAAGGAAGCCAAAGAGAGTA 
R-GGCGCTGACATCATGCTTC 
Ifng 
CNS-6 
F-CCCAGTGAGTGCTTTAAAATTTCT 
R-CTGGATGGTTTTGAAGGATAATGT 
Ifng 
CNS+46 
F-GCAGCCCGGAGCAAGAGT 
R-CCCAATATTACTTCAGTGACAGCA 
SYBR 
Twist1 
binding 
Bcl6 
F-CCCAACATAATTGTCCCAAA 
R-GCGAGAGAGTTGAGCCGTTA 
Il6ra 
F-CGTGGCTCAGATCGGTGT 
R-GCCATCCTACTGGGCTTTC 
Icos 
F-ACACCA CATCAACCTCCACA 
R-GAAGACAAAGACACGGCAGA 
Runx3 
F-TCCTGTAGCCCCACTTTC 
R-TCGTCTATTCTGCCCTCG 
Tbx21 
F-TGGGCATACAGGAGGCAGCA 
R-TCGCTTTTGGTGAGGACTGAAG 
SYBR 
Etv5 
binding 
Bcl6p 
F-TCTTCGCTGTAGCAAAGCTC 
R-GGAAGAATTAGCCCCAGACC 
Il17 
CNS1 
F-
GGAAGGTGCATGTGGCTGACT
 60 
 
T 
R-AATGTGCCAGTCCCTTGGATGA 
Il17 
CNS2 
F-GCCTCCCATGTGGTCATTAT 
R-AGGCTCCTTCTCCATTGGTT 
Il17 
CNS3 
F-TTTGCTCATGCCCATATGTC 
R-TGAACCAACTTTCCCCACTC 
Il17 
CNS4 
F-CTCAAATCCGTGTGCCTTCT 
R-CATCTTGAAGCTGAGGCTGA 
Il17 
CNS5 
F-ACAGCCACACAACTCCCCACTC 
R-GGGCCTCCAAAATGACCTTCAC 
Il17 
CNS6 
F-ACAGGTGACCGCCAATAAAC 
R-GACATACCACAGCCCTTCGT 
Il17 
CNS7 
F-TGGCAAGGGGTAGGGTCAATCT 
R-GCAGACAGTGAGCAGGGCTTTC 
Il17 
CNS8 
F-ATGGTGGCCCTTAAAGCAGGAAR-
CATGGGATCCTGGCTCATTCTC 
SYBR 
Etv5 
binding 
Il17a 
promoter 
F-GCCTTTGTGATTGTTTCTTGCAG 
R-CCTTGCCCAAAGAAACCCTCTC 
Il17f 
promoter 
F-GGGAATCAAAGGGGGACCCTAA 
R-AAAGCAGAACCCACACGCAGAG 
SYBR Other Cxcl10 
F-
TCATCAGGACAGGGTCCACTGAGACT 
R-
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CTTTCAGAGATTTAGAGACTCAATGG
CC 
Irf1 
F-
ACAGGAAAGCACACCCGCATCTTGT 
R-
TGTCAAGAAGGGAGAGATTATGTCCC
TGT 
Socs3 
F-
CCTTCGCAAACTTGCTTTGCATATTCT 
R-
AAGTGACTTGAGCCTTTCTTTCCCTG
G 
Taqman Promoter 
Etv5 
F-AGCTGGATTTGCCTGAAGACA 
R-CACACACGTCCCCATTGGT 
Probe: TAAACAAGAGGTGATGGGC 
Furin 
F-GAAAGGCTGGCAGGAGAAGA 
R-TAGCCAGACCCCCTGAAGGC 
Probe: TGTGCCTGGGTTGC 
Hlx1 
F-GGAATGACAGCTCCGAATAAAACT 
R-TCACCAGAGCTGCTCCAAGA 
Probe: 
ATTTGTGGTCTGCCCTCCTCCTGGC 
Ifng F-ACCCCAAATGGTGTGAAGTAAAA 
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promoter R-CCCACCTGTGCCATTCTTGT 
Probe: TGCTTTCAGAGAATCC 
Taqman Promoter Il8r1 
F-TGAGATCCAGGCAGGAGAACTC 
R-AGAGCTCCACAGTTCCCAGAAC 
Probe: CTCTATCGCCTCAGCG 
 
Table 7-3C primers 
Assay Gene *Location Primer Sequence (5’3’) 
 
Ifng 
-71 F-AGGACCTATACGCTGGCAGT 
-34 R-GCTTCTCTAATGAACTGTAATGTGC 
-6 R-TACACTCATTCCTGCCTGGT 
Promoter R-CAGATGTAAGATGGGATCTC 
Promoter F-GTGTATGCTCCGTGGCTAGT 
+46 F-GACCCATAGCTCTTGCCTCT 
Gapdh 
Anchor1 R-ACACAGGCAAAATACCAATG 
Anchor2 R-GAATGCTTGGATGTACAACC 
Taqman 
probe 
Ifng 
Promoter 
R-6FAM-
CCATAGTGAAAAGTCACATGGCTGAGAA
ACACTTC 
Promoter 
F-6FAM-
AGATCTCTCAGACACTGACTGAGCC 
-34 R-6FAM-CCTCTGCAAGCCTCACAGAGCA 
+46 6FAM-CCATCTACTGCAAAAAGAAGCT 
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Gapdh anchor R-6FAM-AGATCTTAATTCCTGGTCCCTT 
Internal 
control 
Ifng  
F-CCCAGTGAGTGCTTTAAAATTTCT 
R-CTGGATGGTTTTGAAGGATAATGT 
Gapdh  
F-ACAGTCCATGCCATCACTGCC 
R-GCCTGCTTCACCACCTTCTTG 
*Location corresponds to the distance in kilobases from Ifng transcription start 
site (chr 10: 177844040 UCSC mm8, UCSC Genome Browser: 
http://www.genome.ucsc.edu/). F or R designate forward or reverse primers as 
compared to direction of Ifng gene or Gapdh gene transcription. 
 
Induction of EAE and analysis 
Induction and scoring of EAE disease has been described previously (Mo et al., 
2008a). In brief, a cohort of 8-12 week old female WT and Twist1-mutant mice (7 
mice/group) were immunized (s.c.) with 100 ug of myelin oligodendrocyte 
glycoprotein (MOGp35-55) peptide antigen (Genemed Synthesis) in 150 ul 
emulsion of complete Freund’s adjuvant (CFA) (Sigma Aldrich) on days 0 and 7. 
Mice were injected (i.p.) with 100 ng of pertussis toxin (Sigma Aldrich) on days 0 
and 2. The clinical signs were scored daily for 30 days. On day 12 following 
induction of EAE, splenocytes were isolated and stimulated with MOG peptide for 
48 h and cytokine production was measured by ELISA. Mononuclear cells were 
isolated from brain using a 30%/70% Percoll gradient and stimulated with PMA 
and ionomycin for 2 h followed by monensin for a total of 6 h before staining for 
intracellular cytokine production.  
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Sheep Red Blood Cells (SRBCs) immunization  
SRBCs (Rockland, cat#R406-0050) were washed three times with PBS. Mice 
were injected with 1 x 109 cells (i.p.) and sacrificed after 9 days for the analysis.  
 
House Dust Mice (HDM)-induced allergic airway inflammation 
Wild type and Etv5-mutant mice were sensitized by intranasal injection of 40 ug 
HDM (GREER allergy immunotherapy) in PBS each day for three consecutive 
days over five weeks. Mice were sacrificed 24 h after the final intranasal 
challenge of week 5. Serum was collected by cardiac puncture, and HDM-
specific antibodies were measured by ELISA. The trachea was cannulated, and 
lungs were lavaged three times with 1 ml PBS to collects BAL cells and cell-free 
BAL fluid. Cell-free BAL fluid was used to measure cytokine production by 
ELISA. BAL cells, and the single-cell suspension from lungs generated using the 
lung dissociation kit from Miltenyi Biotec, were stimulated with PMA and 
ionomycin for 2 h followed by monensin for a total of 5 h for cytokine analysis by 
ICS. Single-cell suspension from the lungs was used for gene expression 
analysis by qRT-PCR. Total splenocytes and cells from mediastinal lymph nodes 
were stimulated with HDM for 5 days, and cytokine production was analyzed by 
ELISA. Lung tissue was analyzed following for paraffin-embedding and staining 
with hematoxylin and eosin (H&E) for evaluation of the infiltration of inflammatory 
cells, and periodic acid-Schiff (PAS) for mucus production. Eosinophils, 
neutrophils, T cells, B cells and mononuclear cells in the BAL fluid and the lungs 
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were characterized by cell size and expression of CD3, B220, CCR3, CD11c, 
and major histocompatibility complex class II, analysis by flow cytometry. 
 
Human helper T cell differentiation 
The use of human cells was approved by the Institutional review Board of Indiana 
University. Naïve CD4+ T cells were isolated from PBMCs using magnetic beads 
(Miltenyi Biotec). For Th17 cell differentiation, naïve CD4+ cells were activated 
with anti-CD3 (2 ug/ml; HIT3a; BD Pharmingen) and soluble anti-CD28 (0.5 
ug/ml; CD28.2; Biolegend) with additional cytokines and antibodies 10 ng/ml 
human IL-1β (R&D), 25 ng/ml human IL-21 (Cell Sciences), 25 ng/ml human IL-6 
(R&D), 25 ng/ml human IL-23 (R&D), 5 ng/ml human TGF-β (R&D), 10 ug/ml 
anti-IFNγ (R&D) and 10 ug/ml anti-IL-4 (R&D). On day 3, cells were expanded 
with additional media and half concentration of cytokines. Cells were harvested 
for analysis on day 5.  
 
Transfection of siRNA 
siRNAs targeting Twist1, Etv5, Tbx21, and TWIST1 were purchased from Santa 
Cruz. For mouse T cell transfection, CD4+ T cells were transfected with siRNA on 
day 2 using Amaxa Nucleofector kit (Ionza), rested overnight with 50 U/ml hIL-2, 
and restimulated with anti-CD3 for 24 h for gene expression and cytokine 
production analyses. For human Th17 cell transfection, day 5 differentiated Th17 
cells were transfected with siRNA using Human T Cell Nucleofector kit (Lonza), 
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rested overnight with 50 U/ml hIL-2, and restimulated with anti-CD3 for 24 h for 
gene expression analysis.  
 
Luciferase reporter assay 
The IL6RA, IL17A, and IL-17F promoter reporters were purchased from 
SwitchGear Genomics. For analyzing the effect of Twist1 on IL6RA promoter 
activity or Etv5 on IL17A and IL17F promoter activity, Jurkat T cells were grown 
in RPMI 1640 with 10% FBS and transfected with 2-5 ug of the IL6RA, IL17A, 
and IL-17F luciferase reporter plasmids and control or increasing concentration 
of plasmid expressing Twist1 or Etv5 via Fugene6 reagent (Roche). After 24 h, 
transfected cells were stimulated with PMA and ionomycin for 6 h before 
analyzing with the dual luciferase system (Promega).  
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RESULTS 
Part I- Opposing roles of STAT4 and Dnmt3a in Th1 gene expression 
IL-12 induces distinct patterns of gene expression 
T-bet is a master transcription factor of Th1 cells that has been shown to be 
induced by IFNγ signaling during early differentiation and by IL-12 later during 
Th1 cell differentiation (Schulz et al., 2009). Similarly, our data showed that 
adding anti-IFNγ to wild type Th1 cultures resulted in decreased T-bet expression 
for the first two days of differentiation, while Stat4-/- Th1 cells had reduced T-bet 
expression the last three days of differentiation (Figure 14). Ifngr-/- Th1 cells had 
decreased T-bet expression during five days of differentiation and that might due 
to a decrease in Il12rb2 expression and pSTAT4 level (Figure 14). The data 
indicated that T-bet expression is controlled sequentially and cooperatively by 
IFNγ-STAT1 and IL-12-STAT4 signaling.  
 
Figure 14. Gene expression pattern in WT, Stat4-/-, and Ifngr-/- Th1 cells. 
Naïve CD4+CD62L+ T cells were isolated from WT, Stat4-/-, and Ifngr-/- mice and 
differentiated under Th1-polarizing conditions with anti-IFNγ was added to WT 
cell culture. The levels of phospho-STAT4 (pSTAT4) and T-bet expression were 
measured by ICS each day. Data are mean of two mice ± S.D. and 
representative of three independent experiments with similar results. 
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Since STAT4 activated the IFN-induced T-bet expression at distinct time points, 
we wanted to examine this in other genes. In previous work we defined STAT4 
target genes in activated T cells (Good et al., 2009), and observed that a subset 
of STAT4 bound genes (Socs3, Cxcl10, Irf1, and others) is classically defined as 
being interferon-induced genes (Ramana et al., 2002). Thus, we next wanted to 
compare the IL-12-induced gene expression patterns between Th1-associated 
genes and interferon-inducible genes. We examined purified naïve CD4+ T cells 
activated with anti-CD3 for 72 h, a time point when the cells begin to express IL-
12Rβ2 and become IL-12-responsive. We first examined mRNA for Th1-
associated genes and interferon-inducible genes, placing Tbx21 (encoding T-bet) 
in the interferon-inducible category because previous work demonstrated it to be 
primarily IFNγ-inducible early during Th1 differentiation (Schulz et al., 2009). We 
observed that in contrast to the Th1-associated genes that displayed an increase 
in relative expression over the course of 6 h, the IFN-inducible genes displayed a 
rapid increase in expression at 1 h and decreased thereafter (Figure 15). This 
was paralleled by the pattern of STAT4 binding to the genes, increasing over the 
time period at the Th1 gene loci, but initially increasing and then stabilizing or 
decreasing in the IFN-inducible genes (Figure 16A). 
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Figure 15. IL-12-induced gene expression in activated T cells. CD4+CD62L+ 
T cells were isolated from WT mice and activated with anti-CD3 and anti-CD28. 
After 3 days, cells were harvested, stimulated with IL-12 for the indicated times 
and used for analysis of gene expression analysis by qRT-PCR. Data are 
representative of three independent experiments with similar results. 
 
We then examined chromatin modifications at each set of genes to define events 
that would correlate with distinct patterns of gene expression. Acetylation of 
H3K9/18 showed a similar pattern in both sets of genes over 6 h of IL-12 
stimulation (Figure 16B). Acetylation and methylation of H3K27 over the 6 hours 
of IL-12 stimulation displayed varied patterns among the genes that did not 
obviously segregate between IFN-inducible and Th1-associated genes, although 
2 of the 3 Th1-associated genes showed increased H3K27 acetylation (Figure 
16B). Acetylation of H3K36 followed patterns that paralleled STAT4 binding, 
steadily rising over time in Th1-associated genes, and displaying modest or 
transient changes in acetylation at three of the four IFN-inducible genes (Figure 
16B). 
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Figure 16. STAT4 binding and histone modification pattern in IL-12-
stimulated activated WT T cells. (A-B) CD4+CD62L+ T cells were isolated from 
WT mice and activated with anti-CD3 and anti-CD28. After 3 days, cells were 
harvested, stimulated with IL-12 for the indicated times and used for analysis of 
STAT4 binding (A) and histone modification (B) analyses by ChIP assay. Data 
are representative of three independent experiments with similar results. 
 
We then performed similar experiments in differentiated Th1 cells. Naïve CD4+ T 
cells were activated with anti-CD3 and anti-CD28 and polarized towards the Th1 
phenotype in the presence of IL-12 and anti-IL-4. Relative expression of the 
genes was similar to the patterns observed in activated T cells with IFN-inducible 
genes displaying transient induction, and Th1-associated genes displaying more 
sustained induction (Figure 17). 
 
Figure 17. IL-12-induced gene expression in WT Th1 cells. CD4+CD62L+ T 
cells were isolated from WT mice and cultured under Th1-polarizing conditions. 
After 5 days, cells were harvested, stimulated with IL-12 for the indicated times 
and used for analysis of gene expression of Th1 genes or IFN-inducible target 
genes by qRT-PCR. Data are representative of three independent experiments 
with similar results. 
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Figure 18. STAT4 binding and histone modification pattern in IL-12-
stimulated WT Th1 cells. (A-B) CD4+CD62L+ T cells were isolated from WT 
mice and cultured under Th1-polarizing conditions. After 5 days, cells were 
harvested, stimulated with IL-12 for the indicated times and used for analysis of 
STAT4 binding (A) and histone modification (B) analyses by ChIP assay. Data 
are representative of three independent experiments with similar results. 
 
Although STAT4 binding showed the same transient induction at the IFN-
inducible gene loci, there was more heterogeneity in STAT4-binding at the Th1-
associated gene loci (Figure 18A). The patterns of H3K9/18 acetylation were 
similar to that in activated T cells, with transient induction in both sets of genes 
(Figure 18B). Acetylation at H3K36 was transient for the IFN-inducible genes, 
and demonstrated the same trend towards sustained increases, though with 
more heterogeneity than observed in activated T cells (Figure 18B). At H3K27 
residues, IFN-inducible genes showed a transient increase in acetylation and 
generally increasing methylation (Figure 18B). In contrast, the Th1 associated 
genes demonstrated trends towards increased acetylation and decreased 
methylation at H3K27 residues (Figure 18B). Thus, STAT4 binding and changes 
in histone modifications are distinct among IL-12-inducible genes that have 
transient or sustained expression. 
 
STAT4-dependent association of chromatin modifying enzymes at Th1 gene loci 
To further define how STAT4 is required for IL-12-induced gene expression we 
examined the expression of Th1 genes in wild type and Stat4-/- cultures following 
IL-12 stimulation. In the absence of STAT4, Th1 cells have lower basal 
expression of Th1 genes, and IL-12-induced expression is completely absent 
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(Figure 19A). H3K4 methylation is induced by IL-12, and the induction is 
attenuated in Stat4-/- Th1 cells (Figure 19B). In contrast, H3K27 methylation is 
increased in STAT4-deficient Th1 cultures, compared to wild type cultures, and 
the amounts of methylation increased upon IL-12 stimulation (Figure 19B). This 
was concomitant with decreased association of the H3K27 demethylase Jmjd3, 
and increased association of Dnmt3a, the DNA methyltransferase known to 
associate with methylated H3K27 (Figure 19B) (Lindroth et al., 2004; Yu et al., 
2007). Although our previous results suggested that Dnmt3a demonstrated 
increased association with Th1 loci in the absence of STAT4, these results 
suggest that IL-12-induced STAT4 reciprocally modulates Jmjd3 and Dnmt3a 
association at Th1 gene loci. 
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Figure 19. Gene expression, histone modification, and chromatin modifying 
enzyme patterns in IL-12-stimulated WT and Stat4-/-Th1 cells. Naïve 
CD4+CD62L+ T cells were isolated from WT or Stat4-/- WT mice and cultured 
under Th1-polarizing conditions. On day 5, cells were harvested, stimulated with 
IL-12 for the indicated time points, and gene expression was examined by qRT-
PCR (A) or used for STAT4 binding, chromatin modifying enzymes and histone 
modification analyses by ChIP assay using primers specific for the promoters of 
the indicated genes (B). Data are average of replicate samples ± S.D. and 
representative of three independent experiments with similar results.  
 
Jmjd3 facilitates IL-12-induced gene expression 
To determine if Jmjd3 contributes to IL-12-induced gene expression in Th1 cells, 
we transfected wild type Th1 cells with control orJmjd3-specific siRNA. We used 
intracellular staining to assess Jmjd3 expression and observed decreased mean 
fluorescence intensity without any effects on cell viability (Figure 20A-C). 
Reducing Jmjd3 expression resulted in diminished IFNγ production after anti-CD3 
or IL-12 stimulation (Figure 20D-E). Moreover, Jmjd3 siRNA reduced IL-12-
induced Th1 gene expression (Figure 20E). Transfection of Th1 cells with Jmjd3-
specific siRNA resulted in decreased Jmjd3 associated with Th1 cytokine loci, 
and a corresponding decrease in H3K4 tri-methylation and increase in H3K27 tri-
methylation (Figure 21). Decreasing Jmjd3 expression also increased Dnmt3a 
association with Th1 gene loci (Figure 21). STAT4 binding at Th1 gene loci was 
not altered byJmjd3-specific siRNA (Figure 21). These results support a pathway 
in which IL-12 induces STAT4-dependent H3K4 tri-methylation and Jmjd3 
association with Th1 gene loci, which then decreases H3K27 tri-methylation, and 
limits Dnmt3a association with target loci. 
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Figure 20. IL-12-induced gene expression requires Jmjd3. (A-E) Naïve 
CD4+CD62L+ T cells were isolated from WT mice and cultured under Th1-
polarizing conditions. On day 5, cells were harvested, transfected with control or 
Jmjd3-specific siRNA. Cells were rested overnight and stimulated with anti-CD3 
for 6 h, for Jmjd3 (with average of mean fluorescence intensity) and viability 
analyses by intracellular staining (A-C) or 24 h to measure cytokine production by 
ELISA (D). Transfected cells were stimulated with IL-12 for gene expression 
analysis by qRT-PCR (E). Data are average of three mice ± S.D. (A-D) or are 
average of replicated samples ± S.D. and representative of three independent 
experiments with similar results (E). *p<0.05. NS, not significant 
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Figure 21. IL-12-induced chromatin modification requires Jmjd3. Naïve 
CD4+CD62L+ T cells were isolated from WT mice and cultured under Th1-
polarizing conditions. On day 5, cells were harvested, transfected with control or 
Jmjd3-specific siRNA and stimulated with IL-12 before assessing chromatin 
modifying enzyme, histone modification and STAT4 binding by ChIP assay using 
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primers specific for the promoters of the indicated genes. Data are average of 
replicated samples ± S.D. and representative of three independent experiments 
with similar results  
 
Dnmt3a negatively regulates Th1 gene expression 
Based on the increased association of Dnmt3a with Th1 gene loci in the absence 
of STAT4, we tested whether elimination of a negative regulator, Dnmt3a, would 
rescue Th1 differentiation in Stat4-/- T cells. We mated Stat4-/- mice with 
Dnmt3afl/fl CD4-Cre mice to generate compound mutant mice. Naïve CD4+ T cells 
were isolated from wild type, Dnmt3afl/fl CD4-Cre positive and Stat4-/-Dnmt3afl/fl 
mice that were Cre-negative (STAT4-deficient, but expressing Dnmt3a) or Cre-
positive (STAT4- and Dnmt3a-deficient) and differentiated under Th1, Th17, and 
regulatory T cell (iTreg) polarizing conditions. Stat4-deficient Th1 cells had 
diminished IFNγ production compared to wild type cultures when stimulated with 
anti-CD3 or PMA and ionomycin, although there was no significant effect on 
TNFα production (Figure 22A-B). We have previously seen that Dnmt3a-
deficiency resulted in modest increases in IFNγ production (Yu et al., 2012) 
(Figure 22C). However, Th1 cells deficient in both STAT4 and Dnmt3a 
demonstrated greater production of IFNγ than Stat4-/- cells, assessed early using 
intracellular staining (Figure 22A). Recovery of IFNγ production was comparable 
to wild type cells in response to PMA and ionomycin, but was only partially 
restored when cells were stimulated with anti-CD3 (Figure 22A-C). This is 
consistent with the ability of PMA and ionomycin stimulation to overcome some 
of the effects of STAT4-deficiency (Afkarian et al., 2002; Good et al., 2009).  
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Figure 22. Dnmt3a is a negative regulator of Th1 genes. (A-D) Naïve 
CD4+CD62L+ T cells were isolated from WT, Dnmt3afl/fl CD4-Cre positive or 
Dnmt3afl/fl Stat4-/- CD4-Cre negative (-) or positive (+) mice and cultured under 
Th1, Th17 or iTreg polarizing conditions. (A-B) On day 5, Th1 cells were 
harvested, activated with anti-CD3 or PMA and ionomycin for 6 h before 
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assessing cytokine production by ICS, B, Averages of percent positive cells and 
mean fluorescence intensity for data in (A). (C-D) Day 5 Th1 and Th17 cells were 
harvested and activated with anti-CD3 for 24 h before assessing cytokine 
production by ELISA. (E-F) Splenocytes isolated from mice with indicated 
genotypes or day 5 in vitro generated regulatory T (Treg) cells were assessed for 
natural (nTreg, CD4+CD25+Foxp3+) (E) or inducible (Foxp3+) (F) Treg cells by 
intracellular staining. Data is gated on CD4+ cells. Data are average ± S.D. of 
three independent experiments (A-F). *p<0.05  
 
Th17 cell differentiation and ex vivo regulatory T cells (nTreg) were normal in 
cells deficient in both STAT4 and Dnmt3a compared to wild type cells in terms of 
IL-17A production (Th17) and the percentage of CD4+CD25+Foxp3+ cells (nTreg) 
(Figure 22D-E). In vitro derived Treg cells from single Dnmt3a-deficient or double 
STAT4-and Dnmt3a-deficient naïve T cells demonstrated increased 
differentiation to Foxp3-expressing cells, compared to wild type cells (Figure 
22F). 
 
We then examined additional Th1 genes to determine if Dnmt3a had a similar 
negative effect on expression. Stat4-/- Th1 cells had diminished Th1 gene 
expression while Dnmt3a-deficiency resulted in modest increases in IFNγ 
production but minimal effects on the expression of other Th1 genes (Figure 23) 
(Yu et al., 2012). We observed partial recovery of Etv5, Furin, Twist1, Il18r1, and 
Jmjd3 expression in Th1 cells deficient in both STAT4 and Dnmt3a, compared to 
wild type and Stat4-/- Th1 cultures (Figure 23). However, there was no recovery 
of Hlx1, Runx3, or Tbx21 expression (Figure 23). 
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Figure 23. Dnmt3a is a negative regulator of Th1 genes. Naïve CD4+CD62L+ 
T cells were isolated from WT, Dnmt3afl/fl CD4-Cre positive or Dnmt3afl/fl Stat4-/- 
CD4-Cre negative (-) or positive (+) mice and cultured under Th1-polarizing 
conditions. Day 5 Th1 cells were used to examine gene expression by qRT-PCR 
before (Etv5, Furin, Twist1, Il18r1, Hlx1, Runx3, Tbx21, and Jmjd3) or after (Ifng) 
anti-CD3 reactivation. Data are average of replicated samples ± S.D. and 
representative of three independent experiments with similar results.  
 
Since the recovery in STAT4-dependent IFNγ production and Th1 gene 
expression was only partial with simultaneous Dnmt3a deficiency, we wanted to 
determine if this effect was sufficient to enhance inflammation in vivo. To test 
0.0
0.4
0.8
1.2
1.6
R
el
at
iv
e 
ex
pr
es
si
on
Etv5
0.0
0.3
0.6
0.9
1.2
R
el
at
iv
e 
ex
pr
es
si
on
Furin
0.0
0.3
0.6
0.9
1.2
R
el
at
iv
e 
ex
pr
es
si
on
Twist1
0.0
0.4
0.8
1.2
1.6
2.0
R
el
at
iv
e 
ex
pr
es
si
on
Il18r1
0.0
0.4
0.8
1.2
1.6
2.0
R
el
at
iv
e 
ex
pr
es
si
on
Ifng
0.0
0.4
0.8
1.2
1.6
R
el
at
iv
e 
ex
pr
es
si
on
Hlx1
0.0
0.3
0.6
0.9
1.2
R
el
at
iv
e 
ex
pr
es
si
on
Runx3
0.0
0.3
0.6
0.9
1.2
1.5
R
el
at
iv
e 
ex
pr
es
si
on
Tbx21
0.0
0.3
0.6
0.9
1.2
R
el
at
iv
e 
ex
pr
es
si
on
Jmjd3
WT Dnmt3afl/fl Cre+
Dnmt3afl/fl Stat4-/- Cre- Dnmt3afl/fl Stat4-/- Cre+
 83 
 
this, we used the myelin oligodendrocyte glycoprotein (MOG)-induced EAE 
model to compare the level of disease in wild type, Dnmt3afl/fl Cre-positive 
Dnmt3afl/flStat4-/- Cre-negative and Dnmt3afl/flStat4-/- Cre-positive mice. Disease 
development in wild type and Dnmt3afl/fl Cre-positive mice was indistinguishable, 
consistent with a minimal effect of Dnmt3a-deficiency on Th1 development in 
vitro. In agreement with previous reports (Chitnis et al., 2001; Mo et al., 2008b), 
mice deficient in STAT4 had minimal disease that developed much later than 
disease in wild type mice (Figure 24A-B). However, Dnmt3afl/flStat4-/- Cre-positive 
mice demonstrated onset and paralysis that was intermediate to disease in wild 
type and Stat4-/-mice (Figure 24B).The result correlated with increased 
CD4+IFNγ+and CD4+IFNγ+IL-17+ mononuclear cells isolated from brain in 
Dnmt3afl/flStat4-/-Cre-positive mice compared to Stat4-deficient mice (Figure 
24C). MOG-stimulated Dnmt3afl/flStat4-/- Cre-positive splenocytes produced 
significantly more IFNγ and GM-CSF compared to Stat4-deficient cells (Figure 
24D). Both Dnmt3afl/flStat4-/-Cre-positive and Stat4-deficient mice had higher 
CD4+IL-17+ mononuclear cells compared to wild type mice (Figure 24C). 
Similarly, MOG-stimulated Dnmt3afl/flStat4-/- Cre-positive and Stat4-deficient 
splenocytes produced more IL-17A compared to wild type cells (Figure 
24D).Thus, in the absence of Dnmt3a and STAT4, there is a partial recovery in 
inflammatory T cell function. 
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Figure 24. Mice with double deficiency in STAT4 and Dnmt3a had partial 
recovery in inflammatory T cell function. (A-B) Mean clinical score of MOG 
peptide (35-55)-induced EAE in WT, Dnmt3afl/fl CD4-Cre positive (A) or in WT, 
Dnmt3afl/fl Stat4-/- CD4-Cre negative or positive mice scored daily for 30 days (B). 
(C-D) Mice were sacrificed on day 14 and mononuclear cells were isolated from 
brain and stimulated with PMA and ionomycin for 6 h before staining for cytokine 
production (C) or isolated splenocytes were stimulated with MOG peptide for 48 
h and cytokine production was measured using ELISA (D). Data are average ± 
S.E.M. of two independent (A-B, n=6-10 mice/group/experiment) or average ± 
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S.E.M. of 4 mice (C-D). *p<0.05 comparing Dnmt3afl/fl Stat4-/- CD4-Cre negative 
or positive samples. 
 
To further define how Dnmt3a was affecting Th1 gene expression, we examined 
acute IL-12 induced gene expression and histone modification. Although 
deficiency in Dnmt3a increased the basal level of gene expression in STAT4-
deficient T cells following Th1 differentiation (Figure 22A-C, 23 and 25A), we did 
not observe a rescue of IL-12-induced gene expression in the absence of 
Dnmt3a (Figure 25A), suggesting that other STAT family members were not 
compensating for the function of STAT4. Histone modifications associated with 
activated or repressed genes were also altered at five regulatory elements 
across the Ifng locus, and at the Hlx1 promoter. The amount of H3K27me3 at 
each site of the Ifng locus, and the Hlx1 promoter was increased in the absence 
of STAT4 (Figure 25B-C). At three of the five sites in the Ifng locus and at the 
Hlx1 promoter, deficiency of Dnmt3a and STAT4 decreased H3K27me3 to 
amounts close to those in wild type cells (Figure 25B-C). Conversely, H3K4me3 
was decreased at the Ifng locus and the Hlx1 promoter in the absence of STAT4. 
In Th1 cultures deficient in Dnmt3a and STAT4, three of the five sites in the Ifng 
locus, but not the Hlx1 promoter, showed H3K4me3 amounts increased from 
Stat4-/- cells, although not to amounts seen in wild type cells. The results are 
consistent with previous reports of STAT4 binding to the Ifng locus (Figure 25A-
C) (Wei et al., 2010). 
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Figure 25. Gene expression and histone modification in the absence of 
Dnmt3a. (A-B) Naïve CD4+CD62L+ T cells were isolated from WT, Dnmt3afl/fl 
Stat4-/- CD4-Cre negative or positive mice and cultured under Th1-polarizing 
conditions. On day 5, cells were harvested and stimulated with IL-12 for 4 hours 
before gene expression analysis by qRT-PCR (A) or histone modification 
analysis by ChIP assay at the Ifng regulatory elements (B) or the Hlx1 promoter 
(C). Data are average of replicated samples ± S.D. and representative of three 
independent experiments with similar results. 
 
Transcription factor regulation of Ifng in the absence of STAT4 and Dnmt3a 
We then wanted to test whether Dnmt3a deficiency affected transcription factor 
binding at the Ifng locus using chromatin immunoprecipitation. At three sites that 
are known T-bet and Runx3 binding regions, we observed diminished or absent 
binding in Stat4-/- Th1 cells, compared to wild type cells (Figure 26). However, in 
Th1 cultures of cells lacking both STAT4 and Dnmt3a there was a partial 
recovery of binding by T-bet, and complete recovery of Runx3 binding at two of 
the three sites (Figure 26). Since the T-bet-Jmjd3 interaction is required for Ifng 
remodeling in differentiated Th1 cells (Miller et al., 2010), we then examined the 
binding of Jmjd3 at the Ifng locus. Paralleling T-bet binding, the binding of Jmjd3 
at the Ifng locus was partially recovered in Th1 cultures of cells lacking both 
STAT4 and Dnmt3a, compared to Stat4-/- cells (Figure 26). This suggested that at 
least some of the recovery of Ifng expression in Dnmt3afl/flStat4-/- Cre-positive 
Th1 cells was due to increased binding of Ifng-inducing transcription factors and 
histone modifying enzymes. 
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Figure 26. Transcription factor binding in the absence of Dnmt3a. Naïve 
CD4+CD62L+ T cells were isolated from WT, Dnmt3afl/fl Stat4-/- CD4-Cre negative 
or positive mice and cultured under Th1-polarizing conditions. T-bet, Runx3, and 
Jmjd3 bound to the Ifng locus was analyzed by ChIP assay in Th1 cells. Data are 
average of replicated samples ± S.D. and representative of three independent 
experiments with similar results.   
 
In addition to decreased binding of factors to the Ifng locus, there was also 
decreased expression of several factors required for Ifng expression including 
Hlx1, Runx3, and Tbx21 in the absence of STAT4 (Figure 23). To determine if a 
combination of decreased Dnmt3a function and ectopic Th1 transcription factor 
expression would completely rescue IFNγ production, we used retroviral 
transduction to introduce transcription factor expression into Dnmt3afl/flStat4-/- 
Cre-positive and Cre-negative Th1 cultures. Transduction of either Hlx1 or Tbx21 
had modest effects on IFNγ production and no effects on TNFα production 
(Figure 27A). Transduction of Runx3 resulted in some recovery of IFNγ 
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production from Dnmt3afl/flStat4-/- Cre-negative Th1 cells, but only modest effects 
on IFNγ production from Dnmt3afl/flStat4-/- Cre-positive Th1 cells (Figure 27B). We 
reasoned that since Hlx1 expression showed no recovery in Dnmt3afl/flStat4-/-Cre-
positive Th1 cells compared to Dnmt3afl/flStat4-/- Cre-negative Th1 cells (Figure 
23), and since T-bet binding was still diminished in Dnmt3afl/flStat4-/-Cre-positive 
Th1 cells compared to Dnmt3afl/flStat4-/- Cre-negative Th1 cells (Figure 26), 
double-deficient Th1 cells might be especially sensitive to ectopic expression of 
these two factors. Thus, we transduced Dnmt3afl/flStat4-/- Cre-positive and -
negative Th1 cells with retroviruses expressing T-bet and Hlx1. We observed that 
Dnmt3afl/flStat4-/- Cre-negative Th1 cells demonstrated induction of IFNγ 
production, but that Dnmt3afl/flStat4-/- Cre-positive Th1 cells demonstrated an 
even greater fold induction in IFNγ production (Figure 27C-D).  
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Figure 27. Ectopic Th1 transcription factor expression rescues IFNγ 
production. Naïve CD4+CD62L+ T cells were isolated from WT, Dnmt3afl/fl Stat4-
/- CD4-Cre negative (-) or positive (+) mice and cultured under Th1-polarizing 
conditions. On day 2, cells were transduced with retrovirus expressing MIEG-
EGFP (MIEG), MIEG Hlx1-EGFP (Hlx1), or MIEG T-bet-EGFP (Tbx21) (A), or 
control vector Thy1.1 or Runx3-Thy1.1 (Runx3) (B), or both MIEG T-bet-EGFP 
(Tbx21) and MSCV Hlx1-Thy1.1 (Hlx1) or matching controls (C-D). After five 
days of differentiation, Th1 cells were activated with anti-CD3 for 6 h before 
measuring cytokine production by ICS. Average percentage of positive cells 
gated on transduced cells (A-B). (C-D) After five days of differentiation, doubly 
transduced Th1 cells were sorted, reactivated with anti-CD3 for 24 h, and 
cytokine production was measured by ELISA (C) with the fold induction in 
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cytokine production between Dnmt3afl/fl Stat4-/- CD4-Cre negative and positive 
transduced Th1 cells compared to its control cells (D). Data are average ± S.D. 
of three independent experiments. *p<0.05 
 
These results demonstrate that Dnmt3a represses gene expression in the 
absence of STAT4, and that in the absence of both factors, the Ifng locus is de-
repressed and more sensitive to induction by additional Ifng trans-activators. 
Together, these studies reveal the negative regulatory role of Dnmt3a in Th1 
gene expression. 
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Part II- Twist1 regulates Ifng expression in T helper 1 cells by interfering 
with Runx3 function 
The effect of Stat4-target genes on IFNγ production in Th1 cells 
In the previous section, we showed that STAT4 mediates its function in Th1 cells 
by facilitating increased histone acetylation and H3K4 methylation to induce gene 
expression, and by decreasing the association of DNA methyltransferases that 
repress gene expression. STAT4 is also required for the expression of several 
other transcription factors that contribute to Th1 gene expression including 
Twist1, Hlx1, Tbx21, Erg3, Runx3, and Etv5 (Figure 23) (Thieu et al., 2008). 
Thus, we wanted to determine the role of these transcription factors in regulating 
cytokine production in Th1 cells. Ectopic gene expression including Twist1, Hlx1, 
Tbx21, Egr3, Runx3, and Etv5 was performed on wild type Th1 cells, and IFNγ 
production was measured by intracellular staining. Overexpression of Twist1 in 
Th1 cells resulted in decreased IFNγ production compared to control cells (Figure 
28). While overexpression of T-bet and Runx3 resulted in increased IFNγ 
production compared to control cells, ectopic Hlx1, Egr3, and Etv5 expression 
had modest effect on IFNγ (Figure 28). These results suggested that STAT4 
regulates a number of transcription factors that have negative (Twist1) and 
positive (Hlx1, T-bet, Egr3, Runx3, and Etv5) effects on IFNγ in Th1 cells.  
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Figure 28. The effect of STAT4 target genes on Th1 cytokine production. 
Naïve CD4+CD62L+ cells were isolated from WT mice and differentiated under 
Th1 culture conditions. On day 2, cells were transduced with either control or 
Twist1, Hlx1, Tbx21, Egr3, Runx3, or Etv5 expressing retroviruses. On day 5, 
cells were stimulated with PMA and ionomycin for 6 h before intracellular staining 
(ICS) for cytokine production with indicated mean fluorescence intensity. Data 
are gated on transduced cells. Data are representative of two to three 
independent experiments with similar results. 
 
Twist1 is induced by Th1 cell activation 
Despite Twist1 represses cytokine production in Th1 cells, how Twist1 regulates 
Th1 cytokine production remained unknown (Figure 28) (Niesner et al., 2008). To 
begin to define that mechanism, we determined the expression of Twist1 in T cell 
subsets. Twist1 mRNA expression was highest in resting and activated Th1 cells, 
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compared to other T cell subsets (Figure 29A). Previous reports and our data 
identified Twist1 as a STAT4 target gene (Niesner et al., 2008; Thieu et al., 2008) 
(Figure 23). Although Twist1 mRNA expression was detected during 
differentiation, expression was dramatically reduced in Stat4-/- than wild type Th1 
cells (Figure 29B). Stimulation of Th1 cells with anti-CD3 resulted in the induction 
of Twist1 mRNA and protein (Figure 29C-D). Thus, Twist1 is expressed in the 
greatest amounts in Th1 cells compared to other T cell subsets and is induced by 
TCR stimulation. 
 
Figure 29. Twist1 is expressed in activated Th1 cells. (A) Naive WT 
CD4+CD62L+ T cells were differentiated under neutral conditions (Th0) or Th1, 
Th2, Th9, Th17 or Treg-polarizing conditions in vitro. Twist1 mRNA expression in 
resting or anti-CD3 activated Th1 cells was determined by qRT-PCR. (B) Kinetics 
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of Twist1 mRNA expression during Th1 differentiation in WT and Stat4-/- cells. (C-
D) Kinetics of Twist1 mRNA expression (C) and Twist1 protein (D) in Th1 cells 
after stimulation with anti-CD3 for 2, 4, 8, 16, and 24 h. Data are average ± S.D. 
of 3 mice; and representative of two independent experiments (A) or are average 
of replicate samples ± S.D and representative of two to three independent 
experiments with similar results (B-D).  
 
Twist1 negatively regulates the Th1 transcription factor network 
To define how Twist1 regulates Th1 cell function, Twist1 was ectopically 
expressed or targeted by shRNA in Th1 cells using retroviral transduction (Figure 
30A, C). In agreement with a previous report (Niesner et al., 2008), ectopic 
Twist1 expression in Th1 cells reduced IFNγ and TNFα mRNA and protein levels, 
and decreasing Twist1 expression resulted in increased IFNγ and TNFα 
production (Figure 30B, D). The differences in IFNγ and TNFα production in Th1 
cells was not due to altered expression of other cytokines, including Il4 and Il17a 
(Figure 30B). Coincident with decreased cytokine production, the expression of 
Th1-related transcription factors such as T-bet, Hlx1, and Runx3 were decreased 
upon ectopic Twist1 expression and increased upon Twist1 shRNA transduction 
(Figure 30B, D). 
 
 
 
 
 
 
 
 
 
 
 96 
 
0
2
4
6
0
40
80
120
160
200
R
el
at
iv
e 
ex
pr
es
si
on
0
10
20
30
40
R
el
at
iv
e 
ex
pr
es
si
on
0
1
2
3
4
R
el
at
iv
e 
ex
pr
es
si
onTbx21 Runx3
0
2
4
6
Hlx1
R
el
at
iv
e 
ex
pr
es
si
on
0
40
80
120
160
200
R
el
at
iv
e 
ex
pr
es
si
on
0
4
8
12
16
20
R
el
at
iv
e 
ex
pr
es
si
on
0
2
4
6
8
R
el
at
iv
e 
ex
pr
es
si
on
0
1
2
3
4
R
el
at
iv
e
ex
pr
es
si
on
0
50
100
150
200
250 *
IF
N
γ
(n
g/
m
l)
0.0
0.5
1.0
1.5
2.0
2.5
TN
Fα
(n
g/
m
l) *
0.0
0.3
0.6
0.9
1.2
1.5
R
el
at
iv
e 
ex
pr
es
si
on
A
IB:Twist1
IB: β-Actin
MIEG Twist1
0.0
0.4
0.8
1.2
1.6
TN
Fα
(n
g/
m
l) *
Ifng Tnfa
Tbx21 Runx3
Ifng Tnfa
Twist1
shTwist1
control
B
C
D
E F
0.0
0.5
1.0
1.5
2.0
Il4
R
el
at
iv
e 
ex
pr
es
si
on
0
1
2
3
Il17a
R
el
at
iv
e 
ex
pr
es
si
on
0
1
2
3
Hlx1
R
el
at
iv
e 
ex
pr
es
si
on
Twist1
control
Twist1control
0
40
80
120
IF
N
γ
(n
g/
m
l) *
R
el
at
iv
e 
ex
pr
es
si
on
shTwist1control
 97 
 
Figure 30. Twist1 negatively regulates Th1 gene expression and cytokine 
production. (A-F) Naïve WT CD4+CD62L+ T cells were stimulated under Th1-
polarizing conditions. On day 2, cells were transduced with control EGFP (MIEG) 
or retroviral vector expressing Twist1 and EGFP (Twist1) (A, B, E), or control or 
short hairpin Twist1 (shTwist1) (C, D, F). On day 5, GFP+ cells were sorted for 
analysis. (A, C) Altered Twist1 protein expression in cells transduced with Twist1 
(A) and altered Twist1 expression in shRNA transduced Th1 cells (C). (B, D) Th1 
gene expression in ectopic Twist1- (B) or short hairpin- (D) transduced cells were 
assessed by qRT-PCR before (Tbx21, Runx3, and Hlx1) or after (Ifng, Tnfa, Il4, 
and Il17a) 6 h re-stimulation with anti-CD3. (E-F) Sorted GFP+ cells were 
stimulated with anti-CD3 for 24 h, supernatants were collected and analyzed for 
IFNγ and TNFα by ELISA. Data are mean ± S.D. of three independent 
experiments (E-F) or mean of replicate samples ± S.D. and representative of 
three independent experiments with similar results (A-D). *p<0.05 
 
Since STAT4 is required for the expression of many Th1-specific genes (Figure 
23) (Thieu et al., 2008), we examined whether Twist1 was a component in a 
feedback mechanism to control STAT4 activation. Phospho-STAT4, assessed by 
flow cytometry, was lower in Th1 cells transduced with Twist1-expressing 
retrovirus compared to vector control, following re-stimulation with increasing 
doses of IL-12 (Figure 31A). Decreased induction of pSTAT4 correlated with 
reduction in IL-18rα expression, a STAT4-target gene (Figure 31B) (Yu et al., 
2008; Yu et al., 2007). Consistent with this result, reduced Twist1 expression 
resulted in increased IL-12-induced STAT4 phosphorylation (Figure 31C). We 
next examined the expression of genes that contribute to STAT4 activation. 
STAT4 mRNA and protein expression, and mRNA of suppressors of cytokine 
signaling (SOCS) and protein tyrosine phosphatase-Basophil like (PTP-BL) that 
negatively regulate STAT4 activation (Nakahira et al., 2007; Yamamoto et al., 
2003) were not altered (Figure 31D, G). However, Il12rb2 mRNA expression was 
decreased approximately 50% by ectopic Twist1 expression compared to vector 
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control (Figure 31E). In parallel, transduction of Th1 cells with retroviral Twist1 
shRNA resulted in increased Il12rb2 expression (Figure 31F). 
 
Figure 31. Twist1 regulates Il12rb2 expression and STAT4 activation. (A-B) 
Naïve WT CD4+CD62L+ T cells were cultured and transduced as described in 
Figure 29. Transduced Th1 cells were stimulated with IL-12 for 4 h and GFP+ 
cells were analyzed for phospho-STAT4 (pSTAT4) (A) and IL-18rα expression 
(B). (C) Phospho-STAT4 amounts were determined in control or shRNA 
transduced Th1 cells following sorting for GFP expression. (D) Total lysates from 
cells transduced with Twist1 were immunoblotted for STAT4 and β-Actin as a 
control and densitometry analysis of STAT4 protein is indicated. (E-G) Gene 
expression in Twist1 (E, G) or shTwist1 (F) transduced Th1 cells sorted for GFP 
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expression. Data are mean of three to four independent experiments ± S.D. (A-
C) or the average of replicate samples ± S.D. and representative of two to three 
independent experiments with similar results (D-G). *p<0.05 
 
Runx3 rescues the inhibitory effect of Twist1 independent of T-bet and STAT4 
Since Twist1 regulates multiple genes in Th1 cells, we wanted to determine if a 
single factor could rescue the inhibitory effect of Twist1. Initially, we asked 
whether ectopic expression of IL-12Rβ2 could compensate for the repressive 
effect of Twist1 by co-transducing Th1 cells using transduction of both IL-12Rβ2 
and Twist1. IL-12Rβ2 surface expression was decreased in cells with ectopic 
Twist1 expression but was higher in double transduced cells, compared to vector 
control (Figure 32A). Recovery of IL-12Rβ2 expression resulted in increased IL-
12-induced phospho-STAT4 (Figure 32B). Despite recovery of phospho-STAT4 
(Figure 32B), ectopic IL-12Rβ2 expression was unable to rescue IFNγ 
production, but recovered TNFα production (Figure 32C). Co-expression of T-bet 
and Twist1 resulted in higher T-bet expression compared to vector control but 
failed to recover IFNγ and TNFα production (Figure 32D-E). Thus, although 
recovery of IL-12 signaling was able to induce TNFα in the presence of Twist1, 
neither recovery of IL-12 signaling nor T-bet expression was able to compensate 
for the effects of Twist1 on IFNγ production. 
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Figure 32. Ectopic Runx3 expression compensates for the repressive 
activity of Twist1 in Th1 cells. (A-I) Naïve WT CD4+CD62L+ T cells were 
stimulated under Th1-polarizing conditions. On day 2, cells were transduced with 
control retrovirus vectors or (A-C) retroviral vector expressing Twist1-GFP and 
IL-12Rβ2-hCD4 (D, E) Twist1-hCD4 and T-bet-GFP (F-I) Twist1-GFP and 
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Runx3-Thy1.1. Th1 cells were stained for IL-12Rβ2 by surface staining (A) or 
phospho-STAT4 with or without IL-12 stimulation by ICS (B, H), or T-bet by ICS 
(D, I). Analysis was performed by gating on doubly transduced cells. (F) Whole 
cell lysates were extracted from sorted double positive Th1 cells and were 
immunoblotted for Runx3 and β-Actin as a control. (C, E, G) Double positive cells 
were sorted and re-stimulated with anti-CD3 for 24 h. Supernatants were 
collected before IFNγ and TNFα production was measured by ELISA. Data are 
mean of three to four independent experiments ± S.D (A-E, G) or averages of 
replicate samples ± S.D. and representative of two to three independent 
experiments with similar results (F, H-I). *p<0.05. N.S., not significant 
 
Since Runx3 regulates IFNγ independently of T-bet and STAT4 (Yagi et al., 
2010), we hypothesized that regulation of Runx3 by Twist1 might be a critical 
target. Ectopic Twist1 expression resulted in decreased Runx3, and retroviral 
expression of Runx3 resulted in higher Runx3 level in double transduced cells 
compared to control cells (Figure 32F). IFNγ and TNFα production in 
Runx3/Twist1-transduced cells was comparable to that of control transduced 
cells (Figure 32G). The recovery of IFNγ and TNFα production by Runx3 in Th1 
cells was independent of T-bet and STAT4 since there were no recovery of T-bet 
expression or phospho-STAT4-positive cells (Figure 32H-I). Thus, although 
Twist1 can negatively regulate many Th1 genes, the recovery of T-bet and IL-
12Rβ2 expression (and as a consequence, STAT4 phosphorylation) did not 
compensate for the effects of Twist1. These results suggested that Runx3, or a 
Runx3 induced-gene, is at least one of the important Twist1 targets in the 
regulation of IFNγ. 
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Twist1 exists in a complex with Runx3 or T-bet 
Twist1 inhibits osteoblast differentiation by interacting with the Runt domain of 
Runx2, a highly conserved domain shared with related proteins including Runx3 
(Bialek et al., 2004). We hypothesized that Twist1 physically interacts with Runx3 
and inhibits its regulatory function. Using immunoprecipitation of extracts from 
resting and early activated Th1 cells we observed that Twist1 co-purified with 
Runx3, and confirmed the association between Runx3 and T-bet in Th1 cells 
(Figure 33A) (Djuretic et al., 2007). We also found an association between T-bet 
and Twist1 following precipitation with T-bet antibody (Figure 33B). 
 
 
Figure 33. Twist1 physically interacts with Runx3 and T-bet. (A-C) Whole cell 
lysates were extracted from activated WT Th1 cells. Immunoblots were 
performed for the indicated proteins following immunoprecipitation with control or 
Runx3- (A) or T-bet- (B) antibodies as indicated. Input for immunoprecipitation is 
indicated on the right (C).  
 
To examine the function of Runx3 and T-bet in the absence of Twist1, Twist1fl/fl 
mice (Chen et al., 2007) were mated with mice carrying a CD4-Cre transgene to 
generate mice with Twist1-deficient T cells (Twist1fl/fl CD4-Cre+). We confirmed 
the absence of Twist1 expression in Twist1-deficient Th1 cells (Figure 34A-B). 
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Twist1-deficiency did not alter normal lymphocyte development in thymus, 
spleen, and lymph nodes (Figure 34C). Twist1-deficient Th1 cells produced 
significantly greater amounts of IFNγ on a per cell basis and in frequency of IFNγ-
positive cells compared to wild type cells (Figure 35A-D). We also confirmed the 
increase in gene expression of Tbx21, Runx3, and Il12rb2 in Twist1-deficient Th1 
cells, compared to WT Th1 cells.  
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Figure 34. Generation of mice with Twist1-deficient T cells. Naïve 
CD4+CD62L+ T cells from WT and Twist1fl/fl CD4-Cre+ were stimulated under 
Th1-polarizing conditions. (A) Resting Th1 cells were used to measure Twist1 
expression by qRT-PCR. (B) Twist1 protein expression in WT and Twist1-
deficient Th1 cells after reactivated with anti-CD3 for 6 h. (C) Total cells were 
isolated from thymus, spleen, and lymph nodes of WT and Twist1-mutant mice 
and stained for cell surface markers. Results are the average ± S.D. of replicated 
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samples and are representative of three to four independent experiments with 
similar results. N.D., not detectable  
 
Figure 35. Twist1-deficient Th1 cells produce significantly more IFNγ than 
WT Th1 cells. (A-D) Naïve CD4+CD62L+ WT or Twist1fl/fl CD4-Cre+ T cells were 
cultured under Th1-polarizing conditions. IFNγ production was measured by 
ELISA (A) after reactivating with anti-CD3 for 24 h or ICS (B-D) after reactivating 
with PMA and ionomycin for 6 h. (C-D) Graphs indicate the mean fluorescence 
intensity (C) or average percent IFNγ-positive cells (D) of Th1 cells from mice of 
the indicated genotype. Results are the average ± S.E.M. of three to four 
independent experiments with similar results. *p<0.05, ***p<0.001 
 
We next tested the effect of Twist1 on Runx3 and T-bet DNA binding by DNA 
affinity precipitation assay using extracts from Twist1-mutant mice and littermate 
control (WT) activated Th1 cells. Extracts from WT and Twist1-deficient Th1 cells 
were incubated with biotinylated oligonucleotides containing a Twist1-binding 
sequence. Although T-bet and Runx3 were precipitated with DNA-bound Twist1 
in WT cell extracts, T-bet and Runx3 were absent from precipitates of Twist1-
deficient extracts, further supporting the interaction of these transcription factors 
and suggesting that interactions can occur when Twist1 is bound to DNA (Figure 
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36A-B). We observed that Runx3 and Tbx21 mRNA expression increased in 
Twist1-deficient Th1 cells compared to WT cells, although there was a modest 
increase at protein level, suggesting the importance of protein complex formation 
in the function of Twist1. Since there is an association between Twist1, Runx3, 
and T-bet, we tested if, in the absence of Twist1, there would be greater binding 
of Runx3 and T-bet to oligonucleotides containing Runx3 and T-bet specific 
binding sites. In the absence of Twist1, we detected greater binding of Runx3 
and T-bet to the respective oligonucleotides compared to WT samples (Figure 
36C-E, lane 2 vs. 1). When the binding sites of Runx3, T-bet or both were 
mutated, the binding of Runx3 and T-bet was diminished, regardless of Twist1 
expression (Figure 36C). We then tested if Twist1 mediates its inhibitory effect in 
Th1 cells by interfering with the T-bet-Runx3 interaction. Using Runx3 
immunoprecipitation, we detected a Runx3 and T-bet interaction in the absence 
of Twist1 (first lane), although this interaction was diminished in the presence of 
Twist1 (Figure 36F). These results suggested that the decrease in IFNγ 
production in Th1 cells might not only be due to the reduction in Runx3 gene 
expression but also due to diminished association and DNA binding activity of 
Runx3 and T-bet. 
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Figure 36. Twist1 physically interacts with Runx3 and T-bet. (A-F) Naïve 
CD4+CD62L+ WT or Twist1fl/fl CD4-Cre+ T cells were cultured under Th1-
polarizing conditions. (A-B) Nuclear extracts from activated (A-B) or resting (C) 
WT and Twist1fl/fl CD4-Cre+ Th1 cells were incubated with biotinylated 
oligonucleotides containing Twist1-specific binding site (A) or Runx3-T-bet 
specific binding sites (wild type or mutant as indicated) (C). (B, D) Immunoblots 
of precipitated proteins, with densitometry measurements for (E). (F) Mixture of 
whole cell lysates collected from 293T cells transfected with constructs 
expressing Runx3, T-bet or Twist1 were incubated at 4oC overnight. Immunoblots 
indicate proteins immunoprecipitated with Runx3. Results are average ± S.D. (E) 
of three independent experiments or representative of three or more independent 
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experiments with similar results (A-D, F). *p<0.05. DAPA, DNA Affinity 
Precipitation Assay 
 
Twist1 interferes with the binding of Runx3 and T-bet to the Ifng locus 
Twist1 interferes with T-bet and Runx3 DNA binding, however we observed only 
modest binding of Twist1 to the Tbx21, Ifng, and Runx3 promoters (Figure 37A). 
Thus, we hypothesized that the interaction of Twist1 with Th1 transcription 
factors decreased their binding to target genes including Ifng. T-bet and Runx3 
regulate Ifng gene expression by binding to several conserved non-coding 
sequences (CNS) (Yagi et al., 2010). To examine T-bet and Runx3 binding in the 
absence of Twist1, we performed ChIP assay using wild type and Twist1-
deficient Th1 cells and examined the binding at previously documented regions 
including CNS-34, CNS-6, Ifng promoter, and CNS+46 of the Ifng gene (Figure 
37B) (Schoenborn et al., 2007; Yagi et al., 2010), using ChIP for T-bet or CBF-β, 
the binding partner of Runx3 (Yagi et al., 2010). Our data showed that more T-
bet was bound in Twist1-deficient Th1 cells than in wild type cells at the Ifng 
promoter and CNS+46 while there were no difference at CNS-34 and CNS-6 
(Figure 37C). In contrast, more CBF-β was bound at CNS-34 and CNS-6 in 
Twist1-deficient Th1 cells compared to littermate controls (Figure 37C). This 
result suggested that Twist1 interferes with T-bet and CBF-β-Runx3 complex 
binding at specific regulatory regions of Ifng gene. Since T-bet and Runx3 bind to 
many CNS regions of the Ifng locus, and the association between T-bet and 
Runx3 is required for optimal Ifng expression (Djuretic et al., 2007; Yagi et al., 
2010), it is likely that Runx3 binding to the Ifng locus enhances T-bet binding to 
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regulatory elements. This is consistent with the recovery of IFNγ production in the 
Runx3 transduction experiment (Figure 32G).  
 
Figure 37. Twist1 interferes with transcription factor binding at the Ifng 
locus in Th1 cells. (A) Differentiated WT Th1 cells were stimulated with anti-
CD3 for 6 and 24 h and used for ChIP analysis by qPCR using Twist1 antibody. 
(B) Representation of the Ifng locus indicating conserved non-coding sequences 
(CNS) used for analysis. (C) Naïve CD4+CD62L+ T cells from WT and Twist1fl/fl 
CD4-Cre+ were stimulated under Th1-polarizing conditions. ChIP assays were 
performed on Th1 cells using T-bet and CBF-β antibodies. *p<0.05. N.D., not 
detectable 
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The effect of Twist1 on T-bet and CBF-β-Runx3 binding at distinct elements 
suggested that interfering with T-bet-Runx3 interactions might also alter 
chromatin looping at the Ifng locus (Hadjur et al., 2009; Sekimata et al., 2009). 
To determine whether Twist1 interferes with chromatin looping at the Ifng locus, 
a chromosome conformation capture (3C) assay was performed with wild type 
and Twist1-deficient Th1 cells that examined the interactions among Ifng CNS 
regions using an established assay (Figure 38) (Hagege et al., 2007; Sekimata et 
al., 2009) (Figure 39A-B). Using three different anchor points, our results showed 
increased crosslinking frequency between CNS-34, CNS+46, and the Ifng 
promoter, and increased crosslinking of CNS-6 with CNS-34 and CNS+46 
(Figure 39C-E). The distance between the Ifng promoter and CNS-6 is too short 
to provide consistent results in this assay. Crosslinking of the CNS region at -71 
was not altered. Together, these results suggest that Twist1 regulates Ifng 
expression by altering the binding of the Th1 transcription factors T-bet and 
Runx3, and altering the conformation of the Ifng locus. 
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Figure 38. Chromosome conformation capture (3C) assay: methodology 
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Figure 39. Twist1 interferes with chromatin conformation at the Ifng locus 
in Th1 cells. (A-E) Naïve CD4+CD62L+ T cells from WT and Twist1fl/fl CD4-Cre+ 
were stimulated under Th1-polarizing conditions. (A) Th1 cells were fixed and 
digested with BglII enzyme. Undigested and digested samples were subjected for 
qPCR using primer pairs spanning the restriction sites. %Digestion was 
calculated using the formula: 100 – 100/2((CtR –CtC)D –(CtR – CtC) UND); D: digested, 
UND: undigested, R: restriction site, C: internal control. D, Th1 cells as described 
above were fixed (crosslinked) and/or ligated as indicated. (B) qPCR was 
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performed using primer pair 13F-9R. PCR products were run on 2% agarose gel. 
BAC clones were titrated for qPCR and used as control. (C-E), Chromosome 
conformation capture (3C) assay showing the relative cross-linking frequencies 
between the Ifng promoter (C), CNS-34 (D) or CNS+46 (E) as the fixed anchor 
fragments and other BglII fragments containing the indicated CNS regions. 
Results are the average ± S.D. of replicated samples and are representative of 
four independent experiments with similar results. *p<0.05 
 
The Twist1-Runx3 interaction is required to regulate Ifng 
A mutation in Twist1 at amino acid 192 from Serine to Proline (Twist1cc) results 
in diminished interaction between Twist1 and Runx2 (Bialek et al., 2004). Thus 
we wanted to examine whether Twist1 S192P (Twist1cc) could interact with 
Runx3. DAPA using extracts from cells transfected with Runx3, WT Twist1 
(Twist1), and Twist1cc expressing vectors that were incubated with biotinylated 
oligonucleotides containing a Twist1-binding sequence demonstrated decreased 
interaction between Runx3 and Twist1cc (Figure 40A-B). The mutation in 
Twist1cc did not affect the association of Twist1 with T-bet confirmed by co-
immunoprecipitation experiment (Figure 40C). 
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Figure 40. Twist1cc poorly interacts with Runx3. (A, B) Nuclear extracts from 
293T cells co-transfected with either Flag-tagged Twist1 or Flag-tagged 
Twist1cc, and with or without Runx3, were incubated with biotinylated 
oligonucleotides containing Twist1-specifc sequence. Immunoblot demonstrates 
protein expression of Twist1 and Runx3 (A) with densitometry measurements 
(B). (C) 293T cells co-transfected with either Flag-tagged Twist1 or Flag-tagged 
Twist1cc and with or without T-bet. Immunoblots indicate proteins 
immunoprecipitated with T-bet. *p<0.05 
 
The mutant Twist1 provided a tool to mechanistically distinguish the effects of 
Twist1 that rely on interactions with Runx3 at the protein level, versus effects 
independent of Runx3. To test the effects of mutant Twist1, a retrovirus 
expressing Twist1cc was introduced into Th1 cells, and cytokine production and 
gene expression were analyzed. Introduction of Twist1cc did not repress IFNγ 
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production in Th1 cells compared to vector control and wild type Twist1-
transduced cells (Figure 41A-F). Importantly, Twist1cc was able to repress 
expression of several Th1 genes including Il12rb2, Runx3, and Tbx21 as 
effectively as wild type Twist1 (Figure 41F). To further define the function of 
Twist1cc in Th1 cells, we utilized a mouse mutant strain termed Charlie Chaplin 
(Twist1cc/wt) that encodes Twist1 S192P and results in hindlimb polydactyly 
(Bialek et al., 2004; Krawchuk et al., 2010). We mated Twist1cc/wt with Twist1fl/fl 
CD4-Cre+ mice generating Twist1fl/wt CD4-Cre+ and Twist1fl/cc CD4-Cre+ 
(Twist1fl/cc) mice that have T cells expressing one wild type or one mutated allele 
of Twist1, respectively. IFNγ production in Twist1fl/cc Th1 cells was increased 
compared to control cells (Figure 41G-I). These results demonstrate although 
Twist1cc retains some repressive function in Th1 cells independent of Runx3, 
Twist1 control of IFNγ production is primarily through association with Runx3.   
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Figure 41. The Twist1-Runx3 interaction is required for regulation of Ifng. 
(A-I) Naïve CD4+CD62L+ T cells from WT were cultured under Th1-polarizing 
conditions and were infected with retrovirus expressing Twist1 or Twist1cc. (A) 
Twist1 protein was assessed in transduced Th1 cells using immunoblot, with β-
actin as a control. (C-E) IFNγ production was assessed by intracellular staining 
and gating on GFP+ populations following 6h of activation with anti-CD3 (B-D) or 
by ELISA following 24 h stimulation with anti-CD3 of sorted GFP+ populations 
(E). (C-D) Graphs indicate the mean fluorescence intensity (E) or average 
percent IFNγ-positive cells (D) of each transduced population. (F) Th1 gene 
expression in ectopic Twist1 or Twist1cc expression was assessed by qRT-PCR 
before (Il12rb2, Runx3, and Tbx21) or after (Ifng) 6 h re-stimulation with anti-
CD3. (G- I), Naïve CD4+CD62L+ T cells from mice of the indicated genotypes 
were cultured under Th1-polarizing conditions. Th1 cells were stimulated with 
anti-CD3 for 6 h or 24 h respectively for testing Ifng expression by qRT-PCR (G) 
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or IFNγ production by ELISA with the ratio of production from Twist1-deficient or 
Twist1 mutant Th1 cells to the respective controls (H-I). Data are mean of three 
to four independent experiments ± S.D, *p<0.05 (A-E), or are mean of replicate 
samples ± S.D. and representative of two independent experiments with similar 
results (G-I). *p<0.05. N.S., not significant 
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Part III-Twist1 limits Th17 and Tfh cell development by repressing Il6ra 
STAT3-activating cytokines induce Twist1 expression 
Having demonstrated that Twist1 negatively regulated cytokine production in Th1 
cells (Figure 30) (Pham et al., 2012), we next wanted to determine if Twist1 had 
effects in other T helper cell subsets. We compared cytokine production from in 
vitro polarized cultures of naïve CD4+ T cells from wild type and mice carrying a 
conditional mutant allele of Twist1 in T cells. As shown previously, Th1 cells 
display increased production of IFNγ (Figure 42A). Cytokine production by Th2 
and Th9 cells, percentages of Foxp3+ in vitro derived Treg cells, and percentages 
of natural Treg (nTreg; CD4+CD25+Foxp3+) cells were similar between wild type 
and Twist1-deficient cultures (Figure 42A-B). In contrast, there was a marked 
increase in IL-17 production from Th17 cultures (Figure 42A). 
 
We first examined the regulation of Twist1 in Th17 cells. Since STAT3 directly 
binds to the Twist1 promoter in breast cancer cells (Cheng et al., 2008), we 
speculated that STAT3 might induce Twist1 expression in Th17 cultures. 
Stimulation of wild type Th17 cells with IL-6 or IL-23 to activate STAT3, or IL-12 
to activate STAT4, led to increased Twist1 mRNA and protein expression 
compared to unstimulated cells (Figure 43A-B). Since Twist1 expression in Th17 
cells is lower than Th1 cells (Figure 29A) (Pham et al., 2012), we hypothesized 
that an inhibitory signal represses Twist1 expression in developing Th17 cells. 
Indeed, IL-6 or IL-12 induced Twist1 expression in activated CD4+ T cells and 
this was decreased when TGF-β was added to the culture (Figure 43C). To 
 119 
 
further confirm that Twist1 is a STAT3 target gene in Th17 cells, gene expression 
was compared in activated wild type and Stat3-deficient CD4+ T cells. As 
expected, IL-6 stimulated Stat3-deficient CD4+ T cells were unable to induce 
Twist1 expression compared to wild type cells, although expression was equally 
induced in IL-12-stimluated wild type and Stat3-deficient CD4+ T cells (Figure 
43C).  
 
Given that the Twist1 promoter contains STAT3 binding sites (Figure 43D) 
(Cheng et al., 2008), we wanted to determine if STAT3 could directly bind to the 
regulatory regions of Twist1. Differentiated Th17 cells were stimulated with 
cytokines known to activate STAT3, and binding was examined by ChIP assay. 
In Th17 cells, STAT3-activating cytokines, but not IL-12, resulted in STAT3 
binding to the Twist1 promoter, with greatest amounts in the proximal promoter 
segment (Figure 43E). These results suggested that STAT3-activating cytokines 
and TGF-β play opposing roles in regulating Twist1 expression in Th17 cultures.  
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Figure 42. Characterization of T helper cell subsets in Twist1-mutant mice. 
(A) Naive WT and Twist1-deficient CD4+CD62L+ T cells were cultured under Th1, 
Th2, Th9, Th17, and regulatory T (iTreg) cells polarizing conditions. Th1, Th2, 
Th9, and Th17 cells were restimulated with anti-CD3 for 24 h to access cytokine 
production by ELISA. (B) Percentage of Foxp3 expression in inducible Treg 
following in vitro differentiation and percentage of natural Treg cells. Data are 
mean of four independent experiments ± S.E.M. **p<0.01  
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Figure 43. Twist1 is regulated by STAT3 activating cytokines in Th17 cells. 
(A-B) Naive WT and Twist1-deficient CD4+CD62L+ T cells were cultured under 
Th17 polarizing conditions. On day 5, differentiated cells were rested or 
stimulated with IL-6, IL-23, or IL-12 for 2 h before gene expression analysis by 
qRT-PCR (A) and Twist1 expression by immunoblot with densitometry 
normalized against β-Actin (B). (C) Naïve wild type and Stat3-deficient CD4+ T 
cells were activated with anti-CD3 and anti-CD28 in the presence or absence of 
IL-6, TGF-β, or IL-12 and gene expression was analyzed by qRT-PCR after 3 d. 
(D) Schematic of the Twist1 promoter containing STAT3 binding sites. (E) Cells 
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prepared as in (A) were used for ChIP analysis using STAT3 antibody. Data are 
mean of replicate samples ± S.D. and representative of three independent 
experiments with similar results. 
 
Twist1 represses cytokine production in Th17 cells 
To further demonstrate the ability of Twist1 to regulate the Th17 phenotype, we 
ectopically expressed Twist1 in Th17 cells and examined cytokine production. 
Ectopic Twist1 expression in Th17 cells resulted in decreased IL-17A, IL-17F, 
and IFNγ production compared to control cells (Figure 44A-B). Consistent with 
observations in Figure 42A, Twist1-deficient Th17 cells produced more IL-17A, 
IL-17F, GM-CSF, and IFNγ than wild type cells, although IL-10 production was 
similar (Figure 44C-D).  
 
Since TGF-β inhibits Twist1 expression, and Th17 differentiation in the presence 
of IL-23 and absence of TGF-β results in highly encephalitogenic Th17 cells 
(Ghoreschi et al., 2010), we compared the differentiation of wild type and Twist1-
deficient CD4+ T cells in the presence or absence of TGF-β in Th17 cell culture 
conditions. Th17 cells derived in the absence of TGF-β had increased Twist1 
gene expression, compared to those derived under conventional Th17 conditions 
(Figure 44E). Moreover, Twist1-deficient Th17 cells derived in the absence of 
TGF-β had increased secretion of IL-17A, GM-CSF, and IFNγ (Figure 44F). 
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Figure 44. Twist1 suppresses cytokine production in Th17 cells. (A-B) Naïve 
CD4+CD62L+ cells were isolated from WT mice and differentiated under Th17 
culture conditions. On day 2, cells were transduced with either control or Twist1-
GFP (Twist1)-expressing retrovirus. On day 5, cells were stimulated with PMA 
and ionomycin for 6 h before intracellular staining (ICS) for cytokine production 
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(A) with the average of percent positive cells shown in (B). Data are gated on 
GFP+ cells. (C-D) Differentiated WT and Twist1-deficient Th17 cells were 
stimulated with PMA and ionomycin for 6 h before ICS analysis (C) or anti-CD3 
for 24 h for cytokine production measurement using ELISA (D). (E-F) Naïve wild 
type and Twist1-deficient CD4+ T cells were cultured under Th17 polarizing 
conditions with or without TGF-β. On day 5, cells were left unstimulated for gene 
expression analysis by qRT-PCR (E) or reactivated with anti-CD3 for 24 h to 
assess cytokine production by ELISA (F). Data are mean of four to five 
independent experiments ± S.D (A-D, F), or are mean of replicate samples ± 
S.D. and representative of three independent experiments with similar results 
(E). *p<0.05, **p<0.01. N.S., not significant. N.D., not detectable 
 
To demonstrate that Twist1 function is conserved in human Th17 cells, naïve 
CD4+ T cells isolated from the peripheral blood of healthy individuals were 
differentiated into Th17 cells, transfected with siRNA encoding TWIST1, and 
assessed for gene expression. Knockdown of TWIST1 in human Th17 cells 
resulted in increased IL17A, IL17F, and IFNG gene expression (Figure 45A). 
TWIST1 knockdown in human Th17 cells also resulted in increased expression 
of the Th17-inducing genes RORC, BATF, and MAF, compared to control cells 
(Figure 45A). Messenger RNA for Il17a, Rorc, Batf, and Maf was similarly 
increased in Twist1-deficient Th17 cells compared to wild type cells (Figure 45B). 
Since each of these genes is a direct target of STAT3 (Bauquet et al., 2009; 
Brustle et al., 2007; Durant et al., 2010; Ivanov et al., 2006; Schraml et al., 2009), 
we tested whether binding of STAT3 to the promoters of these genes was 
altered. Consistent with gene expression data, we also observed increased 
STAT3 binding to gene promoters in Twist1-deficient Th17 cells compared to wild 
type cells (Figure 45C). Together, these data demonstrate that Twist1 impairs 
differentiation of mouse and human Th17 cells cultured in the presence or 
absence of TGF-β. 
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Figure 45. Gene expression in mouse and human Th17 cells in the absence 
of Twist1. (A) Naïve CD4+CD62L+ cells were isolated from PBMCs and 
differentiated under Th17 culture conditions. On day 5, cells were transfected 
with control or siRNA targeting TWIST1, rested overnight, and stimulated with 
anti-CD3 to assess gene expression by qRT-PCR. (B-C) Differentiated WT and 
Twist1-deficient Th17 cells were used for gene expression analysis by qRT-PCR 
before (Rorc, Batf, and Maf) or after (Il17a) 6 h anti-CD3 stimulation (B) and ChIP 
analysis using STAT3 antibody (C). Data are mean of replicate samples ± S.D. 
and representative of three independent experiments with similar results (A-C).  
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The Twist1-E47 interaction could potentially regulate cytokine production in Th17 
cells 
Twist1 has been shown to form a dimer complex with E47 protein, which is 
inhibited by the DNA-binding inhibitor Id3 (Castanon et al., 2001; Firulli et al., 
2005; Hayashi et al., 2007). Interestingly, Id3-deficient mice have a defect in 
regulatory T cell generation and an enhancement in Th17 differentiation linked to 
the ability of E47 to induce Rorc expression (Maruyama et al., 2011). Maruyama 
et al. suggested that the ability of E47 to transactivate Rorc expression might 
require other factors downstream of IL-6 (Maruyama et al., 2011). In DAPA 
(Figure 36A) using nuclear extracts from WT and Twist1-deficient Th1 cells were 
incubated with biotinylated oligonucleotides containing a Twist1-binding 
sequence, we observed the binding of both Twist1 and E47 to oligonucleotides in 
WT samples (Figure 46A). However, E47 binding to oligonucleotides was 
significantly reduced in Twist1-deficient Th1 cells suggesting Twist1 might be 
required for E47 binding (Figure 46A). In addition, we detected increased E47 
binding at the Il17a and Rorc promoters in Twist1-deficient Th17 cells compared 
to WT cells correlating with increased Rorc and Il17a expression (Figure 46B-C). 
There was no change in either Tcfe2a (encoding E47) or Id3 expression (Figure 
46C). The results suggested that the Twist1-E47 association could play a 
potential role in the regulation of Th17 cell differentiation.  
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Figure 46. Twist1 interacts with E47 in Th1 cells. (A) Naïve CD4+CD62L+ WT 
or Twist1fl/fl CD4-Cre+ T cells were differentiated under Th1 culture conditions. 
Nuclear extracts from resting and activated WT and Twist1-deficient Th1 cells 
were incubated with biotinylated oligonucleotides containing Twist1-specific 
binding site and blotted for indicated proteins. (B-C) Naïve CD4+CD62L+ cells 
were isolated from WT and Twist1-mutant mice and differentiated under Th17 
culture conditions. Day 5 differentiated Th17 cells were used for ChIP analysis at 
the Il17a and Rorc promoters using E47 antibody (B) or assessing gene 
expression by qRT-PCR before (Tcfe2a, Id3 and Rorc) or after (Il17a) anti-CD3 
stimulation (C). Data are mean of replicate samples ± S.D. and representative of 
three independent experiments with similar results.  
 
Twist1 impairs IL-6-STAT3 signaling by repressing Il6ra expression 
Twist1-deficiency resulted in increased binding of STAT3 to Th17 target genes, 
and the balance between STAT3 and STAT5 signaling is crucial in regulating 
Th17 cell differentiation (Yang et al., 2011). We hypothesized that Twist1 was 
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phospho-STAT5 during Th17 differentiation using wild type and Twist1-deficient 
naïve CD4+T cells. The frequency of phospho-STAT3 was higher in Twist1-
deficient Th17 cells on day 2 and day 3 compared to wild type cells, although 
phospho-STAT5 was comparable between the two cell types (Figure 47A). The 
increase in phospho-STAT3 but not phospho-STAT5 in Twist1-deficient Th17 
cells correlates with higher IL-6Rα expression but similar IL-2Rα expression on 
days 2 and 3 compared to wild type cells (Figure 47B-C). Il6st, the gp130 chain 
of IL-6 receptor, and Stat3 expression were similar in both wild type and Twist1-
deficient Th17 cells, and Il6ra mRNA reflected the same pattern as protein 
expression (Figure 47C). Since IL-6Rα expression was increased at early time 
points, we examined cytokine production from Th17 cells during differentiation 
and observed the same increases of cytokine production from T cells that lack 
expression of Twist1 (Figure 47D). 
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Figure 47. Twist1 impairs IL-6-STAT3 signaling in Th17 cells. (A-D) Naïve 
CD4+CD62L+ T cells were isolated from WT and Twist1-mutant mice and 
differentiated under Th17-polarizing conditions. The levels of phospho-STAT3 
(pSTAT3) and phospho-STAT5 (pSTAT5) were measured by ICS each day (A). 
D0 D2 D3
0
20
40
60
80
100
%
 IL
-2
R
α
+
ce
lls
D0 D1 D2 D3 D4 D5
0
10
20
30
40
50
60
%
 p
ST
AT
5+
ce
lls
Days of differentiation
A
D0 D1 D2 D3 D4 D5
0
10
20
30
40
50
60
%
 p
ST
AT
3+
ce
lls
Days of differentiation
**
**
B
D0 D2 D3
0
5
10
15
20
25
30
%
 IL
-6
R
α
+
ce
lls *
**
D
D2 D3
0
5
10
15
20
25
30
35
IL
-1
7A
 (n
g/
m
l) **
**
D2 D3
0
100
200
300
400
IL
-1
7F
 (n
g/
m
l)
**
**
D2 D3
0
1
2
3
G
M
-C
SF
 (n
g/
m
l) **
**
C
WT Twist1fl/fl CD4-Cre+
WT
Twist1fl/fl CD4-Cre+
D0 D2 D3
0.0
0.5
1.0
1.5
R
el
at
iv
e 
ex
pr
es
si
on
Il6ra
D0 D2 D3
0.0
0.5
1.0
1.5
2.0
R
el
at
iv
e 
ex
pr
es
si
on
Il6st
D0 D2 D3
0
2
4
6
8
10
12
14
R
el
at
iv
e 
ex
pr
es
si
on
Stat3
WT
Twist1fl/fl CD4-Cre+
 130 
 
T cells cultured under Th17 conditions for 2 or 3 days were used for surface 
marker analysis (B), gene expression analysis by qRT-PCR (C), or analysis of 
cytokine production after anti-CD3 stimulation (D). Data are mean of four 
independent experiments ± S.D. (A-B, D), or are mean of replicate samples ± 
S.D. and representative of three independent experiments with similar results 
(C). *p<0.05, **p<0.01 
 
To test the requirement for STAT3 in this process, we treated wild type and 
Twist1-deficient Th17 cultures with an inhibitor of STAT3 activation during 
differentiation. Inclusion of the inhibitor decreased STAT3 phosphorylation at 
days 2, 3, and 5 of cultured wild type and Twist1-deficient T cells (Figure 48A). 
There was a corresponding dose-dependent decrease in IL-17 production at all 
time points (Figure 48B), with lower doses of the inhibitor resulting in similar IL-
17 production in Twist1-deficient Th17 cells compared to untreated wild type cells 
(Figure 48B). Thus, STAT3 is required for the increased IL-17 production from 
Twist1-deficient Th17 cells.  
 
Since IL-21 induced phospho-STAT3 and Twist1 expression (Figure 49A), we 
wanted to determine whether Twist1 also has a negative effect on IL-21-STAT3 
signaling. IL-21 was used instead of IL-6 to derive Th17 cultures with wild type 
and Twist1-deficient naïve CD4+ T cells and similar analyses were performed. 
The level of phospho-STAT3 in Twist1-deficient Th17 cells was the same on day 
2 and modestly increased on day 3 compared to WT cells, and the level of 
phospho-STAT5 was comparable between the two cell types (Figure 49B). Il6ra 
and transcription factor (Rorc, Batf, and Runx1) expression and IL-17A 
production were similar between wild type and Twist1-deficient Th17 cells 
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derived with IL-21 (Figure 49C-E). These results suggested that Twist1 
specifically targets IL-6-STAT3 signaling in Th17 cells.  
 
Figure 48. Inhibition of STAT3 activation reduced IL-17A production in 
Twist1-deficient Th17 cells. (A-B) Naïve CD4+CD62L+ T cells were isolated 
from WT and Twist1-mutant mice and differentiated under Th17-polarizing 
conditions with increased doses of STAT3 inhibitor (JSI-124). Cells were 
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harvested on days 2, 3, and 5 and used to measure the level of phospho-STAT3 
(pSTAT3) by ICS (A) or restimulated with anti-CD3 to assess cytokine production 
by ELISA (B). Data are mean of replicate samples ± S.D. and representative of 
three independent experiments with similar results. 
 
Figure 49. Twist1 does not affect IL-21-STAT3 signaling. (A) Naïve 
CD4+CD62L+ T cells were isolated from wild type and Twist1-mutant mice and 
differentiated under Th17 polarizing conditions. On day 5, cells were rested or 
stimulated with IL21 for 2 h before gene expression analysis by qRT-PCR. (B-E) 
Naïve CD4+CD62L+ T cells were isolated from wild type and Twist1-mutant mice 
and differentiated under Th17 polarizing conditions using IL-21 instead of IL-6. 
On days 2 and 3, cells were harvested, stained for pSTAT3 and pSTAT5 by ICS 
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(B), used for gene expression analysis by qRT-PCR (C). On day 5, cells were 
harvested, restimulated with anti-CD3 for 24 h and cytokine production was 
measured by ELISA (D) or rested for gene expression assessment by qRT-PCR 
(E). Data are mean of three independent experiments ± S.D (B-D), or are mean 
of replicate samples ± S.D. and representative of three independent experiments 
with similar results (A, E). 
 
We next wanted to determine whether Twist1 represses Il6ra expression by 
directly binding to the E-box sites in the Il6ra promoter that is conserved in 
mouse and human genes (Figure 50A). When ChIP was performed using wild 
type and Twist1-deficient Th17 cells, the binding of Twist1 to the promoter of 
Il6ra was observed by days 2 and 3 in wild type cell cultures, with the peak of 
binding following the peak of Twist1 expression (Figure 50B-C). To further 
demonstrate the direct consequences of Twist1 binding to the Il6ra promoter, 
Jurkat T cells were transfected with an IL6RA luciferase reporter and a plasmid 
encoding Twist1. Notably, Twist1 repressed the transcriptional activity of the 
IL6RA promoter, but not an NFAT reporter, in a dose-dependent manner (Figure 
50D). 
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Figure 50. Twist1 represses Il6ra transcription. (A) Schematic of the Il6ra 
promoter containing Twist1 binding sites. (B-D) Naïve CD4+CD62L+ T cells were 
isolated from WT and Twist1-mutant mice and differentiated under Th17-
polarizing conditions. T cells cultured under Th17 conditions for 2 or 3 days were 
used for gene expression analysis by qRT-PCR (B), or used for ChIP analysis 
using Twist1 antibody (C). (D) Luciferase activity in Jurkat T cells transfected with 
various concentrations of plasmid encoding Twist1 along with IL6RA or NFAT 
luciferase reporter, then activated for 6 h with PMA and ionomycin. Data are 
representative of three independent experiments with similar results. N.D., not 
detectable 
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Mice with Twist1-deficient T cells display an early onset of MOG-induced EAE 
Although Th1 and Th17 cells have been demonstrated to be crucial in mediating 
the development of experimental autoimmune encephalomyelitis (EAE), the role 
of IFNγ and IL-17 in EAE disease has been controversial (Becher and Segal, 
2011; Pierson et al., 2012). Recently, GM-CSF, produced by Th1 and Th17 cells, 
has been identified as a contributor to the development of EAE (Codarri et al., 
2011; El-Behi et al., 2011). As Twist1 negatively regulates IL-17, GM-CSF, and 
IFNγ in Th17 cells (Figure 44) and IFNγ in Th1 cells (Figure 30) (Pham et al., 
2012), we wanted to compare the development of myelin oligodendrocyte 
glycoprotein (MOG) peptide-induced EAE in wild type and Twist1fl/fl CD4-Cre+ 
mice. Twist1fl/fl CD4-Cre+ mice manifested earlier onset of MOG-induced EAE 
than wild type mice, although maximal severity and recovery were similar (Figure 
51A). Increased disease resulted in a 26% increase in the area under the mean 
clinical disease score curve of Twist1fl/fl CD4-Cre+ mice, compared to control 
mice. The number of days with a mean clinical score greater than one was an 
average of 16.5 for control mice and 21 for Twist1fl/fl CD4-Cre+ mice, an increase 
of 27%. Earlier disease development correlated with an increase in CD4+IL-17A+, 
CD4+IFNγ+, and CD4+IL-17A+IFNγ+ mononuclear cells isolated from the brain of 
Twist1-mutant mice compared to wild type mice at day 12 (Figure 51B-C). In 
addition, MOG-stimulated Twist1-deficient splenocytes produced significantly 
more IL-17, GM-CSF, and IFNγ compared to wild type cells (Figure 51D). The 
earlier onset of MOG-induced EAE in Twist1-mutant mice is not likely due to a 
defect in regulatory T cells since Twist1-mutant mice have percentages of Treg 
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cells in vivo, and in vitro development of Treg cells, that are comparable to wild 
type mice (Figure 42B). Together, these data suggest that Twist1 limits the 
development of inflammatory T cell subsets and autoimmune disease. 
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Figure 51. Early onset of EAE in the absence of Twist1. (A-D) WT and 
Twist1-mutant mice were immunized with MOGp(35-55) to induce EAE. Mean 
clinical score in MOG-induced EAE disease (A). On day 12, mononuclear cells 
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were isolated from brain and stimulated with PMA and ionomycin for 6 h to 
measure cytokine production by ICS (gated on CD4+ T cells) (B,C) or 
splenocytes were stimulated with MOG peptide for 48 h and cytokine production 
was assessed by ELISA (D). Data are mean ± S.E.M. of 7 mice per group (A) or 
4 mice per group (B-D) and representative of two independent experiments with 
similar results. *p<0.05, **p<0.01 
 
Twist1 limits T follicular helper cell development 
In the previous section, we demonstrated that Twist1 impacts IL-6 signaling by 
repressing Il6ra gene expression. In addition, it has been shown that IL-6-
induced STAT3 signaling is required for Tfh development, we wanted to 
determine if Twist1-deficiency in T cells affected Tfh generation. Twist1 is 
expressed at greater amounts in Tfh cells (CD4+CD44+CXCR5+PD-1+) than in 
non-Tfh effector cells (CD4+CD44+CXCR5-PD-1-) or naïve T cells (CD4+CD44-
CD62L+) (Figure 52).  
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Figure 52. Twist1 expression in T follicular helper cells. Twist1 intracellular 
staining in Tfh cells (CD4+CD44hiCXCR5+PD-1+) compared to effector T cells 
(CD4+CD44hiCXCR5-PD-1-) and naïve T cells (CD4+CD44loCD62Lhi) in day 9 
SRBC-immunized WT mice.  
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red blood cells (SRBCs). As observed following MOG peptide immunization, 
SRBC immunization resulted in increased Tfh cell development in Twist1fl/fl CD4-
Cre+ mice, compared to wild type mice (Figure 53C-D). Percentages of Tfh cells 
in the absence of Twist1 were similarly increased defining cells with either ICOS 
Twist1 
CD4
C
D
44
PD-1
C
XC
R
5
CD4
C
D
62
L
MFI = 4953.9
MFI = 3096.1
MFI = 1925.7
 140 
 
or Bcl-6 expression (Figure 53C-D). Moreover, in the absence of Twist1 there 
was an increase in the percentages of CD4+CXCR5+PD-1hi cells that were 
phospho-STAT3-positive and IL-6Rα-positive, and the amount (MFI) of IL-6Rα 
expression (Figure 53C-D). We then sorted Tfh and non-Tfh cells from SRBC-
immunized wild type and Twist1fl/fl CD4-Cre+ mice to examine changes in gene 
expression following normalization for the increased Tfh cell number in the 
absence of Twist1. Consistent with flow cytometry (Figure 52), Twist1 was 
expressed in greater amounts in the Tfh population than in non-Tfh cells, and no 
Twist1 mRNA was detected in Cre+ cells (Figure 53E). We observed little 
difference in gene expression of Batf, Bcl6, and Irf4 between wild type and 
Twist1fl/fl CD4-Cre+ cells in the non-Tfh population. In the Tfh population, the 
absence of Twist1 resulted in modest increases of Batf and Bcl6, and a more 
dramatic increase of Irf4 (Figure 53E). Similar to observations in Th17 cells, the 
gene most increased in Twist1-deficient Tfh cells was Il6ra (Figure 53E). 
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Figure 53. Mice with Twist1-deficient T cells have more T follicular helper 
cells. (A-B) WT and Twist1fl/fl CD4-Cre mice were immunized with MOGp(35-55) 
as in Figure 39. Twenty days following immunization, splenocytes were stained 
for T follicular helper (Tfh) cells (A) with the average percent PD-1+ICOS+ cells in 
(B). (C-E) WT and Twist1fl/flCD4-Cre+ mice were immunized with SRBC. On day 
9, splenocytes were analyzed by flow cytometry with percentages of PD-
1+ICOS+, PD-1+pSTAT3+, and PD-1+IL-6Rα+ cells indicated in (C), and the 
average percent positive cells shown in (D). Following immunization, cell 
populations were sorted for CD4+CXCR5+PD-1+ICOS+ (Tfh) or CD4+CXCR5-PD-
1-ICOS- (non-Tfh) and gene expression was analyzed (E). (A-D) Data are gated 
on CD4+CXCR5+. Data are mean ± S.E.M. of 4-5 mice per group and 
representative of two independent experiments with similar results (A-D), or are 
mean of replicate samples ± S.D. and representative of three independent 
experiments with similar results (E). *p<0.05. N.D., not detectable 
 
We then tested whether T cells activated in the presence or absence of IL-6 (Tfh-
like conditions) demonstrated Twist1-dependent regulation of Tfh genes. Addition 
of IL-6 to activated T cell cultures resulted in increased pSTAT3, increased 
STAT3 binding to the Twist1 promoter, and increased Twist1 expression over 48 
hours of culture (Figure 54A-C). Paralleling the induction of Twist1 expression, 
Twist1 binding to the Il6ra, Bcl6, and Icos promoters was also induced by IL-6 
(Figure 54D). Thus, as in Th17 cells, Twist1 is a component of a STAT3-
inducible negative feedback loop in Tfh cells. 
 
To determine the functional consequences of the increased Tfh cells that develop 
in mice with Twist1-deficient T cells we examined the development of germinal 
center B cells and antibody production following SRBC immunization. We 
observed a 3-fold increase in the percentages of germinal center B cells (defined 
as B220+CD19+Fas+ GL-7+PNA+) (Figure 55A-B). Analysis of SRBC-specific 
antibody production demonstrated increased serum IgG antibody titers in 
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Twist1fl/fl CD4-Cre+ mice, compared to wild type mice (Figure 55C). Isotype-
specific analysis demonstrated greater IgG1 and IgG2a/c serum antibody titers in 
mice that lack Twist1 expression in T cells than in wild type cells. Thus, Twist1 
limits Tfh development and humoral immunity. 
 
Figure 54. Twist1 binds to Tfh cell-associated genes. (A-D) Naïve WT 
CD4+CD62L+ T cells were activated with or without IL-6 for 2 days. Cells were 
harvested daily to measure the level of phospho-STAT3 (pSTAT3) by ICS (A), 
analyze STAT3 binding to the Twist1 promoter (B) or Twist1 binding to the 
indicated promoters (D) by ChIP assay, or to assess gene expression by qRT-
PCR (C). Data are mean of replicate samples ± S.D. and representative of three 
independent experiments with similar results. N.D., not detectable 
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Figure 55. Twist1 represses germinal center B cells and antibody 
production in SRBC-immunized mice. (A-C) WT and Twist1fl/fl CD4-Cre+ mice 
were immunized with SRBC. On day 9, splenocytes were stained for germinal 
center B cells (A) with the average percent positive cells and total cell count 
shown in (B). Data are gated on B220+CD19+Fas+. Serum from WT and Twist1-
deficient mice was diluted and used to measure antibody titers by ELISA (C). 
Data are mean ± S.E.M. of 4-5 mice per group and representative of two 
independent experiments with similar results. *p<0.05 
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Part IV-Etv5 regulates T helper cell development 
Etv5-deficient T cells display defects in T helper cell differentiation  
Having demonstrated that Twist1 negatively regulates Th1 cell differentiation, we 
next wanted to study the role of Etv5, another STAT4-induced transcription 
factor, which has been shown to regulate IFNγ production in Th1 cells (Ouyang et 
al., 1999). However, the role of Etv5 in T helper cell development is still poorly 
understood. In order to study the role of Etv5 in T cells, we generated mice with 
Etv5-deficiency in T cells (Etv5fl/fl CD4-Cre+) by mating Etv5fl/fl mice (Zhang et al., 
2009) with mice carrying a CD4-Cre transgene. We confirmed the absence of 
Etv5 expression in Etv5-deficient T cells using an antibody specific for C-terminal 
region (Figure 56A). Mice with Etv5-deficient T cells display normal lymphocyte 
development in thymus, spleen and lymph nodes compared to wild type 
littermate controls (Figure 56B). To define the role of Etv5 in T helper cell 
differentiation, we first examined Etv5 expression in T helper cell subsets. Etv5 
expression was highest in resting and activated Th1 cells compared to other 
helper cell subsets at the message and protein levels (Figure 57A-B). Naïve 
CD4+ T cells from wild type and Etv5-mutant mice were used to generate Th1, 
Th2, and Th17, and cytokine production and gene expression were assessed. 
Interestingly, there were multiple defects in T helper cell differentiation. Etv5-
deficient Th1 and Th2 cells produced more IFNγ and IL-4, respectively; while 
Etv5-deficient Th17 cells produced significantly less IL-17A compared to those of 
wild type cells (Figure 57C). Similar results were observed at the message level 
in Etv5-deficient T cells compared to wild type cells (Figure 57D). We next 
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examined the expression of transcription factors that are critical for the 
development of each subset. Surprisingly, Gata3 and Rorc expression were 
similar between WT and Etv5-deficient Th2 and Th17, respectively (Figure 57E). 
Etv5-deficient Th1 cells expressed higher Tbx21 compared to WT cells (Figure 
57E).  
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Figure 56. Characterization of mice with Etv5-deficient T cells. Naïve 
CD4+CD62L+ T cells from WT and Etv5fl/fl CD4-Cre+ were activated with anti-CD3 
and anti-CD28 for 5 days. Nuclear lystates were extracted and immunoblotted for 
Etv5 and β-Actin as a control. (B) Total cells were isolated from thymus, spleen 
and lymph nodes of WT and Etv5-mutant mice and stained for cell surface 
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markers. Data are representative of two independent experiments with similar 
results.   
 
Figure 57. T helper cell differentiation in the absence of Etv5 in T cells. (A-
D) Naive wild type and Etv5-deficient CD4+CD62L+ T cells were activated (Th0) 
or cultured under Th1, Th2, Th17, and regulatory T (Treg) cell polarizing 
conditions. Etv5 expression was measured in T helper subsets by qRT-PCR 
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before and after 6 h anti-CD3 stimulation (A) or by intracellular staining (ICS) (B). 
∆MFI was calculated by subtracting the background from the signal of Etv5 
antibody. Th0, Th1, Th2, and Th17 cells were used for assessing cytokine 
production by ELISA after 24 h anti-CD3 stimulation (C), and gene expression 
analysis before (Tbx21, Gata3, and Rorc) or after (Ifng, Il4, and Il17a) 6 h anti-
CD3 stimulation by qRT-PCR (D). Data are gated on CD4+ cells. Data are mean 
of four independent experiments ± S.E.M (A, C-D), or are representative of three 
independent experiments with similar results (B). *p<0.05 
 
We next evaluated the percentages of in vitro generated (iTreg) and thymically 
derived natural regulatory T (nTreg) cells between WT and Etv5-mutant mice. 
The nTreg cell population (defined as CD4+CD25+Foxp3+) in both lymph nodes 
and spleen was modestly but not significantly decreased in Etv5-mutant mice 
compared to WT mice (Figure 58A). Similarly, Etv5-deficient iTreg cells 
expressed less Foxp3 compared to WT cells at both message and protein levels 
(Figure 58B). Thus, mice that lack Etv5 expression in T cells display multiple 
defects in T helper cell differentiation in vitro.  
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Figure 58. Regulatory T cell population in Etv5-mutant mice. (A-B) Cells 
isolated from lymph nodes (LN) and spleens (SPL) with indicated genotypes or 
day 5 in vitro generated regulatory T (Treg) cells were assessed for natural 
(nTreg, CD4+CD25+Foxp3+) (A) or inducible (Foxp3+) Treg cells by intracellular 
staining and qRT-PCR for Foxp3 gene expression (B). Data are gated on CD4+ 
cells. Data are mean of four independent experiments ± S.E.M. *p<0.05 
 
Mice with Etv5-deficient T cells had reduced allergic inflammation 
The data suggested that Etv5 plays a repressive role in Th1 and Th2 cell 
differentiation while promoting Th17 cell differentiation (Figure 57). To distinguish 
the importance of these effects in vivo, we performed house dust mite (HDM)-
induced allergic inflammation in the lung, a model that is Th2- and Th17-
dependent (Wilson et al., 2009b). We sensitized and challenged mice with 
intranasal HDM antigen for five weeks and assessed the inflammation. 
Interestingly, Etv5-mutant mice had significantly decreased numbers of total cells 
and specific cell populations in lung compared to wild type mice (Figure 59A). 
Analysis of the cellular composition of bronchioalveolar lavage (BAL) fluid 
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showed similar results (Figure 59B). Histological examination also demonstrated 
diminished inflammatory cell infiltrates in the lung, and decreased mucus 
production in the airways of Etv5-mutant mice compared to control mice (Figure 
59C). Given that we observed the greatest fold reduction (> 5-fold) of the 
infiltrating neutrophils into the lung and BAL fluid in Etv5-mutant mice compared 
to wild type mice among all cell types (Figure 59A-B), we wanted to examine the 
expression of neutrophil attractant chemokines in total lung RNA. Consistent with 
the decrease in neutrophils, expression of Cxcl2, an IL-17-induced gene, was 
reduced in lung tissue from Etv5-mutant mice compared to control lung tissue 
(Figure 59D). In contrast there was no difference in Cxcl1 expression (Figure 
59D).  
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Figure 59. Etv5-mutant mice have reduced HDM-induced allergic 
inflammation. (A-D) Wild type and Etv5-mutant mice were immunized (i.n.) with 
HDM for five weeks to induce asthma. Inflammatory cells in the lung and BAL 
fluid of WT and Etv5-mutant mice: Eos, eosinophils; Lymph, lymphocytes; DC, 
dendritic cells; Neu, neutrophils; Mac, macrophages (A-B). Cell infiltration in the 
lungs and mucus in the airways of WT and Etv5-mutant mice evaluated by H&E 
and PAS staining (C). Total cells from lungs of WT and Etv5-mutant mice were 
used for gene expression analysis by qRT-PCR (D). Data are mean ± S.E.M. of 6 
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mice per group (A-D) and representative of two independent experiments with 
similar results. *p<0.05, **p<0.01 
 
We next assessed the cytokine production in the lung and BAL cells of HDM-
induced allergic inflammation in wild type and Etv5-mutant mice. Consistent with 
in vitro analyses (Figure 57), there were significant decreased frequency and 
numbers of IL-17A-producing CD4+ T cells from the lung and BAL fluid of Etv5-
mutant mice compared to wild type mice (Figure 60A-B). No change was 
observed in the frequency of IL-13-producing CD4+ T cells from the lung and BAL 
fluid, although the cell number was decreased in Etv5-mutant mice compared to 
control mice (Figure 60A, C). The amount of IL-17A and IFNγ in the BAL fluid 
from Etv5-mutant mice was significantly decreased compared to BAL fluid of wild 
type mice, although similar amounts of IL-13 and IL-4 were observed (Figure 61). 
The frequency of Treg cells (identified by CD4+Foxp3+) and mean fluorescence 
intensity of Foxp3 in the lung and BAL cells were similar between wild type and 
Etv5-mutant mice (Figure 60D-F). We next assessed the generation of helper T 
cell responses in the periphery by stimulating splenic and mediastinal lymph 
nodes cells with HDM extract. IL-17A and IFNγ production were significantly 
reduced in Etv5-mutant mice compared to control mice, although there was no 
difference in the amount of IL-13 or IL-4 (Figure 61). Collectively, these results 
demonstrated that the critical role of Etv5 in vivo in response to an allergic 
allergen in experimental airway inflammation is the regulation of IL-17-secreting 
T cells. 
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Figure 60. Etv5 regulates Th17 cells in HDM-induced allergic inflammation. 
(A-F) Wild type and Etv5-mutant mice were immunized (i.n.) with HDM for five 
weeks to induce asthma. Lung and BAL cells of HDM-induced asthma in WT and 
Etv5-mutant mice were stimulated with PMA and ionomycin for 6 h to assess 
cytokine production (A-C) and Foxp3 expression (D-F) by intracellular staining 
(ICS) with the average percent positive cells, cell number and mean fluorescence 
intensity (MFI) (B-C, E-F). Data are mean ± S.E.M. of 6 mice per group and 
representative of two independent experiments with similar results. *p<0.05 
 
 
Figure 61. Etv5 regulates cytokine production in HDM-induced allergic 
inflammation. Cells from spleens (SPL) and mediastinal lymph nodes (MLN) 
from Figure 57 were stimulated with HDM for 5 days. Cell-free supernatant and 
BAL fluid were used to assess cytokine production by ELISA. Data are mean ± 
S.E.M. of 6 mice per group and representative of two independent experiments 
with similar results. *p<0.05 
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STAT3-activating cytokines induce Etv5 expression 
Given that Etv5 positively regulates IL-17 in vitro and in the HDM-induced allergic 
inflammation (Figure 57C-D, 60), we wanted to more fully elucidate the ability of 
Etv5 to promote Th17 cell differentiation. We first assessed the kinetics of Etv5 
gene expression during Th17 cell differentiation. We observed increased Etv5 
expression 48 h after activation that gradually decreased over the subsequent 
three days of differentiation (Figure 62A). Since STAT4 regulates Etv5 
expression in Th1 cells (Ouyang et al., 1999), we wanted to test whether STAT3 
might induce Etv5 expression in Th17 cultures. Stimulation of wild type Th17 
cells with IL-6 or IL-23 to activate STAT3, or IL-12 to activate STAT4, led to 
increased Etv5 mRNA and protein expression compared to unstimulated cells 
(Figure 62B-C). Since Etv5 expression in Th17 cells is lower than Th1 cells 
(Figure 57A), we hypothesized that an inhibitory signal represses Etv5 
expression in developing Th17 cells. As expected, IL-6 or IL-12 induced Etv5 
expression in activated CD4+ T cells and this was decreased when TGF-β was 
added to the culture (Figure 62D). To further confirm that Etv5 is a STAT3 target 
gene, we treated activated wild type and Stat3-deficient T cells with either IL-6 or 
IL-12, and Etv5 expression was assessed. As expected, IL-6 or IL-12 induced 
Etv5 expression in activated CD4+ T cells (Figure 62D). We next wanted to 
determine if STAT3 could directly bind to the STAT3 binding sites that are 
conserved in mouse and human genes (Figure 62E). Differentiated wild type 
Th17 cells were stimulated with cytokines known to activate STAT3, and binding 
was examined by Chromatin Immunoprecipitation (ChIP) assay. In Th17 cells, 
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STAT3-activating cytokines, but not IL-12 resulted in STAT3 binding to the Etv5 
promoter, in greater amounts at the distal than the proximal binding sites (Figure 
62F). These results suggested that STAT3-activating cytokines and TGF-β play 
opposing roles in regulating Etv5 expression in Th17 cultures.  
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Figure 62. Etv5 is regulated by STAT3 activating cytokines in Th17 cells. (A-
C, F) Naive wild type CD4+CD62L+ T cells were cultured under Th17 polarizing 
conditions. Kinetics of Etv5 gene expression during Th17 cell differentiation (A). 
Th17 cells were stimulated with IL-6, IL-23, and IL-12 for 2 h before gene 
expression analysis by qRT-PCR (B) or protein expression by ICS (C). (D) Naïve 
wild type and Stat3-deficient CD4+ T cells were activated with anti-CD3 and anti-
CD28 in the presence or absence of IL-6, TGF-β, or IL-12 and gene expression 
was assessed by qRT-PCR after 3 d. (E) Schematic of the Etv5 promoter 
containing STAT3 binding sites. (F) Cells prepared as in (B) were used for ChIP 
analysis using STAT3 antibody. Data are mean of replicate samples ± S.D. and 
representative of three independent experiments with similar results (A-F). 
*p<0.05. N.D., not detectable 
 
Etv5 directly activates the Il17a-Il17f locus in Th17 cells 
To further demonstrate the function of Etv5 in Th17 cell programming, we 
ectopically expressed Etv5 in Th17 cells and assessed cytokine production. 
Ectopic Etv5 expression in Th17 cells resulted in increased IL-17A and IL-17F 
production compared to control cells (Figure 63A-B). To test whether Etv5 alone 
could induce IL-17 production in CD4+ T cells, Etv5 was ectopically expressed in 
non-polarized CD4+ T cells (Th0). Ectopic Etv5 expression in Th0 cells was able 
to induce IL-17A production compared to control cells (Figure 63C). Consistent 
with these observations, reduced Etv5 expression in Th17 cells by transfecting T 
cells with siRNA targeting Etv5 (Figure 63D) or using Etv5-deficient T cells 
(Figure 63E) resulted in increased IL-17A and IL-17F compared to control cells. 
GM-CSF production was not significantly different in control cells and cells that 
lack Etv5 expression (Figure 63D-E). We next examined the expression of 
transcription factors that are required for Th17 cell differentiation (Bauquet et al., 
2009; Brustle et al., 2007; Durant et al., 2010; Ivanov et al., 2006; Schraml et al., 
2009). Surprisingly, reduced Etv5 expression did not alter gene expression of 
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Rorc, Batf, Maf, and Irf4 (Figure 64A-B). We also noted a decrease in Bcl6 
expression in cells with reduced Etv5 expression compared to control cells 
(Figure 64A-B).  
 
Figure 63. Etv5 promotes cytokine production in Th17 cells. (A-C) Naïve 
CD4+CD62L+ T cells were isolated from wild type mice and differentiated under 
neutral conditions (Th0) or Th17 culture conditions. On day 2, cells were 
transduced with either control or Etv5-YFP (Etv5)-expressing retrovirus. On day 
5, Th17 cells were stimulated with PMA and ionomycin for 6 h before intracellular 
staining (ICS) for cytokine production (A) with the percent positive cells shown in 
(B). Data are gated on YFP+ cells. Cytokine production from sorted YFP+ Th0 
cells was assessed by ELISA following 24 h stimulation with anti-CD3 (C). WT 
Th17 cells were transfected with control or siRNA-specific Etv5, rested overnight, 
and restimulated with anti-CD3 to assess cytokine production by ELISA (D). Wild 
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type and Etv5-deficient Th17 cells were restimulated with anti-CD3 to assess 
cytokine production by ELISA (E). Data are mean of four independent 
experiments ± S.E.M.(A-B, D-E) or are mean of replicate samples ± S.D. and 
representative of four independent experiments with similar results (C). *p<0.05, 
**p<0.01 
 
Figure 64. Etv5 does not regulate transcription factor expression in Th17 
cells. (A) WT Th17 cells were transfected with control or siRNA-specific Etv5 and 
rested overnight to assess gene expression by qRT-PCR. (B) Resting wild type 
and Etv5-deficient Th17 cells were used assess gene expression by qRT-PCR 
(B). Data are mean of replicate samples ± S.D. and representative of four 
independent experiments with similar results.  
 
Since Etv5 did not impact any of the known regulators of IL-17A/F expression, 
we tested whether Etv5 directly regulated expression of the Il17a-Il17f locus. 
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sites across the Il17a-Il17f locus including the promoters and several conserved 
non-coding sequences (Figure 65A-B). We next transfected Jurkat T cells with 
IL17A and IL17F luciferase reporters and plasmid encoding Etv5 to demonstrate 
the direct consequences of Etv5 binding to the Il17a-f promoters. Notably, Etv5 
promotes the transcriptional activity of the IL17A and IL17F promoters, but not an 
NFAT promoter, in a dose-dependent manner (Figure 65C). To define the 
modifications of histones correlated with active (H3K4 tri-methylation and H3K27 
acetylation) and repressed (H3K27-trimethylation) gene expression at the Il17a-
Il17f locus, we performed ChIP assays from control and Etv5-deficient Th17 
cells. Interestingly, we observed decreased H3K4 methylation and H3K27 
acetylation and increased H3K27 methylation across the Il17a-Il17f locus in the 
absence of Etv5 (Figure 66). In addition, the association of histone 
acetyltransferase p300 was decreased at the Il17a-Il17f locus in Etv5-deficient 
Th17 cells compared to wild type cells (Figure 66). These results suggested that 
Etv5 directly promotes IL-17 production, recruits histone modifying enzyme, and 
mediates changes at the Il17a-Il17f locus in Th17 cells.  
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Figure 65. Etv5 binds the Il17a/f locus in Th17 cells. (A) Schematic of the 
Il17a/f locus containing ETS binding sites. (B) Naïve CD4+CD62L+ T cells were 
isolated from wild type mice and differentiated under Th17 culture conditions. 
ChIP analyses were performed using differentiated WT and Etv5-deficient Th17 
cells to examine Etv5 binding to the Il17a-Il17f locus. (C) Luciferase activity in 
Jurkat T cells transfected with increased concentrations of plasmid encoding 
Etv5 along with IL17A, IL17F, or NFAT luciferase reporters, then activated for 6 h 
with PMA and ionomycin. Data were normalized to control samples. Data are 
mean of replicate samples ± S.D. and representative of three independent 
experiments with similar results.   
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Figure 66. Etv5 mediates epigenetic changes at the Il17a-Il17f locus. ChIP 
analyses were performed using differentiated WT and Etv5-deficient Th17 cells 
to histone modification and the association of histone modifying enzyme at the 
Il17a-Il17f locus. Data are mean of replicate samples ± S.D. and representative 
of three independent experiments with similar results.   
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Th17 cells. Interestingly, there is a potential physical association between Etv5 
and Twist1 (Zhang et al., 2010b). Therefore, we wanted to investigate whether 
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and cytokine production. siRNA knockdown of Etv5 in wild type or Twist1-
deficient Th17 cells decreased IL-17A and IL-17F production, with no effects on 
IFNγ and GM-CSF production compared to control siRNA cells (Figure 67A, B). 
The result suggested that Etv5 could modulate cytokine production in a Twist1-
independent manner. Interestingly, decreased Etv5 expression in wild type Th17 
cells resulted in increased Twist1 expression (Figure 67A). Etv5-dependent 
regulation of Twist1 is likely direct as ChIP assay from Th17 cells demonstrated 
Etv5 bound to the Twist1 promoter (Figure 67C).  
 
Since Etv5 potentially forms a complex with Twist1, we next wanted to determine 
whether Etv5 could recover IL-17A production in Twist1 transduced Th17 cells. 
Ectopic Twist1 or Etv5 expression in wild type Th17 cells resulted in decreased 
or increased IL-17A production, respectively (Figure 67D). However, ectopic Etv5 
expression was not able to rescue IL-17A production in Twist1 transduced Th17 
cells (Figure 67D). Consistently, Etv5 could not prevent Twist1 from repressing 
the transcriptional activity of the Il6ra promoter (Figure 67E). Collectively, these 
results suggested that Etv5 positively regulates IL-17 production in Th17 cells, 
and that Etv5 and Twist1 reciprocally regulate gene expression of the opposing 
factor. However, Twist1 exerts a dominant role over Etv5 in controlling Th17 
cytokine production.  
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Figure 67. Etv5 controls IL-17 production in Twist1-dependent and -
independent manners. (A-B) Naïve CD4+ T cells were isolated from wild type 
and Twist1-mutant mice and differentiated under Th17 polarizing conditions. On 
day 2, cells were transfected with control or siRNA targeting Etv5, rested 
overnight, and analyzed for gene expression by qRT-PCR (A) or stimulated with 
anti-CD3 for cytokine production analysis by ELISA (B). (C) Day 5 differentiated 
wild type Th17 cells were used for ChIP analysis of the Twist1 promoter using 
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Etv5 antibody. (D) Wild type Th17 cells were doubly transduced with control, 
Twist1-expressing, or Etv5-expressing retroviral vectors. Doubly transduced cells 
were sorted on day 5 and stimulated with anti-CD3 for 24 h before cytokine 
production analysis by ELISA. (E) Luciferase activity was measured in Jurkat T 
cells transfected with the combination of plasmid expressing Etv5, Twist1 and 
IL6RA luciferase reporter, following activation for 6 h with PMA and ionomycin. 
Data are mean of replicate samples ± S.D. and representative of three 
independent experiments with similar results. N.D., not detectable 
 
Etv5 is required for T follicular helper cell development 
Since Bcl6 expression was decreased in Th17 cells that lack Etv5 expression 
(Figure 64), and because Bcl-6 is a master regulator of T follicular helper (Tfh) 
cell development, we wanted to determine if Etv5-deficiency in T cells affected 
Tfh generation. Etv5 is expressed at greater amounts in Tfh cells 
(CD4+CD44+CXCR5+PD-1+) than in non-Tfh effector cells (CD4+CD44+CXCR5-
PD-1-) or naïve T cells (CD4+CD44-CD62L+) (Figure 68). To examine the ability 
of Etv5 to regulate Tfh development, we immunized wild type and Etv5fl/fl CD4-
Cre+ mice with sheep red blood cells (SRBC). SRBC immunization resulted in 
dramatically reduced percentages of Tfh cells and cell number (defining cells with 
either ICOS or Bcl-6 expression) in Etv5fl/fl CD4-Cre+ mice, compared to wild type 
mice (Figure 69).  
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Figure 68. Etv5 expression in T follicular helper cells. Etv5 intracellular 
staining in Tfh cells (CD4+CD44hiCXCR5+PD-1+) compared to effector T cells 
(CD4+CD44hiCXCR5-PD-1-) and naïve T cells (CD4+CD44loCD62Lhi) in day 9 
SRBC-immunized WT mice.  
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Figure 69. Mice with Etv5-deficient T cells have reduced T follicular helper 
cells. (A-C) WT and Etv5fl/flCD4-Cre+ mice were immunized with SRBC. On day 
9, splenocytes were analyzed by flow cytometry with percentages of PD-1+ICOS+ 
and PD-1+Bcl-6+ cells indicated in (B), and the average percent positive cells 
shown in (C). Data are mean ± S.E.M. of 4-5 mice per group and representative 
of two independent experiments with similar results. *p<0.05 
 
We then tested whether T cells activated in the presence of absence of IL-6 (Tfh-
like conditions) demonstrated Etv5-dependent regulation of Tfh genes. Addition 
of IL-6 to activated T cell cultures resulted in increased pSTAT3, increased 
STAT3 binding to the Etv5 promoter, and increased Etv5 expression over 48 
hours of culture (Figure 70A-C). Since we identified ETS binding sites in the Bcl6 
promoter that are conserved in mouse and human genes (Figure 70D), we 
examined the ability of Etv5 to bind to the Bcl6 promoter. Paralleling the induction 
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of Etv5 expression, Etv5 binding to the Bcl6 promoter that contains conserved 
Etv5 binding sites was also induced by IL-6 (Figure 70E).  
 
Figure 70. Etv5 binds the Bcl6 promoter. (A-E) Naïve WT CD4+CD62L+ T cells 
were activated with or without IL-6 for 2 days. Cells were harvested daily to 
measure the level of phospho-STAT3 (pSTAT3) by ICS (A), analyze STAT3 
binding to the Etv5 promoter (C) or Etv5 binding to the Bcl6 promoter (D-E) by 
ChIP assay, or to assess gene expression by qRT-PCR (B). Data are mean of 
replicate samples ± S.D. and representative of three independent experiments 
with similar results.  
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SRBC-specific antibody production demonstrated decreased serum IgG antibody 
titers in Etv5fl/fl CD4-Cre+ mice, compared to wild type mice (Figure 71C). Isotype-
specific analysis demonstrated reduced IgG1 and IgG2a/c serum antibody titers 
in mice that lack Etv5 expression in T cells than in wild type cells. Thus, Etv5 is 
required for Tfh development and humoral immunity. 
 
Figure 71. Etv5 promotes germinal center B cells and antibody production 
in SRBC-immunized mice. (A-C) WT and Etv5fl/fl CD4-Cre+ mice were 
immunized with SRBC. On day 9, splenocytes were stained for germinal center B 
cells (A) with the average percent positive cells and total cell count shown in (B). 
Data are gated on B220+CD19+Fas+. Serum from WT and Etv5-mutant mice was 
diluted and used to measure antibody titers by ELISA (C). Data are mean ± 
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S.E.M. of 4-5 mice per group and representative of two independent experiments 
with similar results. *p<0.05 
 
Etv5 promotes Th9 cell development 
We observed Etv5 has a positive role in Th17 and Tfh cell development. We next 
examined the role of Etv5 in Th9 cell differentiation by first ectopically expressing 
Etv5 in Th2 and Th9 cells and assessing cytokine production. Ectopic Etv5 
expression in Th2 and Th9 cells resulted in increased IL-9 and decreased IL-4 
production compared to control cells (Figure 72A). Consistent with these 
observations, reduced Etv5 expression in Th2 and Th9 cells by or using Etv5-
deficient T cells resulted in decreased IL-9 and increased IL-4 at the protein and 
message levels compared to control cells (Figure 72B-D). We next assessed the 
gene expression profiles that have been shown to be expressed highest in Th9 
cells compared to other T helper cells in Etv5-deficient Th9 cells. There were no 
differences in Irf4, Batf, Maf, Gata3, Ahr, Cxcl3, Ahrr, Ccr4, Ccr8, Fasl, and Itgae 
expression between WT and Etv5-deficient Th9 cells (Figure 72E). Surprisingly, 
Sfpi1 expression that encodes for PU.1 was significant higher in Etv5-deficient 
Th9 cells compared to WT cells (Figure 72E). We also detected decreased Erg, 
Crem, Tnfsf13b, Il17rb, and l1rn expression in Etv5-deficient Th9 cells compared 
to wild type cells (Figure 72E). In the HDM-induced allergic inflammation 
described in Figure 61, the level of IL-9 in the BAL fluid was significantly reduced 
in Etv5-mutant mice compared to wild type mice (Figure 73). Similarly, 
stimulating splenic and mediastinal lymph nodes cells with HDM resulted in 
decreased IL-9 production in Etv5-mutant mice compared to wild type mice 
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(Figure 73). These data demonstrated that Etv5 is required for Th9 cell 
development and IL-9 production in an allergen-induced airway inflammation.  
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Figure 72. Etv5 promotes cytokine production in Th9 cells. (A) Naïve 
CD4+CD62L+ T cells were isolated from wild type mice and differentiated under 
Th2 or Th9 culture conditions. On day 2, cells were transduced with either control 
or Etv5-YFP (Etv5)-expressing retrovirus. On day 5, cells were stimulated with 
PMA and ionomycin for 6 h before intracellular staining (ICS). Data are gated on 
YFP+ cells. (B-E) Wild type and Etv5-deficient Th17 cells were restimulated with 
with PMA and ionomycin for 6 h before intracellular staining (ICS) (B) or anti-CD3 
to assess cytokine production by ELISA (C) and gene expression by qRT-PCR 
(D-E). Data are mean of four independent experiments ± S.E.M. (C-E) or are 
mean of replicate samples ± S.D. and representative of four independent 
experiments with similar results (A-B). *p<0.05 
 
 
Figure 73. Etv5 regulates IL-9 production in HDM-induced allergic 
inflammation. Cells from spleen (SPL) and mediastinal lymph nodes (MLN) from 
Figure 57 were stimulated with HDM for 5 days. Cell-free supernatant and BAL 
fluid were used to assess cytokine production by ELISA. Data are mean ± S.E.M. 
of 6 mice per group and representative of two independent experiments with 
similar results. *p<0.05 
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DISCUSSION 
CD4+ T cell differentiation into cell lineage-programmed subsets requires the 
integration of multiple elements such as JAK/STAT signaling pathways, 
transcription factors, and epigenetic modification. Understanding how these 
signals are integrated during the T helper cell development will lead to greater 
insight into the regulatory networks that modulate differentiation.  
 
The Signal Transducer and Activator of Transcription factor STAT4 is required for 
Th1 differentiation and inflammatory disease. STAT4 controls Th1 cell 
differentiation in many aspects such as promoting IFNγ expression, inducing 
transcription factor expression, recruiting and interacting with other factors at 
STAT4 target loci such as histone modifying enzymes and transcription factors to 
regulate gene expression. An additional mechanism for STAT4-dependent gene 
programming is to establish a de-repressed genetic state susceptible to 
transactivation by additional fate-determining transcription factors.  
 
STAT4 not only induces the expression of transcription factors (T-bet, Runx3, 
and Hlx1) that promote Th1 cell differentiation but also modulates the process by 
inducing a negative feedback loop to control inflammatory response. STAT4 
induces the expression of the transcriptional repressor Twist1 that impairs IL-12-
STAT4 signaling and interferes with the transcriptional transactivation function of 
Runx3 and T-bet. Twist1 is not only involved in a STAT4-induced feedback loop 
in Th1 cells but also is a component of a STAT3-induced feedback loop in Th17 
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and Tfh cells that controls IL-6 signals by directly repressing Il6ra. Thus, Twist1 
uniquely represses the function of Th1, Th17, and Tfh cells, and in mediating that 
repression without activation of additional subsets. In addition to Twist1, we 
identify Etv5 as a STAT3- and STAT4- target gene that has an important function 
in controlling T helper cell differentiation. In contrast to the repressive function of 
Twist1, Etv5 promotes Th9, Th17, and Tfh cell development with a modest effect 
in Th1 cell differentiation. Etv5 also plays important roles in the development of 
antigen-induced allergic airway inflammation, the formation of germinal center B 
cells, and antigen-specific antibody production.  
 
Collectively, STAT proteins have a central role in controlling T helper cell 
development from promoting transcription factor expression, initiating epigenetic 
modification, and modulating regulatory mechanism. STAT proteins not only 
induce positive regulators that play critical roles in T helper cell differentiation, 
they also have self-regulatory mechanisms that shutdown the signaling pathway. 
As the result, CD4 T cells are tightly controlled over its differentiation and effector 
function. This is an essential aspect of understanding immune dysregulation and 
inventing therapeutic approach to targeting JAK/STAT signaling pathway in 
autoimmunity and allergic disease. Our studies specifically define IL-12-STAT4- 
and IL-6-STAT3- induced feedback (Twist1) and feed forward (Etv5) regulatory 
loops that impact multiple components of the Th1, Th9, Th17, and Tfh 
transcriptional networks and play a critical role in controlling both cell-mediated 
and humoral immunity. Thus, therapies aimed at altering negative (Twist1) or 
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positive (Etv5) factor, or delivering ectopically expressed Twist1 or Etv5, hold 
promise for modulating pathogen immunity, autoimmune disease, allergic 
inflammation and as an adjunct for limiting immune responses to viral-mediated 
gene therapy. 
 
Part I- Opposing roles of STAT4 and Dnmt3a in Th1 gene expression 
IL-12-induced STAT4 reciprocally modulates Jmjd3 and Dnmt3a association at 
Th1 gene loci 
Although STAT4 is a critical factor in the development of Th1 cells and 
inflammatory immunity, a detailed understanding of how STAT4 programs gene 
expression has not been well documented. We define a pathway for the STAT4-
dependent induction of Th1 gene expression. STAT4 binds to target loci and 
recruits histone acetyltransferases that mediate total histone acetylation 
(O'Sullivan et al., 2004; Yu et al., 2007) and acetylation of specific histone 
residues. STAT4 is required for the IL-12-inducible H3K4 methylation, and 
association of Jmjd3 with target loci (Figure 19). Diminished Jmjd3 expression 
results in decreased Th1 gene induction increased H3K27 methylation, and 
increased Dnmt3a association with target loci (Figure 21). This parallels data 
from Th2 cells that display decreased STAT4 expression accompanied by even 
greater Dnmt3a association and DNA methylation (Yu et al., 2008; Yu et al., 
2007). STAT4 is required for the expression of several other transcription factors 
that contribute to Th1 gene expression including Hlx1. Despite decreased 
expression of several of these factors in Stat4-/- cells, double deficiency of STAT4 
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and Dnmt3a results in a partial increase in Th1 gene expression compared to 
Stat4-/- Th1 cultures. These results demonstrate that Dnmt3a plays an obligate 
role in repressing Th1 gene expression that is attenuated by the activity of 
STAT4. Overall, STAT4 functions by facilitating increased histone acetylation and 
H3K4 methylation to induce gene expression, and by decreasing the association 
of DNA methyltransferases that repress gene expression. 
 
Compensatory role of Dnmt3a-deficiency in Stat4-/- mice results in recovery of 
Th1 function 
Disease models can be complex and rely upon the balance of pro- and anti-
inflammatory effector cells. EAE requires the function of Th1 and Th17 cells, and 
is inhibited by Treg cells (Pierson et al., 2012). Partial recovery of a Th1 
phenotype in Dnmt3afl/fl Stat4-/- Cre-positive cultures was recapitulated in an EAE 
disease model where Dnmt3afl/fl Stat4-/- Cre-positive mice had increased clinical 
disease and IFNγ production compared to Stat4-/- mice. The contribution of Th17 
cells to EAE in Dnmt3afl/flStat4-/- Cre-positive mice is not limiting since there were 
no changes in IL-17-producing mononuclear cells, and Dnmt3afl/flStat4-/- Cre-
positive T cells had similar in vitro Th17 differentiation to Stat4-/- cultures. 
Although DNA methyltransferases have been reported to play an important role 
in the generation of regulatory T cells (Lal et al., 2009), and in vitro derived 
Dnmt3afl/fl Cre-positive iTreg cultures had increased percentages of Foxp3+ cells 
compared to wild type cultures, Dnmt3afl/fl Cre-positive mice displayed normal 
EAE development (Figure 24). IL-12 has also been shown to limit the 
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development of iTreg cells (O'Malley et al., 2009), although in the EAE 
inflammatory environment, there are many other cytokines that can modulate 
Foxp3 and compensate for the lack of STAT4. Moreover, if Tregs were increased 
in Dnmt3afl/flStat4-/- Cre-positive mice, we would not expect to observe increased 
disease. Thus, it is likely that the partial recovery of Th1 target genes contributes 
to the observed EAE phenotype in Dnmt3afl/flStat4-/- Cre-positive mice.  
 
STAT4 function requires additional transcription factors 
STAT4 is a multi-functional transcription factor with the ability to acutely activate 
gene expression in a short time span (within hours) and to program genes for 
lineage expression (lasting days). These intertwined functions likely involve both 
the chromatin remodeling mechanisms we have described here with the direct 
induction of genes via RNA polymerase II-dependent transcription. Although 
STAT4 can activate reporter genes in transient assays, suggesting a direct effect 
on rate of transcription, how it mediates these functions is not yet known. 
Importantly, despite the ability of IL-12 to activate several STAT proteins (Bacon 
et al., 1995; Jacobson et al., 1995), none can substitute for STAT4 in the acute 
induction of gene expression by IL-12 (Figure 19) or in IL-12-induced Th1 gene 
programming (Good et al., 2009). This suggests that STAT4 specifically interacts 
with other transcription factors at target loci to mediate gene induction. The 
specificity of these interactions might also distinguish the effects of STAT4 on the 
IFN-inducible genes, where there is only transient gene induction, from genes 
that are programmed for expression in committed Th1 cells. The identity of some 
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of these interacting factors is still unclear. STAT4 can interact with Jun family 
members (Nakahira et al., 2002; O'Sullivan et al., 2004) and co-operation with 
AP-1 complexes is possible. Previous work defining STAT4-interacting proteins 
identified a LIM domain-containing protein that regulated STAT4 stability and a 
tyrosine phosphatase that regulated STAT4 phosphorylation (Nakahira et al., 
2007; Tanaka et al., 2005). Other interacting transcription factors have not been 
identified. 
 
Although there is no evidence yet for physical interactions with other Th1-
inducing transcription factors, it is clear that STAT4 functions in a network with 
these factors in Th1 cells. T-bet is the most obvious, where STAT4 induces 
expression of Tbx21 and cooperates with T-bet in the induction of a subset of 
Th1 genes (Schulz et al., 2009; Thieu et al., 2008; Yang et al., 2007). Among the 
genes that both STAT4 and T-bet are required for, Runx3 and Hlx1 also 
contribute to expression of Th1 genes (Djuretic et al., 2007; Mullen et al., 2002). 
In this section, we tested the concept that in the absence of STAT4 acting as a 
positive regulator, eliminating a negative regulatory factor would lead to recovery 
of gene expression and differentiation. We observed a partial recovery of 
phenotype in vitro and function in vivo (Figure 22-24), suggesting that STAT4 has 
functions in addition to elimination of Dnmt3a association. Among those 
functions, STAT4 regulates chromatin remodeling in the absence of T-bet (Zhang 
and Boothby, 2006), and the induction of a negative regulatory loop that requires 
the transcription factor Twist1 (Niesner et al., 2008; Pham et al., 2012). Ectopic 
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expression of Runx3 or a combination of T-bet and Hlx1 were able to induce Th1 
gene expression in Dnmt3afl/flStat4-/- Cre-positive Th1 cultures to a greater extent 
than in Stat4-/- Th1 cultures, although still not to wild type expression (Figure 27). 
It is possible that reconstitution of all three factors would lead to complete 
recovery. However, it is also likely that STAT4 plays an indispensible role for 
initiating transcription at many Th1 target loci (Good et al., 2009), and not simply 
as an initial activator of the Th1 transcriptional network. 
 
The cooperation of STAT4 and T-bet may be required for some of the effects 
observed in this section, since T-bet is also required for Jmjd3 recruitment to 
target loci (Miller et al., 2008; Miller et al., 2010). Indeed, we observed 
association of T-bet and Jmjd3 at the Ifng locus was increased in Dnmt3afl/flStat4-
/- Cre-positive Th1 cells, compared to Stat4-/- Th1 cultures (Figure 26). However, 
Dnmt3a association with Th1 loci was increased more in Stat4-/- Th1 cells than in 
Tbx21-/- Th1 cells, suggesting that STAT4 has T-bet/Jmjd3-independent 
mechanisms to limit Dnmt3a association (Thieu et al., 2008). Since Dnmt3a 
interacts with unmethylated H3K4 and tri-methyl-H3K36, an additional possibility 
is STAT4-dependent recruitment of H3K4 methylases and H3K36 acetylases or 
demethylases (Chen et al., 2012; Li et al., 2007; Otani et al., 2009; Yu et al., 
2007; Zhang et al., 2010a).  
 
Collectively, STAT4 plays an indispensible role in controlling Th1 cell 
development from inducing Th1 target genes including transcription factors to 
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recruiting chromatin modifying enzyme complexes. Moreover, STAT4 likely 
interacts with these factors to limit DNA methylation and initiate gene 
transcription. A summary of STAT4 function in Th1 cells is shown in Figure 74. 
 
Figure 74. STAT4 regulates gene expression by recruiting histone 
modifying enzymes and transcription factors to Th1 gene loci  
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Part II- Twist1 function in T helper cells 
Twist1 negatively regulates Th1 cell differentiation through several mechanisms 
Twist1 is expressed in Th1 effector memory cells and limits Th1-mediated 
inflammation in mouse models of delayed-type hypersensitivity and antigen-
induced arthritis (Niesner et al., 2008). We have identified several mechanisms 
by which Twist1 modulates inflammatory cytokine production in Th1 cells. First, it 
negatively regulates the expression of Th1 genes. In macrophages, Twist1 has 
been shown to regulate TNFα and IL-1β by binding to E-boxes in gene promoters 
(Bialek et al., 2004). However, we did not observe Twist1 binding to the Ifng, 
Tnfa, or Il12rb2 promoters, and only minimal binding to the Tbx21 promoter. It is 
still possible that Twist1 binds directly to Th1 genes in regions other than the 
promoter that we tested. The second mechanism of Twist1-dependent gene 
regulation is through complex formation with Runx3. This mechanism appears to 
be the primary mechanism for regulating Ifng. Yet, the Twist1 S192P mutant that 
reduced interactions with Runx3 was still able to transcriptionally regulate other 
Th1 genes, suggesting that Twist1 has gene regulatory activity independent of 
Runx3. The direct regulation of genes other than Ifng might further impact the 
Th1 phenotype and further analysis will be required to further refine this 
regulatory network. 
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STAT3-induced a negative feedback loop that regulates Th17 and Tfh cell 
development 
In addition to repressing cytokine production in Th1 cells, Twist1 also negatively 
regulates Th17 and Tfh cell development. Cytokines, including IL-6, induce the 
STAT3-dependent expression of Twist1, which then binds to the Il6ra promoter, 
repressing transcription and thus limiting IL-6 responsiveness and STAT3 
activation. The ability of Twist1 to repress IL-6 signaling limits the development of 
Th17 cells and Tfh cells in vivo thereby controlling cell-mediated and humoral 
components of the immune response. This observation is consistent with recent 
findings that Twist1 can also regulate the cell fate decisions of multi potential 
cardiac neural crest between neurons and smooth muscle via its direct 
transcriptional repression of Phox2b (Vincentz et al., 2013). 
 
Twist1 likely regulates T helper cell development through several mechanisms. 
We demonstrated that Twist1 inhibits cytokine production in Th17 and Tfh cells 
by repressing Il6ra, hence impairing IL-6-STAT3 signaling. STAT3-dependent 
mechanisms seem to be predominant, since impaired STAT3 signaling 
diminished the effects of Twist1-deficiency. Yet, through transcriptional 
repression, it is possible that Twist1 directly inhibits the expression of additional 
target genes in Th17 and Tfh cells.  
 
Although Twist1 may regulate T helper subset development through several 
mechanisms, one paradigm that emerges is Twist1 being an essential 
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component of a cytokine-induced feedback loop. In Th1 cells, STAT4 induces 
Twist1, which subsequently decreases Il12rb2 expression and STAT4 activation 
(Figure 31) (Pham et al., 2012). Similarly, in Th17 and Tfh cells, STAT3 induces 
Twist1, which represses Il6ra resulting in decreased STAT3 activation. In Th17 
cells, and likely in Tfh cells as well, this alters the balance of activation between 
STAT3 and STAT5 that have opposing roles in both of these subsets (Johnston 
et al., 2012; Nurieva et al., 2008; Nurieva et al., 2012; Yang et al., 2011).Thus, 
Twist1 functions as a balancing factor that regulates signal integration. 
 
Potential function of Twist1 dimer in T helper cell differentiation 
Twist1 functions as either a homodimer or heterodimer with other bHLH factors, 
where the dimerization partners dictate the function (Castanon et al., 2001). 
Altering the balance between Twist1 and Hand2 association has a significant 
impact on limb and craniofacial defects in humans with Saethre-Chotzen 
syndrome (Firulli et al., 2005). Twist1 has been shown to form a dimer complex 
with E47 protein, which is inhibited by the DNA-binding inhibitor Id3 (Castanon et 
al., 2001; Firulli et al., 2005; Hayashi et al., 2007). Moreover, Th1 cells 
differentiated from E2a-deficient mice showed a decrease in IFNγ production 
compared to WT cells (Pan et al., 2004). Thus, it is possible that E12/E47 
sequesters Twist1 in heterodimer complexes to inhibit its repressive function in 
Th1 cells. In the absence of E2A gene products, there is more “free” Twist1 to 
form homodimers and thus inhibit cytokine production. In addition, Id3-deficient 
mice have a defect in regulatory T cell generation and an enhancement in Th17 
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differentiation linked to the ability of E47 to induce Rorc expression (Maruyama et 
al., 2011). Maruyama et al. suggested that the ability of E47 to transactivate Rorc 
expression might require other factors downstream of IL-6 (Maruyama et al., 
2011). Consistent with this, we observed an increase in E47 binding at the Rorc 
promoter in Twist1-deficient Th17 cells compared to WT cells, although there 
was no change in either Tcfe2a (encoding E47) or Id3 expression. E2A and Id3 
also have opposing roles in the generation of Tfh-like cells, and E2A contributes 
to germinal center B cell development, suggesting a similar role in this subset 
(Kwon et al., 2008; Miyazaki et al., 2011). Further studies need to be performed 
to dissect the relationship between Twist1, E47, and the lineage determining 
factors for the development of each subset. 
 
Moreover, Twist1 can also function through non-canonical bHLH protein-protein 
interactions. We have previously shown that Twist1 inhibits IFNγ production by 
forming a complex with Runx3 through its Runt DNA binding domain and 
preventing it from binding DNA (Figure 33, 36-37) (Pham et al., 2012). Because 
Runx1 transactivates Rorc expression, it is possible that Twist1 interacts with 
Runx1, thus repressing Rorc expression. Whether Runx1 or Runx3 contribute to 
Tfh development has not been defined. 
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Twist1 is a novel repressor of Th1, Th17, and Tfh cell development 
Many transcription factors contribute to the development of T helper cell lineages 
(Kanno et al., 2012; Zhou et al., 2009; Zhu et al., 2010). However, the majority of 
factors promote one lineage, at the expense of another. For example, GATA3 
promotes Th2 differentiation as it inhibits the development of Th1 and Th17 cells 
(Usui et al., 2003; Yagi et al., 2010). In this respect, Twist1 is novel in that it 
represses Th1, Th17 and Tfh development, without any corresponding increase 
in cytokine secretion characteristic of other T helper subsets. In targeting these 
subsets, Twist1 regulates particular components of the inflammatory T cell-
mediated immune response. The additional ability of Twist1 to limit B cell 
responses suggests that signaling pathways regulating Twist1 expression 
represent potential therapeutic targets for broad modulation of the immune 
response. A summary of Twist1 function in T helper subsets is shown in Figure 
75. 
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Figure 75. The function of Twist1 in T helper cell development 
  
Th1
Tfh
STAT4
T-bet
Th17 STAT3
RORγt
STAT3
Bcl-6
Th9Th2 STAT6
GATA3
STAT6
Pu.1
TregSTAT5
Foxp3
TWIST1
Il6ra
Bcl6
Il12rb2
Il6ra
Twist1
Runx3
inhibition
 189 
 
Part III-Etv5 regulates T helper cell development 
Etv5 expression was detectable in all T helper cells with highest expression in 
Th1 and Th2 cells. Thus, it is possible that Etv5 might function in other T helper 
cell subsets. Our initial analysis suggested that Etv5 acts as a positive regulator 
in Th9, Th17, and Tfh cells and a negative regulator in Th2 cells. However, it 
remains unknown what determines Etv5 function in each T helper cell subset. 
 
In Th1 cells, Etv5 has been shown to genetically cooperate with T-bet to promote 
IFNγ production (Ouyang et al., 1999). Surprisingly, we observed a modest 
increase in IFNγ production in Etv5-deficient Th1 cells compared to wild type 
cells (Figure 57). In addition, Etv5-deficient Th2, Th9, Th17, and Treg cells 
produced significantly more IFNγ compared to wild type cells, and that was 
correlated with increased T-bet expression (Figure 78). Our data suggested that 
Etv5 negatively regulates IFNγ production by repressing T-bet expression. Etv5 
has been shown to physically interact with Twist1, a transcriptional repressor of 
Th1 cells (Pham et al., 2012; Zhang et al., 2010b) suggesting a possible 
mechanism in which Etv5-Twist1 complex represses T-bet expression in T helper 
cell subsets. We have shown that in addition to promoting Th17 cell 
differentiation, Etv5 directly binds to the Bcl6 promoter and promotes Tfh cell 
differentiation. Because the ability of T-bet to represses Bcl-6 in Tfh cell 
differentiation (Nakayamada et al., 2011), Etv5 might indirectly regulate Tfh cell 
development by suppressing T-bet expression.  
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PU.1, an ETS transcription factor, has been shown to be the master regulator of 
Th9 cell subset (Chang et al., 2010). Interestingly, Etv5 also positively regulates 
IL-9 production in T cells (Figure 72). Since PU.1 and Etv5 recognize the same 
ETS consensus sequence, it will be interesting to determine whether there is a 
functional association between PU.1 and Etv5 in controlling IL-9 production in T 
cells. In addition, a subset of genes that are enriched and regulated by BATF in 
Th9 cells were decreased in Etv5-deficient Th9 cells compared to wild type cells 
(Figure 72E). Therefore, it is remained to be determined whether BATF and Etv5 
control IL-9 production in T cells in a parallel pathway. Our data further add 
another transcription factor into a complex regulatory network in Th9 cells.  
 
Ets-1, another member of ETS family transcription factors, has been shown to 
exert similar functional complexity as Etv5 in T helper cell differentiation. Ets-1 
promotes Th1, Th2, and regulatory T cell development while inhibiting Th17 cell 
differentiation (Grenningloh et al., 2005; Moisan et al., 2007; Strempel et al., 
2010). In addition, Ets-1 and Etv5 have been demonstrated to have opposing 
function in regulating sonic hedgehog (Shh) gene expression during limb 
development (Lettice et al., 2012). Thus, Etv5 might have functional collaboration 
or mutual antagonism with other members of Ets family transcription factors in 
regulating T helper cell development.  
 
The requirement for IL-17 in asthma is not completely defined. Increased IL-17A 
and IL-17F are associated with severe asthma in patients (Al-Ramli et al., 2009). 
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IL-17 produced from activated CD4+ T cells induces the expression of 
macrophage and neutrophil attracting chemokines that recruit inflammatory cells 
into the airways (Laan et al., 1999). However, in mouse models, IL-17 has 
differential effects during sensitization or challenge, and the requirement for IL-17 
varies among model systems (Lajoie et al., 2010; Moreira et al., 2011; Nakae et 
al., 2002; Schnyder-Candrian et al., 2006; Yang et al., 2008a). Importantly, the 
house dust mite adjuvant-free model is dependent upon IL-17, in addition to Th2 
cytokines. IL-17 production and neutrophil recruitment in the lung were increased 
following house dust mite sensitization and challenge (Phipps et al., 2009). 
Consistent with previous observations, we observed a significant decrease of the 
IL-17 production in the lung, BAL fluid, and in the peripheral lymphoid organs, as 
well as diminished neutrophil-attracting chemokines, and neutrophil recruitment 
to the lung in Etv5-mutant mice, compared to control mice. Although house dust 
mite sensitization and challenge elicits Th2 and Th9 responses (Figure 61, 73) 
(Phipps et al., 2009), the results demonstrated that IL-17 was the most abundant 
cytokine produced in the lung suggesting IL-17 production from T cells is critical 
for inflammation in this model. In the absence of Etv5 in T cells, there is 
diminished inflammation, and reduced IL-17 concentrations, without any 
corresponding effects on the amounts of Th2 cytokine production. In addition to 
decreased neutrophil recruitment to the lung, eosinophil number was also 
reduced. Since IL-17A and IL-17F are shown to have differential effects on 
eosinophil recruitment during antigen-induced airway inflammation (Yang et al., 
2008a), further studies are needed to determine whether IL-17 is responsible for 
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the reduction in eosinophil number in the lung in our model. Our results suggest 
that Th17 production of IL-17 provides a unique contribution to the inflammatory 
milieu in the development of allergic pulmonary inflammation. 
 
Our data show that Etv5-deficiency in T cells does not alter expression of Th17 
transcription factors, or other Th17 cytokines, suggesting a restricted effect on 
expression of the Il17-Il17f locus. This is unique among transcription factors that 
promote Th17 development including RORγt, IRF4 and BATF that regulate 
multiple components of the Th17 genetic program (Brustle et al., 2007; Ciofani et 
al., 2012; Ivanov et al., 2006; Manel et al., 2008; Schraml et al., 2009). It is also 
important to note that Etv5 has a critical role in Th17 cytokine production despite 
expression of Etv5 not being specific for Th17 cells. This highlights that amount 
of expression of a transcription factor is not always the most important 
determinant of function. Our results further document that transcription factors 
that are not restricted to a particular subset still play obligate roles in defining 
cellular phenotype, in cooperation with lineage-specific factors. 
 
These results demonstrate that Etv5 is a novel STAT3-induced transcription 
factor that directs expression of the Il17-Il17f locus in Th17 cells. This is 
consistent with a recent report that Etv5 also contributes to IL-17 production in γδ 
T cells, and suggests that Etv5 may have common functions among multiple IL-
17-secreting T cell populations (Jojic et al., 2013). Our results further suggest 
that in addition to lineage regulators, such as Rorc, Irf4 and Batf that regulate 
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multiple genes in a subset, there are additional transcription factors that are part 
of the T helper subset differentiation program that have a more restricted and 
specific function. Thus, Etv5 represents a unique contributing factor that 
positively regulates inflammatory responses in Th17 cells and promotes allergic 
airway inflammation 
 
Collectively, we identified the ETS family transcription factor Etv5 downstream of 
STAT3 and STAT4 as a controller of T helper cell development. Etv5 promotes 
cytokine production that contributes to the antigen-induced airway inflammation. 
In addition, Etv5 plays a role in B cell responses and antibody production. A 
summary of Etv5 function in T helper subsets is shown in Figure 76. 
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Figure 76. The function of Etv5 in T helper cell development 
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FUTURE DIRECTIONS 
Part I- To define the role of Jmjd3 in gene regulation in Th1 cells  
The apparent opposing function of STAT4 and Dnmt3a raises the question 
whether STAT4 is required to activate gene expression, or whether it functions 
solely by eliminating negative regulators or recruiting positive regulators of gene 
expression from target loci. In Stat4-/- deficient Th1 cells, we observed decreased 
Jmjd3 association at Th1 target genes (Figure 19). When Jmjd3 was knocked 
down in Th1 cells using siRNA targeting Jmjd3, we observed decreased IFNγ 
production compared to control cells (Figure 20). Our results suggest that Jmjd3 
is recruited to Th1 gene loci by STAT4 to limit Dnmt3 association. Interestingly, 
we observed heterogeneous populations when wild type Th1 cells were co-
stained with IFNγ and Jmjd3 (Figure 77) suggesting variable Jmjd3 expression in 
the Th1 cell population. Jmjd3 function is not limited to Th1 cells since 
knockdown of Jmjd3 in Th17 cells result in decreased IL-17 production (Ciofani 
et al., 2012). The result suggests that Jmjd3 might play an important role in other 
T helper subsets. These observations raise the question of how the expression of 
Jmjd3 integrates with other transcription factors in regulating gene expression 
and cytokine production in T helper cell subsets.  
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Figure 77. Jmjd3 expression in Th1 cells. Naïve CD4+CD62L+ T cells were 
isolated from wild type mice and differentiated under Th1 culture conditions. On 
day 5, cells were restimulated with PMA and ionomycin for 6 h before 
intracellular staining (ICS). 
 
We will address the question with three approaches: first we will to determine the 
correlation between Jmjd3 and Th1 gene expression by generating Jmjd3 
reporter mice and comparing gene expression and cytokine production profiles 
among different Jmjd3 populations in Th1 cells that include Jmjd3neg, Jmjd3lo, 
Jmjd3mid, and Jmjd3hi. Different Jmjd3 populations (neg, low, mid, and high 
expression) will be sorted to assess Th1 gene expression by qRT-PCR and 
cytokine production by ELISA. We will also examine the cell cycle and 
proliferation by CFSE to determine whether Jmjd3 has an effect on cell growth 
and survival. The second approach is to define the molecular mechanism of 
Jmjd3 in regulating Th1 cell differentiation. Subpopulation of Jmjd3 expressing 
Th1 cells will be sorted and the level of phospho-STAT1 and phospho-STAT4 will 
be assessed by ICS after restimulating the cells with IFNγ and IL-12, 
respectively. We will determine whether Jmjd3 interacts with STAT1 and STAT4 
by performing co-IP and DAPA experiments using wild type Th1 cells. To 
examine how different amounts of Jmjd3 expression affects transcription factors 
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binding to Th1 gene loci, sorted cells as described above will be used to assess 
the ability of transcription factor (T-bet, Stat4, Hlx1, Runx3, and Twist1) bound to 
the regulatory elements of Ifng and other Th1 gene loci. Similarly, we will also 
examine histone modification and the association of histone modifying enzymes 
such as Dnmt3a at Th1 gene loci. The third approach is to define the role of 
Jmjd3 in other T helper subsets. We will examine Jmjd3 expression and the 
possibility of Jmjd3 associating with other STAT proteins (STAT3, STAT5, and 
STAT6) in Th2, Th9, Th17, Treg, and Tfh cells. We will generate mice with 
Jmjd3-deficient T cells by crossing Jmjd3fl/fl mice (Zhao et al., 2013) with CD4-
Cre transgene mice to generate Jmjd3fl/fl CD4-Cre+. Gene expression and 
cytokine production profiles for each T helper subset will be examined using wild 
type and Jmjd3-deficient T cells. Because Jmjd3 has a positive role in Th1 and 
Th17 cell differentiation, we will determine the effect of Jmjd3 in vivo using 
mouse models such as Listeria monocytogenes-induced Th1 development and 
HDM-induced airway inflammation (Th17).  
 
These three approaches will elucidate the role of Jmjd3 in regulating gene 
expression in T helper cell differentiation.  
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Part II- Twist1 regulates T helper cell development  
As shown in the previous section, STAT proteins are crucial factors in T helper 
cell differentiation that regulate a number of transcription factors involved in the 
process. Twist1 is a transcriptional repressor that is induced by STAT4 in Th1 
cells and by STAT3 in Th17 and Tfh cells. Our results demonstrate that Twist1 
negatively regulates subsets of genes shared by Th1 and Th17 cells (Ifng and 
Tbx21) or Th17 and Tfh cells (Il6ra, Batf, and Maf). Thus, we ask whether Twist1 
regulates distinct gene expression in Th1, Th17, and Tfh cells that are 
responsible for its development. We will address the question with two aims: the 
first aim is to define gene expression profiles in T cells that lack Twist1 
expression. We will perform a microarray assay using in vitro generated wild type 
and Twist1-deficient Th1, Th17, Tfh-like cells and Tfh cells from day 9 SRBC-
immunized wild type and Twist1-mutant mice. The experiment will allow us to 
define genes that are distinctly regulated by Twist1 by Th1, Th7, and Tfh cells. 
Given that the ability of Twist1 to directly bind and repress gene expression, the 
second aim is to determine the direct target of Twist1 in regulating T helper cell 
differentiation. We will perform ChIP-seq assay to determine the ability of Twist1 
binding to its target genes in Th1, Th17, and Tfh cells using wild type and Twist1-
deficient T cells. We will perform ChIP and DAPA assays to validate ChIP-seq 
data and luciferase assay using Twist1 target genes to determine whether Twist1 
could repress its transcriptional activity. The results will provide additional insight 
into the understanding of Twist1-mediated gene regulation in T helper cell 
differentiation.  
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Twist1 functions as a homodimer, or as a heterodimer with bHLH factors and 
non-bHLH factors. We observed Twist1 forms complexes with T-bet, Runx3, and 
E47 in Th1 cells (Figure 33 and 46). Thus, the Twist1 heterodimer plays curcial 
role in regulating T helper cell programming. We will determine the existence of 
other possible Twist1 interacting partners that are potentially involved in 
regulating T helper cell differentiation. Runx1 contains the Runt DNA binding 
domain that has crucial role in Th17 and Treg cell development (Kitoh et al., 
2009; Lazarevic et al., 2011; Rudra et al., 2009). However, mice with Twist1-
deficient T cells have defects in Th17 cell differentiation but not Treg cell 
differentiation. We want to determine whether the Twist1-Runx1 complex exists 
in Th17 cells using DAPA and co-IP assays. Similarly, we observed Twist1 
interacts with E47 in Th1 cells, and that E47 binding to its target gene was 
decreased in the absence of Twist1 in Th17 cells (Figure 46). Thus, we will 
determine the association between Twist1 and E47 in Th17 cells using DAPA 
and co-IP assays. Given that a Twist1 and Etv5 interaction has been described 
(Zhang et al., 2010b), and that Twist1 and Etv5 have opposing function in T 
helper cell development, we want to determine whether there is an association 
between Twist1 and Etv5 in T helper cell subsets using DAPA and co-IP assays.  
Because Twist1-mutant mice have severe onset of MOG-induced EAE than wild 
type mice, we will mate Twist1fl/fl CD4-Cre mice with Etv5fl/fl CD4-Cre mice to 
generate compound mutant mice. We will perform MOG-induced EAE using wild 
type, Twist1-mutant, Etv5-mutant, and Twist1- and Etv5-doubly mutant mice. It 
will be interesting to see whether Twist1- and Etv5-doubly mutant mice develop 
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similar onset disease compared to wild type mice. These experiments will 
elucidate the interacting partners of Twist1 and their functions in regulating T 
helper cell development. 
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Part III-Etv5 regulates T helper cell development 
To define the mechanism by which Etv5 promotes Th9 cell differentiation 
We demonstrate that Etv5-deficient Th9 cells produce significantly less IL-9 
compared to wild type cells (Figure 72B-D). Etv5-deficient Th9 cells also have 
less Th9-specific gene expression compared to wild type cells (Figure 72E). 
Moreover, in the HDM-induced airway inflammation model, we detect reduced IL-
9 production by splenocytes and in the BAL fluid in Etv5-mutant mice compared 
to wild type mice (Figure 73).  
 
Thus, our results suggest that Etv5 positively regulates IL-9 production in Th9 
cells. We hypothesize that Etv5 is a novel transcription factor that promotes IL-9 
production in T cells. We will address the hypothesis with two aims: the first aim 
is to define the mechanism in which Etv5 regulates IL-9 in Th9 cells. In this aim, 
we will determine whether Etv5 could directly bind and promote Il9 expression 
using DAPA and luciferase assays. We will also determine the histone 
modification (H3K4me3, H3K27me3, H3K27ac, H4K5ac, H4K8ac, H4K16ac, 
H3K9/18ac, and H3K36ac), the association of histone modifying enzymes (p300, 
PCAF, and Gcn5), and transcription factor binding (PU.1, IRF4, and BATF) at Il9 
locus. Given that IL-9 is important for immune responses against worm infection 
(Faulkner et al., 1998; Richard et al., 2000), we will determine whether Etv5-
mutant mice have worsened worm burden compared to wild type mice in the 
Trichuris muris model. Given that Etv5 and PU.1 belong to the ETS family of 
transcription factors, the second aim is to determine the cooperative effect of 
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Etv5 and PU.1 in regulating Th9 cell differentiation. We will perform the DAPA 
and luciferase assays to test the ability of Etv5 and PU.1 to cooperate and 
transcriptionally promote Il9 expression. To test whether Etv5 and PU.1 
genetically cooperate to regulate Th9 cell development, we will ectopically 
express Etv5 or Sfpi1 in Sfpi1-deficient or Etv5-deficient Th9 cells, respectively; 
and examine cytokine production by ICS and ELISA and gene expression by 
qRT-PCR. To test whether both Etv5 and PU.1 are required for the optimal Th9 
cell development, we will mate Sfpifl/fl mice with Etv5fl/fl CD4-Cre mice to generate 
compound mutant mice. We will examine cytokine production, gene expression, 
histone modification, and the association of histone modifying enzymes at Il9 
locus using wild type, Sfpi1-deficient, Etv5-deficient, and Sfpi1- and Etv5-doubly 
deficient Th9 cells. We expect significantly decreased cytokine production and 
gene expression by Sfpi1- and Etv5-doubly deficient Th9 cells compared to 
Sfpi1-deficient and Etv5-deficient Th9 cells. We next want to test the requirement 
of Etv5 and PU.1 regulating IL-9 using in vivo disease models. We will test 
whether mice with Sfpi1- and Etv5-doubly deficient T cells have worsened worm 
burden compared to mice with Sfpi1-deficient or Etv5-deficient T cells in the 
Trichuris muris model. In contrast, because IL-9 is a key player in allergic airway 
inflammation, we can to test whether mice with Sfpi1- and Etv5-doubly deficient T 
cells have less inflammation compared to mice with Sfpi1-deficient or Etv5-
deficient T cells in the OVA-induced airway inflammation model. The results will 
add additional insight into the transcription factor network in controlling Th9 cell 
development.  
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To define the mechanism in which Etv5 regulates Foxp3 function 
We demonstrate that mice with Etv5-deficient T cells have less nTreg and iTreg 
compared to wild type cells (Figure 58B). Thus we hypothesize that Etv5 
positively regulates Treg cell development. We will address the hypothesis with 
two aims: in the first aim, we will define the mechanism in which Etv5 promotes 
Treg cell differentiation. We will perform the suppression assay to test whether 
Etv5-deficient Treg cells adequately suppress effector T cells compared to wild 
type cells. We will perform ChIP assay testing the ability of Etv5 binding to the 
regulatory elements of the Foxp3 locus using differentiated wild type and Etv5-
deficient Treg cells. We will also perform luciferase assay to test whether Etv5 
could repress the transcriptional activity at the Foxp3 promoter. We will also 
determine the histone modification and the association of histone modifying 
enzymes at the Foxp3 locus. In the second aim, we will define Treg function in 
the absence of Etv5 in T cells in vivo using disease model. Because Etv5-
deficient T cells have increased IFNγ compared to wild type in vitro cultures 
(Figure 78A-B), we want test the ability of Etv5-deficient Treg cells to suppress 
inflammation in vivo in a T cell transfer model of colitis that induces strong Th1-
mediated colitogenic inflammation. We will adoptively transfer Il10-deficient T 
cells together with wild type or Etv5-deficient Treg cells into Rag1-deficient mice 
and assess weight loss, changes in colon length, and histological analysis.  
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To define the role of Etv5 in Tfh cell development  
We demonstrate that Etv5 directly binds to the Bcl6 promoter, positively 
regulates its expression, and promotes Tfh cell development in vivo (Figure 69-
70). Thus, we hypothesize that Etv5 is an upstream factor that positively 
regulates Bcl6 expression and promotes Tfh cell differentiation. We will test our 
hypothesis with the approach that is to define the role of Etv5 in regulating Tfh 
cell differentiation. Given that Etv5-deficient and Bcl6-deficient mice have 
impaired Tfh cell development, we will generate Tfh-like cells in vitro and perform 
a microarray assay to compare gene expression profiles between Etv5-deficient 
and Bcl6-deficient T cells. This experiment will allow us to define subsets of gene 
that are distinctly regulated by Etv5 and Bcl6. Since we showed that Etv5 directly 
binds to the Bcl6 promoter (Figure 70), we will further examine whether Etv5 is 
an upstream factor of Bcl-6 in regulating Tfh cell differentiation. We will 
ectopically express Bcl6 in Etv5-deficient T cells in vitro, transfer to SRBC-
immunized Etv5-deficient mice, and examine the formation of GC B cells. The 
results will add additional insight into the transcription factor network in Tfh cell 
development. 
 
To define the mechanism in which Etv5 regulates Ifng expression in T helper 
cells  
We show that Etv5-deficient Th2, Th9, Th17, and Treg cells express significantly 
higher Ifng and Tbx21 expression compared to wild type cells, although 
deficiency has a with a modest effect in Th1 cells (Figure 78). We demonstrate 
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that knocking down T-bet using specific siRNA in Etv5-deficient Treg cells results 
in decreased IFNγ production compared to control cells and modest increased 
Foxp3 expression compared to wild type cells (Figure 79). Thus, we hypothesize 
that Etv5 contributes to T helper cell identity by repressing Tbx21 and Ifng 
expression.  
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Figure 78. Ifng and Tbx21 expression in Etv5-deficient T cells. (A-C) Naive 
wild type and Etv5-deficient CD4+CD62L+ T cells were activated (Th0) or cultured 
under Th1, Th2, Th9, Th17, and regulatory T (Treg) cell polarizing conditions. On 
day 5, cells were used for assessing IFNγ production by ELISA after 24 h anti-
CD3 stimulation (A), and gene expression analysis before (Tbx21) (C) or after 
(Ifng) (B) 6 h anti-CD3 stimulation by qRT-PCR. Data are mean of four 
independent experiments ± S.E.M. *p<0.05 
 
 
 
 
Figure 79. Etv5 represses Ifng and Tbx21 expression in Treg cells. (A-C) 
Naïve CD4+CD62L+ T cells were isolated from wild type and Etv5-mutant mice 
and differentiated under Th1 or Treg cell culture conditions. On day 5, cells were 
transfected with control or siRNA-specific Tbx21, rested overnight, stained for T-
bet expression by ICS (A), assessed for Foxp3 expression by qRT-PCR (B), and 
restimulated with anti-CD3 to measure IFNγ production by ELISA (C). Data are 
mean of replicate samples ± S.D. and representative of four independent 
experiments with similar results. 
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perform ChIP assay to examine histone modification, the association of histone 
modifying enzymes, and T-bet binding at the Ifng locus in wild type and Etv5-
deficient Th1, Th2, Th9, Th17, and Treg cells. To determine whether Etv5 
negatively regulates IFNγ production in non-Th1 cells by repressing T-bet 
expression, we will perform similar analysis by assessing Etv5 binding at the 
Tbx21 locus. We will mate Etv5fl/fl CD4-Cre positive with Tbx21-/- to generate 
Etv5fl/fl Tbx21-/- CD4-Cre positive with Cre-negative littermates as control mice.  
We will examine cytokine production, gene expression, histone modification, and 
the association of histone modifying enzymes at the Tbx21 and Ifng loci using 
wild type, Etv5-deficient, Tbx21-/-, and Tbx21- and Etv5-doubly deficient T cells. 
To determine the function of IFNγ-producing cells in Etv5-mutant mice, we will 
test the ability of Etv5-deficient IFNγ-producing T cells to mediate protective 
function against Listeria monocytogenes or Toxoplasma gondii. We will cross 
Etv5fl/fl CD4-Cre+ mice with IFNγ reporter mice (The Jackson Laboratory) to 
generate Etv5fl/fl CD4-Cre+- IFNγ GFP mice. We will differentiate Th0, Th1, Th2, 
Th9, Th17, and Treg cells in vitro using Etv5fl/fl CD4-Cre+- IFNγ GFP mice, sort 
IFNγ-producing T cells (GFP+), and adoptively transfer to RAG2-/- recipients that 
have been infected with Listeria monocytogenes or Toxoplasma gondii. These 
experiments will allow us to determine whether IFNγ production by Etv5-deficient 
Th1, Th2, Th9, Th17, and Treg cells are capable of promoting protection against 
Listeria monocytogenes or Toxoplasma gondii. 
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In summary, these future studies not only dissect the role of Jmjd3, Twist1 and 
Etv5 in T helper cell subsets but also provide valuable information to the 
understanding of how transcription factor networks regulate T helper cell function 
and their roles in disease models. Different strategies can be employed to target 
transcription factors as a therapeutic approach such as small molecules targeting 
upstream activating pathways of transcription factors and DNA-binding activity. 
Therefore, Twist1 and Etv5 might be potential candidates for future therapy in 
autoimmune diseases and allergic inflammation.  
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